This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Benign neoplasm: Skin of eyelid, including canthus
CD2_BENIGN_SKIN_EYELID
eyelid neoplasm: Tumors of cancer of the EYELIDS.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519870 |
1. Apply sex-specific ruleNone |
519870 |
2. Check conditionsNone |
519870 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
6980 |
4. Check minimum number of eventsNone |
6980 |
5. Include endpointsNone |
6980 |
6. Filter based on genotype QC (FinnGen only) |
6791 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- D23
- Name in latin
- Neoplasma benignum cutis palpebrae
Similar endpoints
↥List of similar endpoints to
Benign neoplasm: Skin of eyelid, including canthus
based on the number of shared cases.
Similar with more cases:
- Other benign neoplasms of skin
- Benign neoplasms
- Neoplasms
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 6791 | 4331 | 2460 |
| Unadjusted period prevalence (%) | 1.39 | 1.54 | 1.13 |
| Median age at first event (years) | 62.36 | 60.60 | 65.46 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 6980
- Matched controls
- 69800
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
CBB99
NOMESCO Finland
Other excision or destruction of lesion of eyelid
40.1
307.7
240
62
CBB50
NOMESCO Finland
Excision of lesion of eyelid and reconstruction using graft or flap
30.6
307.7
217
73
CBA10
NOMESCO Finland
Biopsy of eyelid
73.8
307.7
851
131
D23.1
ICD-10 Finland
Benign neoplasm: Skin of eyelid, including canthus
27586.7
307.7
6819
107
CBB30
NOMESCO Finland
Excision of lesion of eyelid
232.0
307.7
3887
376
C44.11
ICD-10 Finland
Basocellular carcinoma of the skin of the eyelids including the corner of the eye
19.0
307.7
437
244
8090/3-C44.1
ICD-O-3
Basal cell carcinoma, NOS, of eyelid
18.7
257.4
205
113
C44.10
ICD-10 Finland
Malignant tumor of the skin of the eyelids including the corner of the eye without histology
18.6
232.2
185
102
H00.1
ICD-10 Finland
Chalazion
4.0
160.9
482
1270
L82
ICD-10 Finland
Seborrhoeic keratosis
2.0
116.9
1684
9665
R23.8
ICD-10 Finland
Other and unspecified skin changes
1.9
110.5
1840
11054
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.7
104.2
3455
25317
CBB00
NOMESCO Finland
Excision of chalazion
5.9
103.6
187
322
21602
ICD-8 Finland
Benign neoplasm of skin, Palpebrae (cantho incluso)
+∞
102.3
98
*
D22.1
ICD-10 Finland
Melanocytic naevi of eyelid, including canthus
10.4
91.3
101
98
C44.19
ICD-10 Finland
Malignant tumor of the skin of the eyelids including corner of the eye or other unspecified histology
31.3
90.5
59
19
S18
ICPC
Laceration/cut
1.7
89.5
3548
26843
D31.0
ICD-10 Finland
Benign neoplasm: Conjunctiva
7.2
85.8
128
181
XCK10
NOMESCO Finland
Photography of fundus of eye
2.1
76.2
798
4027
CB9S4
NOMESCO Finland
Photography of eyelids and eyebrows
9.8
76.0
88
91
WX110
NOMESCO Finland
Infiltration anesthesia
1.6
74.9
4877
40851
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
2.0
68.5
791
4131
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
2.1
68.0
762
3935
SPAT1153
SPAT
Removal of sutures
1.6
67.2
2319
16606
CBA00
NOMESCO Finland
Incision of eyelid
17.0
65.2
54
32
H02.3
ICD-10 Finland
Blepharochalasis
2.2
63.1
589
2835
3201
FHL
Removal of a small eyelid tumor in the operating room
25.4
61.5
43
17
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
2.2
61.3
591
2879
Z01.0
ICD-10 Finland
Examination of eyes and vision
1.7
56.4
1327
8585
H04.10
ICD-10 Finland
Dry eye syndrome
1.8
55.7
930
5463
F29
ICPC
Eye symptom/complaint other
1.9
55.4
812
4579
H01.0
ICD-10 Finland
Blepharitis
2.2
54.8
517
2494
CFA20
NOMESCO Finland
Biopsy of conjunctiva
10.6
53.2
58
55
S82
ICPC
Naevus/mole
1.7
52.6
1048
6470
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
2.0
49.7
573
2977
ZXA05
NOMESCO Finland
Left side
1.5
48.6
1736
12350
J01DB01
ATC
cefalexin; oral
1.6
48.3
5599
50242
L57.0
ICD-10 Finland
Actinic keratosis
1.8
47.2
875
5282
ZXA00
NOMESCO Finland
Right side
1.5
47.1
1857
13473
S29
ICPC
Skin symptom/complaint other
1.6
47.0
1493
10332
XCW99
NOMESCO Finland
Other investigative procedure of eye
1.8
45.7
819
4895
CD2S4
NOMESCO Finland
Photography of eye
5.8
45.2
82
142
D48.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Skin
2.0
44.9
546
2886
F16
ICPC
Eyelid symptom/complaint
2.2
44.2
414
1988
Z2221
NOMESCO Finland
Medical doctor
1.5
44.2
1788
13015
E0000UV, ,
ATC
1.4
41.9
2788
22253
H02.8
ICD-10 Finland
Other specified disorders of eyelid
6.3
40.6
68
109
H02.0
ICD-10 Finland
Entropion and trichiasis of eyelid
2.9
40.1
192
675
CBB40
NOMESCO Finland
Electrocoagulation of lesion of eyelid
66.1
40.1
46
7
H00.00
ICD-10 Finland
Hordeolum
2.2
40.0
331
1513
M79.6
ICD-10 Finland
Pain in limb
1.4
39.2
2992
24366
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic
1.4
38.9
2369
18543
N02BE01
ATC
paracetamol; systemic, rectal
1.7
38.9
6172
57351
ZXD10
NOMESCO Finland
Scheduled procedure
1.4
38.5
2500
19784
A98
ICPC
Health maint/preventive medicine
2.1
38.3
6634
63009
H02.1
ICD-10 Finland
Ectropion of eyelid
3.9
38.1
114
299
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.4
37.5
2027
15512
CFC00
NOMESCO Finland
Excision of lesion of conjunctiva
6.1
36.1
62
102
SAA01
NOMESCO Finland
Simple examination of mouth
1.4
36.0
4572
40245
R22.9
ICD-10 Finland
Localized swelling, mass and lump, unspecified
1.8
35.8
586
3401
R01AD09
ATC
mometasone; nasal
1.4
35.8
2849
23247
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
1.4
35.5
1980
15205
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.4
34.9
2366
18781
S21
ICPC
Skin texture symptom/complaint
1.5
34.7
1085
7427
TCW99
NOMESCO Finland
Other minor procedure in eye surgery
3.2
33.8
136
433
H02.4
ICD-10 Finland
Ptosis of eyelid
2.4
33.7
241
1034
L72.1
ICD-10 Finland
Trichilemmal cyst
1.9
33.5
473
2623
ZXE00
NOMESCO Finland
One hour or less
1.4
33.4
2453
19692
2161X
ICD-9 Finland
Benign neoplasm of skin, Eyelid, including canthus[SILMÄLUOMEN BEN KASVAIN,TARK MÄÄRITT HYVÄNLAAT KASV]
+∞
33.4
32
*
CK2S4
NOMESCO Finland
Plain photography of ocular fundus
1.8
32.9
477
2667
EB1AA
NOMESCO Finland
Intraoral radiographic dental examination
1.4
32.8
3475
29510
D23.3
ICD-10 Finland
Benign neoplasm: Skin of other and unspecified parts of face
2.4
32.8
226
954
CBB11
NOMESCO Finland
Resection of lax skin in upper eyelid
2.4
32.6
236
1018
ZXA10
NOMESCO Finland
Bilateral
1.5
32.5
1256
8976
SAA02
NOMESCO Finland
Basic examination of mouth
1.4
31.9
4154
36330
UJF32
NOMESCO Finland
Coloscopy
1.4
31.8
1802
13822
WX002
NOMESCO Finland
Sedation and analgesia
1.5
31.4
1295
9371
WX100
NOMESCO Finland
Conjunctival surface anesthesia
1.5
31.0
961
6553
S01GX01
ATC
cromoglicic acid; ophthalmic
1.5
30.9
1241
8927
L17
ICPC
Foot/toe symptom/complaint
1.4
30.8
2089
16503
Z71.8
ICD-10 Finland
Other specified counselling
1.4
30.7
2159
17154
N02AX02
ATC
tramadol; systemic, rectal
1.3
30.4
2834
23507
I10
ICD-10 Finland
Essential (primary) hypertension
1.3
30.2
4312
38078
WZA90
NOMESCO Finland
Other medical or dental certificate
1.4
29.5
1451
10832
CBB10
NOMESCO Finland
Excision of redundant skin of eyelid
2.5
29.1
187
765
S04
ICPC
Lump/swelling localized
1.6
28.7
729
4746
Z01.2
ICD-10 Finland
Dental examination
1.3
28.3
2870
24023
A02BC02
ATC
pantoprazole; systemic
1.3
28.3
4658
41788
H02.9
ICD-10 Finland
Disorder of eyelid, unspecified
5.8
28.0
51
89
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.3
27.8
2602
21510
A02BC05
ATC
esomeprazole; systemic
1.3
27.6
2682
22282
D07AC01
ATC
betamethasone; topical
1.3
27.4
2347
19139
B07.9
ICD-10 Finland
Verruca simplex
2.2
27.2
235
1093
R74
ICPC
Upper respiratory infection acute
1.4
26.8
1812
14242
SFA20
NOMESCO Finland
Two-surface restoration
1.3
26.7
3577
31034
L30.9
ICD-10 Finland
Dermatitis, unspecified
1.4
26.7
1337
9995
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.3
26.4
2809
23593
J01CA04
ATC
amoxicillin; systemic
1.4
26.3
5286
48538
G47.3
ICD-10 Finland
Sleep apnoea
1.4
26.2
1394
10525
SFA10
NOMESCO Finland
One-surface restoration
1.3
26.2
3391
29253
R03AC02
ATC
salbutamol; inhalant
1.3
26.1
3487
30202
SDA03
NOMESCO Finland
Periodontal treatment
1.3
26.0
2482
20522
Z87.1
ICD-10 Finland
Personal history of diseases of the digestive system
1.3
25.8
2670
22318
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
2.1
25.7
234
1111
H01.1
ICD-10 Finland
Noninfectious dermatoses of eyelid
4.9
25.7
56
115
M01AE01
ATC
ibuprofen; systemic, rectal
1.4
25.7
5892
55153
L03
ICPC
Low back symptom/complaint
1.4
25.6
1883
14973
M25.5
ICD-10 Finland
Pain in joint
1.3
25.6
2092
16900
XCC00
NOMESCO Finland
Investigative irrigation of lacrimal passages
3.0
25.6
113
381
J01DA01
ATC
[U] cefalexin
1.3
25.2
3929
34669
ZXC50
NOMESCO Finland
Cryotherapy
2.1
25.2
246
1201
R22.0
ICD-10 Finland
Localized swelling, mass and lump, head
2.1
24.7
238
1156
M03BX02
ATC
tizanidine; oral
1.3
24.7
3867
34102
H01.80
ICD-10 Finland
Prolonged inflammation in the edge of the eyelid
3.4
24.4
88
263
R42
ICD-10 Finland
Dizziness and giddiness
1.4
24.3
1588
12383
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
1.3
23.8
2800
23734
F72
ICPC
Blepharitis/stye/chalazion
2.4
23.8
160
669
R06AE07
ATC
cetirizine; oral
1.3
23.8
2731
23076
C44.51
ICD-10 Finland
Basocellular carcinoma of the skin on the torso
2.1
23.6
231
1128
SDE03
NOMESCO Finland
Periodontal treatment by dental hygienist, extensive
1.4
23.4
1396
10717
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.3
23.2
2772
23517
M54.5
ICD-10 Finland
Low back pain
1.3
23.1
2289
18936
L13
ICPC
Hip symptom/complaint
1.4
23.0
1359
10413
K02.1
ICD-10 Finland
Caries of dentine
1.3
23.0
3528
30897
R06.0
ICD-10 Finland
Dyspnoea
1.3
22.8
1809
14499
TQW99
NOMESCO Finland
Other minor procedure on skin
1.8
22.8
352
2004
QAA25
NOMESCO Finland
Destruction of lesion of head or neck
2.2
22.5
200
941
CK2X4
NOMESCO Finland
Optical coherence tomography (OCT) of ocular fundus
1.5
22.4
657
4409
L01
ICPC
Neck symptom/complaint
1.4
22.3
1022
7496
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
1.5
22.2
660
4441
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
1.4
22.2
1288
9836
E000001, ,
ATC
1.4
22.1
1159
8699
L12
ICPC
Hand/finger symptom/complaint
1.4
22.0
1083
8043
H10.3
ICD-10 Finland
Acute conjunctivitis, unspecified
1.7
21.9
416
2511
SAA03
NOMESCO Finland
Extended examination of mouth
1.3
21.8
2283
18993
CBG00
NOMESCO Finland
Epilation of cilia by electrolysis
5.3
21.8
43
81
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.4
21.6
1154
8688
CJE20
NOMESCO Finland
Phakoemulsification with implantation of artificial lens in posterior chamber
1.3
21.3
2274
18957
C44.30
ICD-10 Finland
Malignant tumor of the skin on another or unspecified part of the face without histology
2.9
21.2
97
334
J01FA10
ATC
azithromycin; systemic
1.3
21.2
3443
30241
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.4
21.2
1364
10580
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
1.7
21.2
448
2783
Z03
ICD-10 Finland
Medical observation and evaluation for suspected diseases and conditions, ruled out
1.6
21.2
501
3200
R01AD08
ATC
fluticasone; nasal
1.3
21.2
1677
13417
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
1.5
20.9
675
4621
KMAK, ,
NOMESCO Finland
1.3
20.8
2986
25816
H10.0
ICD-10 Finland
Mucopurulent conjunctivitis
1.7
20.7
420
2582
L08
ICPC
Shoulder symptom/complaint
1.3
20.6
1491
11763
TQW40, ,
SPAT
1.5
20.6
651
4437
J01AA02
ATC
doxycycline; systemic
1.3
20.6
5140
47542
D07AB02
ATC
hydrocortisone butyrate; topical
1.3
20.5
1824
14816
N02AJ06
ATC
codeine and paracetamol; systemic
1.3
20.5
2674
22836
D23.9
ICD-10 Finland
Benign neoplasm: Skin, unspecified
2.2
20.3
162
731
J20
ICD-10 Finland
Acute bronchitis
1.5
20.1
634
4319
L15
ICPC
Knee symptom/complaint
1.3
20.1
1653
13281
R05
ICD-10 Finland
Cough
1.3
20.0
1362
10641
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.3
19.9
3162
27618
EB1SA
NOMESCO Finland
Dental X-ray, bite-wing X-ray on one side of the mouth
1.3
19.4
2652
22726
K03.64
ICD-10 Finland
Dental calculus supragingival
1.3
19.4
1859
15235
SDE02
NOMESCO Finland
Periodontal treatment by dental hygienist
1.3
19.3
1375
10810
H10.5
ICD-10 Finland
Blepharoconjunctivitis
2.4
19.3
126
521
K03.65
ICD-10 Finland
Deposits [accretions] on teeth betel
1.4
19.3
1274
9905
A02BC03
ATC
lansoprazole; oral
1.3
19.2
1816
14849
R05
ICPC
Cough
1.3
19.2
1557
12474
ZXD20
NOMESCO Finland
Day surgery
1.4
19.1
764
5456
CF2S4
NOMESCO Finland
Photography of conjunctiva
7.2
19.1
28
39
K03.82
ICD-10 Finland
Split tooth for reasons other than trauma
1.3
19.0
1797
14694
M03BC01
ATC
orphenadrine (citrate); systemic
1.3
18.9
1271
9905
R60.0
ICD-10 Finland
Localized oedema
1.4
18.8
853
6231
H25.1
ICD-10 Finland
Senile nuclear cataract
1.3
18.7
1923
15887
M01AH05
ATC
etoricoxib; oral
1.3
18.6
3916
35222
M54.4
ICD-10 Finland
Lumbago with sciatica
1.4
18.5
1107
8467
UJF30
NOMESCO Finland
Ileoscopy through colon
1.5
18.5
664
4642
TQW40
NOMESCO Finland
Remowal of suture of skin
1.6
18.4
442
2831
SDA02
NOMESCO Finland
Periodontal treatment, brief
1.3
18.4
2124
17806
H02.6
ICD-10 Finland
Xanthelasma of eyelid
5.5
18.3
35
64
H02AB06
ATC
prednisolone; systemic
1.3
18.3
3038
26573
A06AC01
ATC
ispaghula (psylla seeds); oral
1.3
18.3
1747
14292
Z01.6
ICD-10 Finland
Radiological examination, not elsewhere classified
1.5
18.3
644
4487
N17
ICPC
Vertigo/dizziness
1.4
18.1
859
6321
D01AC20
ATC
imidazoles/triazoles in combination with corticosteroids; topical
1.3
18.1
1414
11251
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.3
18.1
1394
11071
TCC10
NOMESCO Finland
Probing of lacrimal canaliculus/duct
4.0
18.0
50
125
CBN50
NOMESCO Finland
Excision of tarsus and skin
6.3
18.0
30
48
WX408
NOMESCO Finland
General anesthesy, balanced
1.3
17.9
1545
12466
R07.4
ICD-10 Finland
Chest pain, unspecified
1.3
17.8
1826
15068
QBA25
NOMESCO Finland
Destruction of lesion of skin of trunk
2.3
17.7
134
592
D19
ICPC
Teeth/gum symptom/complaint
1.3
17.5
1784
14698
XCH00
NOMESCO Finland
Eye pressure measurement
1.7
17.5
328
1973
P01AB01
ATC
metronidazole; oral, rectal
1.3
17.5
2456
21037
QAA05
NOMESCO Finland
Incision for biopsy of skin of head or neck
2.1
17.5
172
844
SPAT1312
SPAT
General health counselling
1.3
17.4
1857
15388
CBD11
NOMESCO Finland
Opening of eylid graft or flap
42.1
17.3
21
5
J02AC01
ATC
fluconazole; systemic
1.3
17.2
2392
20461
I78.1
ICD-10 Finland
Naevus, non-neoplastic
2.2
17.1
151
710
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
1.5
17.0
631
4437
M79.1
ICD-10 Finland
Myalgia
1.4
16.9
876
6543
K21.9
ICD-10 Finland
Gastro-oesophageal reflux disease without oesophagitis
1.5
16.7
638
4514
C10AA01
ATC
simvastatin; oral
1.2
16.6
2738
23843
D82
ICPC
Teeth/gum disease
1.3
16.6
2120
17936
R06.5
ICD-10 Finland
Mouth breathing
1.5
16.4
491
3307
SDA04
NOMESCO Finland
Demanding periodontal treatment
1.3
16.3
1661
13663
M02AA07
ATC
piroxicam; topical
1.3
16.3
2279
19471
M70.6
ICD-10 Finland
Trochanteric bursitis
1.4
16.3
909
6869
D18.0
ICD-10 Finland
Haemangioma, any site
2.1
16.2
160
787
D07AC13
ATC
mometasone; topical
1.3
16.1
1710
14139
E78.0
ICD-10 Finland
Pure hypercholesterolaemia
1.3
16.1
1415
11422
C44.12
ICD-10 Finland
Spinocellular carcinoma of the skin of the eyelids including the corner of the eye
16.7
16.0
25
15
A97
ICPC
No disease
1.3
16.0
1230
9749
C10AA05
ATC
atorvastatin; oral
1.2
15.8
2786
24392
Z3229
NOMESCO Finland
Other healthcare associate professional
1.5
15.8
501
3415
R01AD58
ATC
fluticasone, combinations; nasal
1.3
15.8
1347
10826
C05AA08
ATC
fluocortolone; rectal, topical
1.4
15.7
820
6127
D06BB10
ATC
imiquimod; topical
1.6
15.7
325
2009
R01AD12
ATC
fluticasone furoate; nasal
1.3
15.6
1729
14359
H29
ICPC
Ear symptom/complaint other
1.4
15.5
784
5826
C08CA01
ATC
amlodipine; oral
1.2
15.5
2555
22198
Z01.8
ICD-10 Finland
Other specified special examinations
1.3
15.4
1398
11322
C10AA07
ATC
rosuvastatin; oral
1.2
15.3
2162
18459
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
1.4
15.3
811
6071
R01BA52
ATC
pseudoephedrine, combinations; oral
1.3
15.3
1793
14985
J01FF01
ATC
clindamycin; systemic
1.3
15.3
1603
13219
J01MA02
ATC
ciprofloxacin; systemic
1.2
15.3
2417
20899
M51.1
ICD-10 Finland
Lumbar and other intervertebral disc disorders with radiculopathy
1.4
15.1
832
6268
CBN99
NOMESCO Finland
Other operation on eyelid for malposition
3.5
15.1
51
147
R02
ICPC
Shortness of breath/dyspnoea
1.4
14.9
868
6595
H02
ICPC
Hearing complaint
1.3
14.9
967
7470
D01BA02
ATC
terbinafine; oral
1.3
14.9
1504
12344
Z3231
NOMESCO Finland
Registered nurse
1.3
14.8
1616
13384
C10AX09
ATC
ezetimibe; oral
1.3
14.7
1061
8322
C08CA13
ATC
lercanidipine; oral
1.3
14.7
948
7315
D07BC01
ATC
betamethasone and antiseptics; topical
1.4
14.7
688
5044
E78.01
ICD-10 Finland
Pure hypercholesterolaemia
1.3
14.7
1663
13835
H01.89
ICD-10 Finland
Other specified inflammation of eyelids
3.5
14.6
50
145
D01
ICPC
Abdominal pain/cramps general
1.4
14.6
711
5249
S15
ICPC
Foreign body in skin
1.5
14.5
402
2663
D07AB08
ATC
desonide; topical
1.4
14.5
610
4392
D02AE01
ATC
carbamide; topical
1.6
14.5
361
2335
N40
ICD-10 Finland
Hyperplasia of prostate
1.3
14.4
1147
9119
R06AX27
ATC
desloratadine; oral
1.3
14.4
1587
13156
M48.0
ICD-10 Finland
Spinal stenosis
1.4
14.3
792
5970
A01
ICPC
Pain general/multiple sites
1.4
14.3
647
4716
G04CB01
ATC
finasteride; oral
1.4
14.3
573
4089
CBB35
NOMESCO Finland
Cryotherapy of lesion of eyelid
27.2
14.3
19
7
R35
ICD-10 Finland
Polyuria
1.5
14.2
418
2803
CA1CG
NOMESCO Finland
Eye and orbita extensive MRI examination with high intensity magnet
3.1
14.2
58
188
R03DC03
ATC
montelukast; oral
1.3
14.2
948
7351
SFC01
NOMESCO Finland
Additional procedure necessary for restorative treatment
1.3
14.2
1551
12838
SPAT1141
SPAT
Excision of skin or mucous membrane lesion
1.7
14.1
268
1619
R21
ICPC
Throat symptom/complaint
1.3
14.1
1045
8227
SPAT1156
SPAT
Guidance concerning treatment of rash and skin
1.4
14.1
830
6318
CBN30
NOMESCO Finland
Shortening of canthal ligament
3.6
14.1
45
125
D22
ICD-10 Finland
Melanocytic naevi
1.7
14.0
279
1709
Z96.1
ICD-10 Finland
Presence of intraocular lens
1.3
13.9
947
7363
M17.9
ICD-10 Finland
Gonarthrosis, unspecified
1.4
13.9
840
6418
M54
ICD-10 Finland
Dorsalgia
1.4
13.9
682
5041
N62
ICD-10 Finland
Hypertrophy of breast
1.7
13.7
236
1388
R53
ICD-10 Finland
Malaise and fatigue
1.3
13.7
1526
12652
J45
ICD-10 Finland
Asthma
1.4
13.7
603
4374
J01CE02
ATC
phenoxymethylpenicillin; oral
1.2
13.7
4030
36956
SPAT1263
SPAT
Sampling
1.2
13.6
2502
21900
WZB00
NOMESCO Finland
Telephone prescription or other care instructions
1.3
13.6
1653
13843
M01AB05
ATC
diclofenac; systemic, rectal
1.2
13.6
4102
37690
S08
ICPC
Skin colour change
1.6
13.6
354
2313
CBG10
NOMESCO Finland
Cryotherapy for trichiasis
12.0
13.6
24
20
CBW99
NOMESCO Finland
Other operation on eyelid
14.7
13.5
22
15
G44.2
ICD-10 Finland
Tension-type headache
1.4
13.5
775
5871
R52.9
ICD-10 Finland
Pain, unspecified
1.4
13.5
619
4521
K08.80
ICD-10 Finland
Toothache NOS
1.5
13.5
481
3355
SPAT1325
SPAT
Vaccination
1.2
13.5
2049
17583
H92.0
ICD-10 Finland
Otalgia
1.6
13.5
349
2276
N03AX12
ATC
[U] gabapentin; oral
1.3
13.5
971
7610
T82
ICPC
Obesity
1.7
13.3
220
1280
D22.9
ICD-10 Finland
Melanocytic naevi, unspecified
1.6
13.3
284
1769
QAA50
NOMESCO Finland
Cryotherapy of skin of head or neck
2.8
13.3
64
228
CAB00
NOMESCO Finland
Anterior orbitotomy with excision of lesion
21.2
13.3
19
9
C07AB07
ATC
bisoprolol; oral
1.2
13.3
3196
28702
M17.1
ICD-10 Finland
Other primary gonarthrosis
1.3
13.3
1424
11748
K05.10
ICD-10 Finland
Gingivitis (chronic) NOS
1.3
13.3
859
6628
DFF00
NOMESCO Finland
Pure tone audiometry
1.4
13.3
645
4758
R06AX22
ATC
ebastine; oral
1.3
13.2
949
7431
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.2
13.1
1766
14951
G04CA02
ATC
tamsulosin; oral
1.3
13.1
1242
10092
SPAT1144
SPAT
Treatment of reopened or infected surgical wound
1.5
13.1
416
2837
N02BF01
ATC
gabapentin; oral
1.4
13.1
630
4642
J01FA09
ATC
clarithromycin; systemic
1.2
13.0
1788
15165
D31.6
ICD-10 Finland
Benign neoplasm: Orbit, unspecified
5.9
13.0
23
39
ZXE10
NOMESCO Finland
More than one and less than three hours
1.2
13.0
2153
18625
M53.1
ICD-10 Finland
Cervicobrachial syndrome
1.4
13.0
651
4825
SFA30
NOMESCO Finland
Three-surface restoration
1.2
13.0
2509
22041
A02BC04
ATC
rabeprazole; oral
1.4
13.0
510
3622
J01FA06
ATC
roxithromycin; oral
1.2
13.0
2394
20935
N03AX16
ATC
[U] pregabalin
1.3
13.0
1401
11564
L02
ICPC
Back symptom/complaint
1.4
13.0
576
4184
A04
ICPC
Weakness/tiredness general
1.3
13.0
958
7533
H11.3
ICD-10 Finland
Conjunctival haemorrhage
1.6
12.9
276
1722
D11AH01
ATC
tacrolimus; topical
3.0
12.9
56
189
M47.2
ICD-10 Finland
Other spondylosis with radiculopathy
1.5
12.8
382
2572
C09CA06
ATC
candesartan; oral
1.3
12.7
1475
12272
WX006
NOMESCO Finland
Intravenous sedation or analgesia without general anesthesia
1.5
12.7
436
3020
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.2
12.7
3080
27644
SHA01
NOMESCO Finland
Stomatognathic treatment, simple
1.4
12.6
568
4135
L98.9
ICD-10 Finland
Disorder of skin and subcutaneous tissue, unspecified
2.3
12.5
96
428
T90
ICPC
Diabetes non-insulin dependent
1.3
12.4
1505
12579
SPAT1249
SPAT
Treatment-related counselling outside office
1.2
12.4
2289
19997
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
1.3
12.4
738
5622
H00
ICD-10 Finland
Hordeolum and chalazion
2.8
12.4
60
215
SCA01
NOMESCO Finland
Preventive oral health care, short
1.2
12.4
1503
12568
SFA00
NOMESCO Finland
Small restoration
1.3
12.3
798
6157
D22.3
ICD-10 Finland
Melanocytic naevi of other and unspecified parts of face
2.0
12.3
134
685
EBA05
NOMESCO Finland
Complicated extraction of tooth
1.3
12.2
1251
10256
XQ848
NOMESCO Finland
Dermatological photography
1.8
12.2
179
1008
D07AD01
ATC
clobetasol; topical
1.3
12.1
1008
8047
C44.1
ICD-10 Finland
Malignant neoplasm: Skin of eyelid, including canthus
15.9
12.1
19
12
D12.5
ICD-10 Finland
Benign neoplasm: Sigmoid colon
1.6
12.1
266
1671
H02AB04
ATC
methylprednisolone; systemic
1.3
12.1
846
6600
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
1.3
12.1
739
5654
K02.0
ICD-10 Finland
Caries limited to enamel
1.3
12.0
987
7865
H43.8
ICD-10 Finland
Other disorders of vitreous body
1.4
12.0
602
4465
M01AE02
ATC
naproxen; oral, rectal
1.2
11.9
3349
30401
WX290
NOMESCO Finland
Other blockage of nerve
1.2
11.9
2547
22551
D11
ICPC
Diarrhoea
1.4
11.9
633
4741
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
1.3
11.8
911
7198
M01AX05
ATC
glucosamine; oral
1.3
11.8
1273
10493
J45.9
ICD-10 Finland
Asthma, unspecified
1.3
11.8
1139
9266
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
1.8
11.8
187
1078
R4110
NOMESCO Finland
Physiotherapy
1.2
11.7
1669
14190
N06AX11
ATC
mirtazapine; oral
1.2
11.6
2052
17821
D04.1
ICD-10 Finland
Carcinoma in situ: Skin of eyelid, including canthus
16.4
11.6
18
11
-1, ,
NOMESCO Finland
1.2
11.6
1768
15134
TCC30
NOMESCO Finland
Intubation of lacrimal canaliculus/duct
2.7
11.6
60
223
E000002, ,
ATC
1.4
11.6
562
4145
SPAT1310
SPAT
Counselling related to known health issue
1.2
11.5
1836
15786
R04.0
ICD-10 Finland
Epistaxis
1.4
11.5
455
3240
D07BB04
ATC
hydrocortisone butyrate and antiseptics; topical
1.3
11.4
723
5557
WX320
NOMESCO Finland
Spinalanesthesy
1.2
11.4
1512
12750
F03
ICPC
Eye discharge
1.5
11.4
372
2552
J31.0
ICD-10 Finland
Chronic rhinitis
1.4
11.4
464
3321
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.3
11.3
1121
9141
Z01.1
ICD-10 Finland
Examination of ears and hearing
1.3
11.3
860
6780
H26.4
ICD-10 Finland
After-cataract
1.3
11.3
684
5225
K04.5
ICD-10 Finland
Chronic apical periodontitis
1.2
11.2
1570
13309
D07AA02
ATC
hydrocortisone; topical
1.3
11.2
721
5554
R03BA02
ATC
budesonide; inhalant
1.3
11.2
1011
8152
QAE99
NOMESCO Finland
Other excision or repair surgery of skin and subcutaneous tissue in head and neck
1.9
11.2
136
722
WZC00
NOMESCO Finland
Treatment plan or consultation
1.2
11.2
2217
19457
UKC02
NOMESCO Finland
Cystoscopy
1.3
11.2
932
7441
J05AB01
ATC
aciclovir; systemic
1.3
11.1
1290
10714
M17.0
ICD-10 Finland
Primary gonarthrosis, bilateral
1.3
11.1
939
7507
R05FB02
ATC
cough suppressants and expectorants; systemic
1.2
11.1
2271
19985
R83
ICPC
Respiratory infection other
1.3
11.1
1233
10193
M15.9
ICD-10 Finland
Polyarthrosis, unspecified
1.4
11.0
429
3043
H10
ICD-10 Finland
Conjunctivitis
1.5
11.0
363
2497
D23.5
ICD-10 Finland
Benign neoplasm: Skin of trunk
1.9
11.0
134
713
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
1.3
11.0
989
7974
G04CA01
ATC
alfuzosin; oral
1.4
10.9
606
4564
Z00.0
ICD-10 Finland
General medical examination
1.3
10.9
1110
9080
K80
ICPC
Cardiac arrhythmia NOS
1.4
10.9
531
3918
A02BC01
ATC
omeprazole; systemic
1.2
10.9
1638
13986
UJH02
NOMESCO Finland
Anoscopy
1.6
10.7
232
1452
K42.9
ICD-10 Finland
Umbilical hernia without obstruction or gangrene
1.6
10.7
253
1618
CBF20
NOMESCO Finland
Resection of part of tarsus for ectropion
5.6
10.7
20
36
G03CA03
ATC
estradiol; nasal, systemic, rectal, transdermal, vaginal
1.2
10.7
3116
28271
C03EA01
ATC
hydrochlorothiazide and potassium-sparing agents; oral
1.3
10.7
973
7854
UJF45
NOMESCO Finland
Flexible sigmoidoscopy with biopsy
1.4
10.6
485
3539
JN3AD
NOMESCO Finland
Abdominal CT examination
1.3
10.6
786
6173
D06BX01
ATC
metronidazole; topical
1.4
10.6
608
4602
R60.9
ICD-10 Finland
Oedema, unspecified
1.5
10.6
350
2406
UDH02
NOMESCO Finland
Rhinopharyngoscopy
1.5
10.5
357
2467
M02AA10
ATC
ketoprofen; topical
1.3
10.5
956
7714
H13
ICPC
Plugged feeling ear
1.2
10.5
1205
9993
U02
ICPC
Urinary frequency/urgency
1.3
10.5
925
7436
H01
ICPC
Ear pain/earache
1.3
10.4
625
4764
K03.00
ICD-10 Finland
Approximal wear
1.4
10.4
406
2882
D06AX01
ATC
fusidic acid; topical
1.4
10.4
482
3527
M75.1
ICD-10 Finland
Rotator cuff syndrome
1.2
10.4
1527
12998
M01AE03
ATC
ketoprofen; systemic, rectal
1.2
10.4
2200
19393
A10BK01
ATC
dapagliflozin; oral
1.4
10.3
453
3285
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
1.2
10.3
1729
14912
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
1.3
10.3
738
5771
H10.4
ICD-10 Finland
Chronic conjunctivitis
2.5
10.3
61
243
N01
ICPC
Headache
1.4
10.3
543
4059
WW200, ,
SPAT
1.2
10.2
1834
15914
R01AD11
ATC
triamcinolone; nasal
1.4
10.2
459
3341
L20.0
ICD-10 Finland
Besnier prurigo
1.5
10.1
322
2199
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
1.2
10.1
1602
13738
WX105
NOMESCO Finland
Surface analgesia on skin or mucosa
1.4
10.0
534
3996
A08
ICPC
Swelling
1.5
10.0
363
2544
F13
ICPC
Eye sensation abnormal
1.7
10.0
162
941
I84.2
ICD-10 Finland
Internal hemorrhoids without complication
1.4
10.0
410
2939
C44.62
ICD-10 Finland
Spinocellular carcinoma of the skin of the upper extremity including the shoulder
3.3
10.0
37
114
J01EA01
ATC
trimethoprim; systemic
1.2
10.0
1591
13650
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.2
9.9
2273
20155
U07
ICPC
Urine symptom/complaint other
1.4
9.9
523
3907
R4110, ,
SPAT
1.3
9.9
838
6695
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
1.2
9.9
1428
12131
H57.1
ICD-10 Finland
Ocular pain
1.6
9.8
207
1288
QXA25
NOMESCO Finland
Destruction of lesion of skin, site unspecified
1.7
9.8
168
991
CBB30, ,
SPAT
26.0
9.8
13
5
F74
ICPC
Neoplasm of eye/adnexa
20.0
9.8
14
7
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
1.3
9.8
607
4650
R5140
NOMESCO Finland
Monitoring the use of the aid
1.3
9.8
603
4616
S10
ICPC
Boil/carbuncle
1.5
9.8
321
2207
UDQ12
NOMESCO Finland
Flexible laryngoscopy
1.5
9.7
318
2185
XKD00
NOMESCO Finland
Uroflowmetry
1.3
9.7
824
6589
R07.3
ICD-10 Finland
Other chest pain
1.3
9.6
605
4642
H10.1
ICD-10 Finland
Acute atopic conjunctivitis
1.8
9.6
135
751
XCK00
NOMESCO Finland
Perimetry
1.4
9.6
368
2603
Z76.0
ICD-10 Finland
Issue of repeat prescription
1.2
9.6
1544
13244
C44.41
ICD-10 Finland
Basocellular carcinoma of the skin of the scalp and neck
1.9
9.6
109
566
C44.71
ICD-10 Finland
Basocellular carcinoma of the skin of the lower extremity including the hip
2.4
9.6
66
282
SPAT1149
SPAT
Suture or treatment of traumatic wound
1.3
9.6
689
5389
8070/3-C44.9
ICD-O-3
Squamous cell carcinoma, NOS, of skin, NOS
2.0
9.6
100
505
Z3226
NOMESCO Finland
Physiotherapist
1.3
9.6
1018
8364
H04.5
ICD-10 Finland
Stenosis and insufficiency of lacrimal passages
1.8
9.5
135
754
R01AD05
ATC
budesonide; nasal
1.4
9.5
403
2905
R06AX13
ATC
loratadine; oral
1.3
9.5
765
6074
D07CA01
ATC
hydrocortisone and antibiotics; topical
1.3
9.5
674
5263
S12
ICPC
Insect bite/sting
1.4
9.5
521
3919
M03BC51
ATC
orphenadrine, combinations; systemic
1.2
9.4
1508
12930
H81.1
ICD-10 Finland
Benign paroxysmal vertigo
1.3
9.4
638
4949
N64.4
ICD-10 Finland
Mastodynia
1.7
9.4
171
1025
L28
ICPC
Limited function/disability (L)
1.2
9.4
1232
10352
S01GX08
ATC
ketotifen; ophthalmic
1.6
9.4
228
1469
XQ800
NOMESCO Finland
Prick test
1.4
9.4
357
2525
S01GX05
ATC
lodoxamide; ophthalmic
2.1
9.4
82
388
R06AE09
ATC
levocetirizine; oral
1.3
9.4
733
5799
D06
ICPC
Abdominal pain localized other
1.4
9.4
504
3780
R03BA05
ATC
fluticasone; inhalant
1.3
9.3
985
8081
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
1.4
9.3
341
2394
L16
ICPC
Ankle symptom/complaint
1.3
9.3
676
5295
A02BA02
ATC
ranitidine; systemic
1.2
9.3
1132
9438
JHB30
NOMESCO Finland
Rubber band ligature of haemorrhoids or prolapse of mucosa
1.4
9.3
336
2354
Z00.8
ICD-10 Finland
Other general examinations
1.4
9.3
425
3106
M01AC06
ATC
meloxicam; systemic, rectal
1.2
9.2
2190
19454
J05AB11
ATC
valaciclovir; oral
1.3
9.2
840
6774
SDA01
NOMESCO Finland
Periodontal treatment, very brief
1.2
9.2
1508
12956
R03BA08
ATC
ciclesonide; inhalant
1.4
9.2
478
3565
CJB10
NOMESCO Finland
Laser discission of secondary cataract
1.3
9.2
554
4228
SPAT1301
SPAT
No procedures
1.2
9.1
1845
16157
AA1AD
NOMESCO Finland
CT of head and brain
1.2
9.1
1815
15872
H10.9
ICD-10 Finland
Conjunctivitis, unspecified
1.4
9.1
348
2462
C03AA03
ATC
hydrochlorothiazide; oral
1.3
9.1
543
4136
K85
ICPC
Elevated blood pressure
1.2
9.1
1071
8895
D22.5
ICD-10 Finland
Melanocytic naevi of trunk
1.5
9.1
301
2074
DHB00
NOMESCO Finland
Excision of lesion of external nose
2.3
9.1
63
271
A11
ICPC
Chest pain NOS
1.3
9.0
520
3939
C44.21
ICD-10 Finland
Basocellular carcinoma of the skin of the outer ear and the outer ear canal
2.3
9.0
65
284
E66.01
ICD-10 Finland
Obesity due to excess calories
1.4
9.0
462
3441
L90
ICPC
Osteoarthrosis of knee
1.4
9.0
430
3166
NJ2MA
NOMESCO Finland
Measurement of mechanical axis of lower leg with X-ray
1.4
8.9
432
3184
H16.0
ICD-10 Finland
Corneal ulcer
1.5
8.9
249
1655
R96
ICPC
Asthma
1.3
8.9
581
4482
M01AX17
ATC
nimesulide; oral
1.2
8.9
1437
12321
K44.9
ICD-10 Finland
Diaphragmatic hernia without obstruction or gangrene
1.4
8.9
472
3531
J01AA07
ATC
tetracycline; systemic
1.3
8.9
722
5738
H35.31
ICD-10 Finland
Senile macular degeneration (atrophic)(exudative)
1.5
8.9
268
1813
R03AK07
ATC
formoterol and budesonide; inhalant
1.2
8.8
1148
9632
K04.1
ICD-10 Finland
Necrosis of pulp
1.3
8.8
549
4208
S01
ICPC
Pain/tenderness of skin
1.5
8.8
273
1856
EB1VA, ,
NOMESCO Finland
1.2
8.8
967
7973
WZC10
NOMESCO Finland
Written specialist consultation based on a referral from a dentist or a physician
1.5
8.8
238
1574
QDE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in lower limb
1.7
8.8
171
1046
C03CA01
ATC
furosemide; systemic
1.2
8.7
1943
17146
R51.80
ICD-10 Finland
Headache
1.3
8.7
827
6699
NG1AA
NOMESCO Finland
Knee X-ray examination without contrast
1.3
8.7
785
6319
H02AB07
ATC
prednisone; oral
1.3
8.7
771
6193
R22.4
ICD-10 Finland
Localized swelling, mass and lump, lower limb
1.7
8.7
147
866
X58
ICD-10 Finland
Exposure to other specified factors
1.3
8.7
751
6018
215
Kela drug reimbursment
Diabetes, non-insulin-treated
1.2
8.7
1432
12306
SHB00
NOMESCO Finland
Preparing and fitting the occlusal splint in the mouth
1.4
8.6
443
3298
SPAT1220
SPAT
Assessment of need for rehabilitation and/or rehabilitation plan
1.4
8.6
342
2441
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.2
8.5
944
7783
N39.4
ICD-10 Finland
Other specified urinary incontinence
1.3
8.5
604
4714
K30
ICD-10 Finland
Functional dyspepsia
1.3
8.5
642
5053
M15
ICD-10 Finland
Polyarthrosis
1.4
8.5
323
2285
H02.2
ICD-10 Finland
Lagophthalmos
3.3
8.5
31
95
HAD30
NOMESCO Finland
Reduction mammoplasty with transposition of areola
1.6
8.5
188
1188
E66.00
ICD-10 Finland
Metabolic syndrome
1.5
8.4
287
1988
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
1.4
8.4
335
2390
ZZR00
NOMESCO Finland
Flap of skin
1.8
8.4
131
754
H53.1
ICD-10 Finland
Subjective visual disturbances
1.4
8.4
390
2857
L04AA01
ATC
[U] ciclosporin
2.1
8.4
77
372
D04.7
ICD-10 Finland
Carcinoma in situ: Skin of lower limb, including hip
2.6
8.4
48
189
M19.0
ICD-10 Finland
Primary arthrosis of other joints
1.3
8.3
601
4702
2161C
ICD-9 Finland
Benign neoplasm of skin, Eyelid, including canthus[SILMÄLUOMEN BEN KASVAIN,VERRUCA SEBORRHOICA]
+∞
8.3
8
*
2161G
ICD-9 Finland
Benign neoplasm of skin, Eyelid, including canthus[SILMÄLUOMEN BEN KASVAIN,MUU MÄÄR HYVÄNLAAT KASV]
+∞
8.3
8
*
J01DA09
ATC
[U] cefadroxil
1.2
8.3
1434
12364
M17
ICD-10 Finland
Gonarthrosis [arthrosis of knee]
1.3
8.3
683
5435
N77.1*B37.3
ICD-10 Finland
Candidiasis of vulva and vagina
1.9
8.3
99
525
R13
ICD-10 Finland
Dysphagia
1.4
8.3
410
3036
H90.3
ICD-10 Finland
Sensorineural hearing loss, bilateral
1.2
8.3
1091
9167
H10.8
ICD-10 Finland
Other conjunctivitis
2.4
8.2
56
239
R05FA02
ATC
opium derivatives and expectorants; systemic
1.2
8.2
2325
20902
J45.0
ICD-10 Finland
Predominantly allergic asthma
1.4
8.2
438
3282
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.2
8.2
1106
9316
L86
ICPC
Back syndrome with radiating pain
1.4
8.2
351
2539
L02.2
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of trunk
1.5
8.1
237
1592
M01AH01
ATC
celecoxib; oral
1.2
8.1
1055
8849
T83
ICPC
Overweight
1.8
8.1
110
608
D07CC01
ATC
betamethasone and antibiotics; topical
1.3
8.1
663
5275
G04BD12
ATC
mirabegron; oral
1.3
8.1
752
6078
K13.79
ICD-10 Finland
Change in the oral mucosa UNS
1.6
8.0
168
1046
N05CF02
ATC
zolpidem; oral
1.2
8.0
947
7862
F02
ICPC
Red eye
1.5
8.0
238
1605
B02AA02
ATC
tranexamic acid; systemic
1.3
8.0
770
6246
B01AB05
ATC
enoxaparin; parenteral
1.2
8.0
1934
17162
H81
ICPC
Excessive ear wax
1.2
8.0
1054
8851
R5130
NOMESCO Finland
Repair work or maintenance done on the aid
1.5
8.0
213
1404
M19.8
ICD-10 Finland
Other specified arthrosis
1.5
8.0
236
1590
K03.80
ICD-10 Finland
Irradiated enamel
1.5
8.0
273
1894
C07AA05
ATC
propranolol; systemic
1.2
8.0
1051
8828
L85.80
ICD-10 Finland
Hudhorn
2.8
7.9
37
131
R05DA20
ATC
opium alkaloids and derivatives - combinations
1.2
7.9
1406
12152
H11.4
ICD-10 Finland
Other conjunctival vascular disorders and cysts
2.5
7.9
47
189
T93
ICPC
Lipid disorder
1.3
7.9
439
3312
3203
FHL
Eyelid tumor removal and plastic
13.0
7.9
13
10
VALMI, ,
NOMESCO Finland
1.2
7.8
1225
10461
Z01.7
ICD-10 Finland
Laboratory examination
1.2
7.8
938
7799
317
Kela drug reimbursment
Topical pimecrolimus and tacrolimus
2.1
7.8
68
322
JN3BD
NOMESCO Finland
Extensive abdominal CT
1.3
7.8
536
4167
E04
ICD-10 Finland
Other nontoxic goitre
3.4
7.8
27
80
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
1.3
7.8
732
5924
XCD10
NOMESCO Finland
Electrophysiological examination of eye
1.7
7.7
126
736
D07XC01
ATC
betamethasone; topical
1.3
7.7
648
5172
SPAT1256
SPAT
Intramuscular and subcutaneous injection
1.2
7.7
2451
22208
CA1DG
NOMESCO Finland
Eye and orbita very extensive MRI examination with high intensity magnet
6.3
7.7
19
30
P06
ICPC
Sleep disturbance
1.3
7.7
665
5327
WYA10
NOMESCO Finland
Emergency care or similar visit
1.4
7.7
357
2618
SPAT1053
SPAT
Memory test
1.2
7.7
860
7100
M65.3
ICD-10 Finland
Trigger finger
1.5
7.7
260
1802
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
1.3
7.6
514
3984
CS444
NOMESCO Finland
Visual field testing with Octopus automated perimetry
1.6
7.6
187
1210
M54.2
ICD-10 Finland
Cervicalgia
1.3
7.6
429
3242
PA6BD
NOMESCO Finland
Extensive CT of neck arteries
1.5
7.6
205
1356
S01AA01
ATC
chloramphenicol; ophthalmic
1.5
7.6
259
1797
SPA00
NOMESCO Finland
Changing form of teeth in prepation for prosthodontic work
1.5
7.6
231
1567
H93.1
ICD-10 Finland
Tinnitus
1.4
7.6
376
2786
G56.0
ICD-10 Finland
Carpal tunnel syndrome
1.3
7.6
778
6360
M13.9
ICD-10 Finland
Arthritis, unspecified
1.4
7.6
401
3002
CBJ30
NOMESCO Finland
Plastic repair of levator aponeurosis of eyelid
2.8
7.6
36
129
N06AB04
ATC
citalopram; systemic
1.2
7.6
1158
9868
K62.5
ICD-10 Finland
Haemorrhage of anus and rectum
1.4
7.5
314
2259
L60.0
ICD-10 Finland
Ingrowing nail
1.5
7.5
251
1733
NGB20
NOMESCO Finland
Primary total prosthetic replacement of knee joint without patellar part
1.3
7.5
690
5565
SPAT1148
SPAT
Treatment of chronic ulcer or burn
1.3
7.5
756
6163
PG1DE
NOMESCO Finland
Other extensive ultrasound examination of artery
1.5
7.5
257
1783
L84
ICD-10 Finland
Corns and callosities
1.5
7.5
192
1254
R07.0
ICD-10 Finland
Pain in throat
1.4
7.5
336
2447
SBB00
NOMESCO Finland
Clinical photography of mouth and teeth
1.6
7.5
164
1033
H53.9
ICD-10 Finland
Visual disturbance, unspecified
1.5
7.5
208
1383
D01AE16
ATC
amorolfine; topical
1.3
7.5
654
5246
CBJ50
NOMESCO Finland
Operation for ptosis of eyebrow
2.5
7.5
45
182
K05.18
ICD-10 Finland
Chronic gingivitis
1.4
7.5
369
2733
E11
ICD-10 Finland
Type 2 diabetes mellitus
1.2
7.5
894
7432
E000006, ,
ATC
1.4
7.5
365
2699
L04AX01
ATC
azathioprine; systemic
1.5
7.4
207
1378
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
1.3
7.4
464
3560
L05
ICPC
Flank/axilla symptom/complaint
1.4
7.4
355
2615
A03FA02
ATC
cisapride; oral, rectal
1.3
7.4
418
3160
H25.0
ICD-10 Finland
Senile incipient cataract
1.4
7.4
397
2979
D23.4
ICD-10 Finland
Benign neoplasm: Skin of scalp and neck
2.1
7.4
68
330
D17.2
ICD-10 Finland
Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs
1.7
7.3
117
679
X15
ICPC
Vaginal symptom/complaint other
1.6
7.3
174
1118
D12.6
ICD-10 Finland
Benign neoplasm: Colon, unspecified
1.4
7.3
307
2211
E66.8
ICD-10 Finland
Other obesity
1.4
7.3
260
1819
JFA15
NOMESCO Finland
Endoscopic polypectomy in colon
1.4
7.3
349
2572
M75.4
ICD-10 Finland
Impingement syndrome of shoulder
1.4
7.3
377
2813
L14
ICPC
Leg/thigh symptom/complaint
1.3
7.3
467
3597
H04.2
ICD-10 Finland
Epiphora
2.4
7.3
49
209
J30.10
ICD-10 Finland
Allergic rhinitis due to pollen
1.5
7.2
220
1492
T78.4
ICD-10 Finland
Allergy, unspecified
1.5
7.2
210
1413
I84.5
ICD-10 Finland
External hemorrhoids without complication
1.6
7.2
156
983
K03.66
ICD-10 Finland
Tooth plaque
1.3
7.1
411
3117
NG1AE
NOMESCO Finland
Knee joint ultrasound exmination
2.0
7.1
74
375
H40.13
ICD-10 Finland
Chronic glaucoma with open ventricular angle
1.4
7.1
274
1945
S79
ICPC
Neoplasm skin benign/unspecified
1.8
7.1
101
567
346
Kela drug reimbursment
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)
1.4
7.1
286
2048
J32.0
ICD-10 Finland
Chronic maxillary sinusitis
1.3
7.1
393
2964
285
Kela drug reimbursment
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)
1.4
7.1
307
2226
C10AA04
ATC
fluvastatin; oral
1.3
7.1
494
3850
I25
ICD-10 Finland
Chronic ischaemic heart disease
1.4
7.1
253
1773
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
1.2
7.0
1081
9209
205
Kela drug reimbursment
Chronic hypertension
1.2
7.0
1593
14039
WX199
NOMESCO Finland
Other local analgesia
1.5
7.0
193
1282
L04
ICPC
Chest symptom/complaint
1.4
7.0
350
2596
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
1.2
7.0
1431
12505
EB4VA, ,
NOMESCO Finland
1.2
7.0
845
7030
H02BX01
ATC
methylprednisolone, combinations; systemic
1.4
7.0
283
2028
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
1.3
7.0
599
4794
M67.4
ICD-10 Finland
Ganglion
1.4
7.0
350
2600
NE1BG
NOMESCO Finland
Pelvic, hip and femur MRI examination with high intensity magnet
1.6
7.0
173
1125
M20.1
ICD-10 Finland
Hallux valgus (acquired)
1.3
6.9
492
3842
N05CF01
ATC
zopiclone; oral
1.2
6.9
1920
17186
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
1.4
6.9
276
1972
R10.1
ICD-10 Finland
Pain localized to upper abdomen
1.2
6.9
1019
8647
G45.0
ICD-10 Finland
Vertebro-basilar artery syndrome
1.6
6.9
141
876
H18.6
ICD-10 Finland
Keratoconus
2.9
6.9
31
108
R01AD01
ATC
beclometasone; nasal
1.2
6.9
800
6629
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
1.5
6.9
221
1518
NK4EA, ,
SPAT
3.2
6.8
26
82
ZXD31
NOMESCO Finland
Major difficulties in performing procedure
1.6
6.8
160
1027
C03DA01
ATC
spironolactone; oral
1.2
6.8
708
5794
Z97.4
ICD-10 Finland
Presence of external hearing-aid
1.4
6.8
285
2055
Z01.5
ICD-10 Finland
Diagnostic skin and sensitization tests
1.3
6.8
452
3500
N92.0
ICD-10 Finland
Excessive and frequent menstruation with regular cycle
1.3
6.8
388
2941
B01AC04
ATC
clopidogrel; oral
1.2
6.8
944
7967
J30.3
ICD-10 Finland
Other allergic rhinitis
1.6
6.8
161
1037
X59
ICD-10 Finland
Exposure to unspecified factor
1.2
6.8
1023
8702
I84.9
ICD-10 Finland
Unspecified hemorrhoids without complication
1.4
6.8
243
1705
WZC00, ,
SPAT
1.2
6.7
815
6779
P20
ICPC
Memory disturbance
1.2
6.7
891
7479
E000007, ,
ATC
1.4
6.7
254
1797
CBF10
NOMESCO Finland
Shortening of canthal ligaments and tarsal plate for ectropion
3.6
6.7
21
58
K58.9
ICD-10 Finland
Irritable bowel syndrome without diarrhoea
1.5
6.7
172
1127
R03BA01
ATC
beclometasone; inhalant
1.2
6.7
756
6245
I87.2
ICD-10 Finland
Venous insufficiency (chronic)(peripheral)
1.2
6.7
676
5516
NA7BT
NOMESCO Finland
Injection to spinal facet joint with radiological guidance
2.9
6.7
29
99
R03BB04
ATC
tiotropium bromide; inhalant
1.3
6.7
549
4371
I50
ICD-10 Finland
Heart failure
1.5
6.7
170
1112
A10BA02
ATC
metformin; oral
1.2
6.7
1650
14638
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
1.3
6.6
442
3423
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
1.3
6.6
373
2820
D31.9
ICD-10 Finland
Benign neoplasm: Eye, unspecified
5.9
6.6
17
29
M72.2
ICD-10 Finland
Plantar fascial fibromatosis
1.3
6.6
429
3313
H66
ICD-10 Finland
Suppurative and unspecified otitis media
1.7
6.6
103
596
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
1.2
6.6
671
5481
CBJ40
NOMESCO Finland
Resection of levator muscle of eyelid
2.2
6.6
49
219
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
1.2
6.5
724
5967
R31
ICD-10 Finland
Unspecified haematuria
1.3
6.5
545
4347
J02AC02
ATC
itraconazole; systemic
1.2
6.5
960
8142
M23.9
ICD-10 Finland
Internal derangement of knee, unspecified
1.3
6.5
465
3635
D23
ICD-10 Finland
Other benign neoplasms of skin
1.7
6.5
110
650
NA3CG
NOMESCO Finland
Lumbar spine extensive MRI examination with high intensity magnet
1.5
6.5
211
1452
M51.3
ICD-10 Finland
Other specified intervertebral disc degeneration
1.3
6.5
435
3373
XF400
NOMESCO Finland
ECG with 12 standard connections
1.2
6.5
848
7111
CBH99
NOMESCO Finland
Other operation on canthus
69.9
6.4
7
*
K59.09
ICD-10 Finland
Constipation, unspecified
1.3
6.4
394
3018
K07
ICPC
Swollen ankles/oedema
1.4
6.4
283
2060
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
1.5
6.4
163
1067
A10BJ06
ATC
semaglutide; parenteral
1.4
6.4
263
1892
M54.3
ICD-10 Finland
Sciatica
1.4
6.4
323
2404
SPAT1283
SPAT
Restricted health certificate
1.3
6.4
631
5137
CA1CM
NOMESCO Finland
Eye and orbita extensive MRI examination with 3 Tesla magnet
3.7
6.4
19
51
M23.2
ICD-10 Finland
Derangement of meniscus due to old tear or injury
1.3
6.3
591
4777
R23
ICD-10 Finland
Other skin changes
2.0
6.3
66
336
C44.81
ICD-10 Finland
Overall basocellular carcinoma of the skin
2.7
6.3
32
119
J37.0
ICD-10 Finland
Chronic laryngitis
1.5
6.3
169
1118
D04.5
ICD-10 Finland
Carcinoma in situ: Skin of trunk
2.1
6.3
55
262
SPAT1043
SPAT
Audiometry
1.3
6.3
583
4709
K05.30
ICD-10 Finland
Periodontitis complex
1.2
6.3
833
6997
SPAT1216
SPAT
Assessment of functional ability
1.2
6.2
907
7685
XW000
NOMESCO Finland
Bone marrow biopsy
1.5
6.2
213
1482
Z03.8
ICD-10 Finland
Observation for other suspected diseases and conditions
1.5
6.2
204
1409
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
1.3
6.2
493
3911
XQ802
NOMESCO Finland
Epicutan test
1.5
6.2
190
1295
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
1.3
6.2
412
3194
XQ845
NOMESCO Finland
Dermatoscopy
1.7
6.1
108
646
K62.3
ICD-10 Finland
Rectal prolapse
1.9
6.1
75
403
8090/3-C44.5
ICD-O-3
Basal cell carcinoma, NOS, of skin of trunk
1.8
6.1
88
497
ZXC15
NOMESCO Finland
Use of photodynamic technique
1.8
6.1
80
439
UJD02
NOMESCO Finland
Gastroscopy
1.4
6.1
249
1788
D02
ICPC
Abdominal pain epigastric
1.3
6.1
334
2516
SGA01
NOMESCO Finland
Emergency treatment
1.2
6.1
747
6221
QCE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in upper limb
1.6
6.1
143
919
OAB42, ,
SPAT
1.2
6.1
684
5645
K07.60
ICD-10 Finland
Snapping jaw
1.4
6.1
235
1672
C44.61
ICD-10 Finland
Basocellular carcinoma of the skin of the upper extremity including the shoulder
2.0
6.1
64
327
L85.3
ICD-10 Finland
Xerosis cutis
2.0
6.1
64
327
K58.0
ICD-10 Finland
Irritable bowel syndrome with diarrhoea
1.4
6.1
268
1951
R00.2
ICD-10 Finland
Palpitations
1.3
6.1
413
3209
K50.0
ICD-10 Finland
Crohn disease of small intestine
1.9
6.1
70
369
C69.00
ICD-10 Finland
Malignant tumor of the conjunctiva without histology
12.5
6.1
10
8
D12.0
ICD-10 Finland
Benign neoplasm: Caecum
1.6
6.0
144
930
F32.9
ICD-10 Finland
Depressive episode, unspecified
1.3
6.0
575
4662
G03DB01
ATC
dydrogesterone; oral
1.2
6.0
607
4953
TimeCodeWAS
↥TODO / Current known limitations:
- Only showing the top 300 codes, because showing all (sometimes 20k) makes the page too slow.
- Legend / how to read the glyphs.
- Show details (e.g. Fisher or Chi-square test, LR+, etc.) when clicking on a row.
- Explanation on the underlying data / how the TimeCodeWAS is done (e.g. matched cases / controls, eligibility).
- Download CSV.
- No filters and sorters.
- Limited amount of endpoints (~400) having TimeCodeWAS data.
- Cross-links to Risteys lab test pages for lab test codes.
OMOP concept
ln(OR)
%cases with code / %controls with code
2×2 table
Benign neoplasm: Skin of eyelid, including canthus
D23.1 [45600585]
D23.1 [45600585]
2.1e+00
5.3e+00
1.0e+50
1.0e+50
1.0e+50
7.7e+00
5.4e+00
cases:0.17%
controls:0.02%
cases:1.48%
controls:0.01%
cases:0.86%
controls:0.00%
cases:98.13%
controls:0.00%
cases:18.40%
controls:0.00%
cases:18.23%
controls:0.01%
cases:5.73%
controls:0.03%
12
14
6873
68795
102
5
6785
68817
59
0
6828
68822
6758
0
129
68822
1266
0
5615
68716
1231
7
5522
67071
332
15
5465
56537
Ophthalmology
18 [38004463]
18 [38004463]
3.2e-01
1.1e+00
1.7e+00
1.1e+01
3.1e+00
1.8e+00
6.3e-01
cases:20.94%
controls:16.14%
cases:18.60%
controls:7.33%
cases:6.64%
controls:1.34%
cases:95.64%
controls:0.05%
cases:23.72%
controls:1.37%
cases:31.75%
controls:7.43%
cases:30.98%
controls:19.33%
1442
11103
5443
57706
1281
5044
5606
63778
457
920
6430
67902
6587
35
300
68787
1632
941
5249
67775
2144
4985
4609
62093
1796
10933
4001
45619
Basocellular carcinoma of the skin of the eyelids including the corner of the eye
C44.11 [2000500784]
C44.11 [2000500784]
1.8e+00
2.8e+00
—
1.0e+50
5.4e+00
4.9e+00
3.2e+00
cases:0.41%
controls:0.07%
cases:0.62%
controls:0.04%
—
—
cases:0.57%
controls:0.00%
cases:1.66%
controls:0.01%
cases:4.49%
controls:0.04%
cases:2.12%
controls:0.09%
28
47
6857
68762
43
26
6844
68796
—
39
0
6848
68822
114
5
6767
68711
303
24
6450
67054
123
51
5674
56501
Excision of lesion of eyelid
CBB30 [2001300933]
CBB30 [2001300933]
1.7e+00
3.1e+00
1.0e+50
1.0e+50
—
6.1e+00
3.4e+00
cases:0.49%
controls:0.09%
cases:0.58%
controls:0.03%
cases:0.70%
controls:0.00%
cases:43.08%
controls:0.00%
—
—
cases:8.78%
controls:0.02%
cases:2.33%
controls:0.08%
34
60
6851
68749
40
18
6847
68804
48
0
6839
68822
2967
0
3920
68822
—
593
15
6160
67063
135
43
5662
56509
Tissue Pathology biopsy report
66121-5 [40768804]
66121-5 [40768804]
2.2e-01
5.4e-01
1.4e+00
7.7e+00
2.1e+00
1.1e+00
7.2e-01
cases:9.59%
controls:7.83%
cases:4.79%
controls:2.85%
cases:1.25%
controls:0.32%
cases:13.05%
controls:0.01%
cases:2.08%
controls:0.26%
cases:7.48%
controls:2.50%
cases:15.11%
controls:7.99%
660
5387
6225
63422
330
1963
6557
66859
86
218
6801
68604
899
5
5988
68817
143
177
6738
68539
505
1675
6248
65403
876
4517
4921
52035
Medical doctor
Z2221 [2001311556]
Z2221 [2001311556]
5.3e-01
7.2e-01
9.9e-01
6.7e+00
1.4e+00
1.1e+00
8.6e-01
cases:7.36%
controls:4.47%
cases:2.90%
controls:1.43%
cases:0.55%
controls:0.20%
cases:5.71%
controls:0.01%
cases:0.76%
controls:0.18%
cases:3.58%
controls:1.26%
cases:7.14%
controls:3.14%
507
3077
6378
65732
200
985
6687
67837
38
141
6849
68681
393
5
6494
68817
52
124
6829
68592
242
844
6511
66234
414
1774
5383
54778
Chalazion
H00.1 [45542919]
H00.1 [45542919]
1.2e+00
3.2e+00
—
1.0e+50
3.8e+00
2.5e+00
1.4e+00
cases:0.89%
controls:0.27%
cases:2.15%
controls:0.09%
—
—
cases:0.51%
controls:0.00%
cases:0.41%
controls:0.01%
cases:0.74%
controls:0.06%
cases:1.17%
controls:0.30%
61
186
6824
68623
148
60
6739
68762
—
35
0
6852
68822
28
6
6853
68710
50
43
6703
67035
68
168
5729
56384
Entropion and trichiasis of eyelid
H02.0 [45595977]
H02.0 [45595977]
6.9e-01
1.7e+00
2.9e+00
1.0e+50
3.4e+00
2.0e+00
1.1e+00
cases:0.38%
controls:0.19%
cases:0.44%
controls:0.08%
cases:0.19%
controls:0.01%
cases:0.46%
controls:0.00%
cases:0.26%
controls:0.01%
cases:0.67%
controls:0.09%
cases:0.81%
controls:0.26%
26
131
6859
68678
30
53
6857
68769
13
7
6874
68815
32
0
6855
68822
18
6
6863
68710
45
59
6708
67019
47
148
5750
56404
Eye symptom/complaint other
F29 [2002000412]
F29 [2002000412]
5.0e-01
1.7e+00
2.5e+00
3.1e+00
1.8e+00
8.7e-01
4.4e-01
cases:1.58%
controls:0.97%
cases:1.87%
controls:0.35%
cases:0.38%
controls:0.03%
cases:0.16%
controls:0.01%
cases:0.32%
controls:0.06%
cases:0.78%
controls:0.33%
cases:2.14%
controls:1.39%
109
665
6776
68144
129
243
6758
68579
26
21
6861
68801
11
5
6876
68817
22
38
6859
68678
53
222
6700
66856
124
787
5673
55765
Ectropion of eyelid
H02.1 [45533184]
H02.1 [45533184]
1.1e+00
1.9e+00
—
1.0e+50
3.2e+00
2.7e+00
1.4e+00
cases:0.25%
controls:0.08%
cases:0.22%
controls:0.03%
—
—
cases:0.23%
controls:0.00%
cases:0.17%
controls:0.01%
cases:0.41%
controls:0.03%
cases:0.41%
controls:0.10%
17
57
6868
68752
15
22
6872
68800
—
16
0
6871
68822
12
5
6869
68711
28
18
6725
67060
24
58
5773
56494
Other investigative procedure of eye
XCW99 [2001301491]
XCW99 [2001301491]
4.3e-01
1.2e+00
1.3e+00
4.7e+00
1.2e+00
1.0e+00
4.8e-01
cases:2.50%
controls:1.63%
cases:1.89%
controls:0.59%
cases:0.32%
controls:0.09%
cases:0.81%
controls:0.01%
cases:0.29%
controls:0.09%
cases:1.57%
controls:0.57%
cases:2.74%
controls:1.72%
172
1125
6713
67684
130
406
6757
68416
22
62
6865
68760
56
5
6831
68817
20
62
6861
68654
106
384
6647
66694
159
974
5638
55578
Blepharochalasis
H02.3 [45586340]
H02.3 [45586340]
7.3e-01
1.8e+00
2.6e+00
—
2.3e+00
2.0e+00
8.5e-01
cases:1.31%
controls:0.64%
cases:1.25%
controls:0.21%
cases:0.41%
controls:0.03%
—
—
cases:0.33%
controls:0.03%
cases:1.55%
controls:0.22%
cases:1.86%
controls:0.81%
90
438
6795
68371
86
145
6801
68677
28
21
6859
68801
—
23
23
6858
68693
105
149
6648
66929
108
456
5689
56096
chloramphenicol
S02AA01 [21605147]
S02AA01 [21605147]
8.0e-01
1.9e+00
2.3e+00
1.0e+50
2.8e+00
1.5e+00
8.4e-01
cases:2.51%
controls:1.15%
cases:2.53%
controls:0.39%
cases:0.54%
controls:0.06%
cases:1.19%
controls:0.00%
cases:0.68%
controls:0.04%
cases:1.76%
controls:0.40%
cases:3.11%
controls:1.36%
173
790
6712
68019
174
265
6713
68557
37
38
6850
68784
82
0
6805
68822
47
29
6834
68687
119
268
6634
66810
180
771
5617
55781
chloramphenicol; ointment
D06AX02 [21602063]
D06AX02 [21602063]
8.0e-01
1.9e+00
2.3e+00
1.0e+50
2.8e+00
1.5e+00
8.4e-01
cases:2.51%
controls:1.15%
cases:2.53%
controls:0.39%
cases:0.54%
controls:0.06%
cases:1.19%
controls:0.00%
cases:0.68%
controls:0.04%
cases:1.76%
controls:0.40%
cases:3.11%
controls:1.36%
173
790
6712
68019
174
265
6713
68557
37
38
6850
68784
82
0
6805
68822
47
29
6834
68687
119
268
6634
66810
180
771
5617
55781
chloramphenicol
G01AA05 [21602367]
G01AA05 [21602367]
8.0e-01
1.9e+00
2.3e+00
1.0e+50
2.8e+00
1.5e+00
8.4e-01
cases:2.51%
controls:1.15%
cases:2.53%
controls:0.39%
cases:0.54%
controls:0.06%
cases:1.19%
controls:0.00%
cases:0.68%
controls:0.04%
cases:1.76%
controls:0.40%
cases:3.11%
controls:1.36%
173
790
6712
68019
174
265
6713
68557
37
38
6850
68784
82
0
6805
68822
47
29
6834
68687
119
268
6634
66810
180
771
5617
55781
chloramphenicol
D10AF03 [21602307]
D10AF03 [21602307]
8.0e-01
1.9e+00
2.3e+00
1.0e+50
2.8e+00
1.5e+00
8.4e-01
cases:2.51%
controls:1.15%
cases:2.53%
controls:0.39%
cases:0.54%
controls:0.06%
cases:1.19%
controls:0.00%
cases:0.68%
controls:0.04%
cases:1.76%
controls:0.40%
cases:3.11%
controls:1.36%
173
790
6712
68019
174
265
6713
68557
37
38
6850
68784
82
0
6805
68822
47
29
6834
68687
119
268
6634
66810
180
771
5617
55781
Blepharitis
H01.0 [45533180]
H01.0 [45533180]
7.9e-01
1.8e+00
2.8e+00
1.0e+50
2.2e+00
1.4e+00
9.4e-01
cases:1.12%
controls:0.51%
cases:1.18%
controls:0.20%
cases:0.26%
controls:0.02%
cases:0.35%
controls:0.00%
cases:0.17%
controls:0.02%
cases:0.87%
controls:0.21%
cases:1.85%
controls:0.73%
77
350
6808
68459
81
135
6806
68687
18
11
6869
68811
24
0
6863
68822
12
13
6869
68703
59
141
6694
66937
107
413
5690
56139
Outpatient Visit
OP [9202]
OP [9202]
3.5e-01
4.5e-01
4.9e-01
6.3e+00
1.2e+00
6.5e-01
5.8e-01
cases:78.13%
controls:71.57%
cases:61.87%
controls:50.73%
cases:16.09%
controls:10.49%
cases:72.18%
controls:0.49%
cases:26.87%
controls:10.35%
cases:65.87%
controls:50.11%
cases:86.75%
controls:78.52%
5379
49247
1506
19562
4261
34915
2626
33907
1108
7222
5779
61600
4971
334
1916
68488
1849
7114
5032
61602
4448
33611
2305
33467
5029
44406
768
12146
Ptosis of eyelid
H02.4 [45605583]
H02.4 [45605583]
6.0e-01
1.9e+00
2.2e+00
—
2.7e+00
2.0e+00
1.1e+00
cases:0.48%
controls:0.26%
cases:0.77%
controls:0.11%
cases:0.16%
controls:0.02%
—
—
cases:0.23%
controls:0.02%
cases:0.73%
controls:0.10%
cases:0.93%
controls:0.32%
33
181
6852
68628
53
78
6834
68744
11
12
6876
68810
—
16
11
6865
68705
49
65
6704
67013
54
180
5743
56372
dexamethasone
C05AA09 [21601613]
C05AA09 [21601613]
7.7e-01
1.8e+00
2.2e+00
1.0e+50
2.6e+00
1.3e+00
7.1e-01
cases:2.51%
controls:1.18%
cases:2.73%
controls:0.47%
cases:0.55%
controls:0.06%
cases:1.19%
controls:0.00%
cases:0.68%
controls:0.05%
cases:1.91%
controls:0.52%
cases:3.57%
controls:1.79%
173
809
6712
68000
188
321
6699
68501
38
42
6849
68780
82
0
6805
68822
47
36
6834
68680
129
347
6624
66731
207
1010
5590
55542
dexamethasone
D07AB19 [21602116]
D07AB19 [21602116]
7.7e-01
1.8e+00
2.2e+00
1.0e+50
2.6e+00
1.3e+00
7.1e-01
cases:2.51%
controls:1.18%
cases:2.73%
controls:0.47%
cases:0.55%
controls:0.06%
cases:1.19%
controls:0.00%
cases:0.68%
controls:0.05%
cases:1.91%
controls:0.52%
cases:3.57%
controls:1.79%
173
809
6712
68000
188
321
6699
68501
38
42
6849
68780
82
0
6805
68822
47
36
6834
68680
129
347
6624
66731
207
1010
5590
55542
dexamethasone
S02BA06 [21605168]
S02BA06 [21605168]
7.7e-01
1.8e+00
2.2e+00
1.0e+50
2.6e+00
1.3e+00
7.1e-01
cases:2.51%
controls:1.18%
cases:2.73%
controls:0.47%
cases:0.55%
controls:0.06%
cases:1.19%
controls:0.00%
cases:0.68%
controls:0.05%
cases:1.91%
controls:0.52%
cases:3.57%
controls:1.79%
173
809
6712
68000
188
321
6699
68501
38
42
6849
68780
82
0
6805
68822
47
36
6834
68680
129
347
6624
66731
207
1010
5590
55542
dexamethasone
D10AA03 [21602286]
D10AA03 [21602286]
7.7e-01
1.8e+00
2.2e+00
1.0e+50
2.6e+00
1.3e+00
7.1e-01
cases:2.51%
controls:1.18%
cases:2.73%
controls:0.47%
cases:0.55%
controls:0.06%
cases:1.19%
controls:0.00%
cases:0.68%
controls:0.05%
cases:1.91%
controls:0.52%
cases:3.57%
controls:1.79%
173
809
6712
68000
188
321
6699
68501
38
42
6849
68780
82
0
6805
68822
47
36
6834
68680
129
347
6624
66731
207
1010
5590
55542
dexamethasone; local oral
A01AC02 [21600035]
A01AC02 [21600035]
7.6e-01
1.8e+00
2.2e+00
1.0e+50
2.5e+00
1.3e+00
7.1e-01
cases:2.60%
controls:1.23%
cases:2.74%
controls:0.47%
cases:0.57%
controls:0.06%
cases:1.19%
controls:0.00%
cases:0.68%
controls:0.05%
cases:1.95%
controls:0.52%
cases:3.59%
controls:1.80%
179
845
6706
67964
189
326
6698
68496
39
43
6848
68779
82
0
6805
68822
47
37
6834
68679
132
351
6621
66727
208
1018
5589
55534
Clinical & Laboratory Dermatological Immunology Physician
207NI0002X [38003841]
207NI0002X [38003841]
5.5e-01
7.9e-01
1.1e+00
4.1e+00
1.1e+00
9.0e-01
7.3e-01
cases:11.52%
controls:7.02%
cases:6.19%
controls:2.90%
cases:1.54%
controls:0.51%
cases:1.48%
controls:0.03%
cases:1.35%
controls:0.47%
cases:6.89%
controls:2.93%
cases:14.11%
controls:7.31%
793
4828
6092
63981
426
1999
6461
66823
106
354
6781
68468
102
18
6785
68804
93
325
6788
68391
465
1966
6288
65112
818
4132
4979
52420
chloramphenicol
S01AA01 [21603554]
S01AA01 [21603554]
5.7e-01
1.5e+00
2.1e+00
—
2.8e+00
1.6e+00
6.2e-01
cases:11.42%
controls:6.82%
cases:9.63%
controls:2.41%
cases:2.47%
controls:0.30%
—
—
cases:4.43%
controls:0.29%
cases:10.87%
controls:2.46%
cases:15.06%
controls:8.70%
786
4691
6099
64118
663
1662
6224
67160
170
204
6717
68618
—
305
197
6576
68519
734
1651
6019
65427
873
4921
4924
51631
chloramphenicol
S03AA08 [21605197]
S03AA08 [21605197]
5.7e-01
1.5e+00
2.1e+00
—
2.8e+00
1.6e+00
6.2e-01
cases:11.42%
controls:6.82%
cases:9.63%
controls:2.41%
cases:2.47%
controls:0.30%
—
—
cases:4.43%
controls:0.29%
cases:10.87%
controls:2.46%
cases:15.06%
controls:8.70%
786
4691
6099
64118
663
1662
6224
67160
170
204
6717
68618
—
305
197
6576
68519
734
1651
6019
65427
873
4921
4924
51631
dexamethasone and antiinfectives
S01CA01 [21603652]
S01CA01 [21603652]
7.7e-01
1.7e+00
2.2e+00
1.0e+50
2.4e+00
1.3e+00
7.1e-01
cases:2.95%
controls:1.38%
cases:2.93%
controls:0.52%
cases:0.57%
controls:0.07%
cases:1.19%
controls:0.00%
cases:0.68%
controls:0.06%
cases:2.03%
controls:0.57%
cases:3.93%
controls:1.98%
203
953
6682
67856
202
360
6685
68462
39
45
6848
68777
82
0
6805
68822
47
41
6834
68675
137
381
6616
66697
228
1120
5569
55432
Benign neoplasm: Conjunctiva
D31.0 [45576386]
D31.0 [45576386]
1.3e+00
3.3e+00
—
1.0e+50
—
3.7e+00
1.8e+00
cases:0.16%
controls:0.05%
cases:0.35%
controls:0.01%
—
—
cases:0.22%
controls:0.00%
—
—
cases:0.49%
controls:0.01%
cases:0.29%
controls:0.05%
11
31
6874
68778
24
9
6863
68813
—
15
0
6872
68822
—
33
8
6720
67070
17
28
5780
56524
Infiltration anesthesia
WX110 [2001310767]
WX110 [2001310767]
1.8e-01
2.9e-01
7.0e-01
5.4e+00
1.1e+00
7.2e-01
3.5e-01
cases:19.22%
controls:16.63%
cases:8.65%
controls:6.61%
cases:1.64%
controls:0.82%
cases:7.36%
controls:0.03%
cases:2.41%
controls:0.84%
cases:12.71%
controls:6.62%
cases:25.38%
controls:19.35%
1323
11441
5562
57368
596
4549
6291
64273
113
563
6774
68259
507
24
6380
68798
166
580
6715
68136
858
4441
5895
62637
1471
10941
4326
45611
Malignant tumor of the skin of the eyelids including the corner of the eye without histology
C44.10 [2000500783]
C44.10 [2000500783]
1.7e+00
4.1e+00
1.0e+50
1.0e+50
—
—
2.9e+00
cases:0.17%
controls:0.03%
cases:0.45%
controls:0.01%
cases:0.30%
controls:0.00%
cases:0.23%
controls:0.00%
—
—
—
—
cases:0.55%
controls:0.03%
12
23
6873
68786
31
5
6856
68817
21
0
6866
68822
16
0
6871
68822
—
—
32
17
5765
56535
Basal cell carcinoma, NOS, of skin, NOS
8090/3-C44.9 [44505057]
8090/3-C44.9 [44505057]
6.2e-01
1.2e+00
2.0e+00
1.0e+50
3.3e+00
1.0e+00
4.7e-01
cases:1.13%
controls:0.61%
cases:0.52%
controls:0.16%
cases:0.17%
controls:0.02%
cases:1.34%
controls:0.00%
cases:0.47%
controls:0.02%
cases:0.49%
controls:0.17%
cases:1.17%
controls:0.74%
78
420
6807
68389
36
110
6851
68712
12
16
6875
68806
92
0
6795
68822
32
12
6849
68704
33
116
6720
66962
68
418
5729
56134
combinations of corticosteroids
D07XB30 [21602188]
D07XB30 [21602188]
4.1e-01
7.2e-01
9.1e-01
4.5e+00
9.6e-01
5.9e-01
5.0e-01
cases:15.82%
controls:11.11%
cases:7.78%
controls:3.93%
cases:1.36%
controls:0.55%
cases:1.25%
controls:0.01%
cases:1.31%
controls:0.51%
cases:6.96%
controls:3.96%
cases:17.61%
controls:11.44%
1089
7648
5796
61161
536
2703
6351
66119
94
381
6793
68441
86
10
6801
68812
90
348
6791
68368
470
2658
6283
64420
1021
6468
4776
50084
combinations of corticosteroids
D07AB30 [21602118]
D07AB30 [21602118]
4.1e-01
7.2e-01
9.1e-01
4.5e+00
9.6e-01
5.9e-01
5.0e-01
cases:15.82%
controls:11.11%
cases:7.78%
controls:3.93%
cases:1.36%
controls:0.55%
cases:1.25%
controls:0.01%
cases:1.31%
controls:0.51%
cases:6.96%
controls:3.96%
cases:17.61%
controls:11.44%
1089
7648
5796
61161
536
2703
6351
66119
94
381
6793
68441
86
10
6801
68812
90
348
6791
68368
470
2658
6283
64420
1021
6468
4776
50084
Excision of chalazion
CBB00 [2001300922]
CBB00 [2001300922]
1.2e+00
2.5e+00
1.0e+50
1.0e+50
1.0e+50
2.9e+00
2.0e+00
cases:0.19%
controls:0.06%
cases:0.19%
controls:0.02%
cases:0.25%
controls:0.00%
cases:1.03%
controls:0.00%
cases:0.10%
controls:0.00%
cases:0.27%
controls:0.01%
cases:0.29%
controls:0.04%
13
40
6872
68769
13
11
6874
68811
17
0
6870
68822
71
0
6816
68822
7
0
6874
68716
18
10
6735
67068
17
22
5780
56530
Senile nuclear cataract
H25.1 [45581628]
H25.1 [45581628]
9.8e-02
8.6e-01
1.2e+00
4.5e+00
1.0e+00
5.4e-01
2.0e-01
cases:4.20%
controls:3.82%
cases:3.28%
controls:1.42%
cases:0.67%
controls:0.20%
cases:0.93%
controls:0.01%
cases:0.62%
controls:0.23%
cases:2.50%
controls:1.47%
cases:6.45%
controls:5.32%
289
2628
6596
66181
226
978
6661
67844
46
138
6841
68684
64
7
6823
68815
43
159
6838
68557
169
984
6584
66094
374
3010
5423
53542
Biopsy of eyelid
CBA10 [2001300920]
CBA10 [2001300920]
1.1e+00
—
—
1.0e+50
—
5.2e+00
3.0e+00
cases:0.13%
controls:0.04%
—
—
—
—
cases:8.61%
controls:0.00%
—
—
cases:1.38%
controls:0.01%
cases:0.81%
controls:0.04%
9
30
6876
68779
—
—
593
0
6294
68822
—
93
5
6660
67073
47
22
5750
56530
dexamethasone and antiinfectives
S03CA01 [21605206]
S03CA01 [21605206]
6.8e-01
1.5e+00
1.9e+00
—
2.1e+00
1.2e+00
6.8e-01
cases:3.83%
controls:1.99%
cases:3.09%
controls:0.68%
cases:0.61%
controls:0.10%
—
—
cases:0.70%
controls:0.08%
cases:2.27%
controls:0.73%
cases:4.80%
controls:2.48%
264
1369
6621
67440
213
469
6674
68353
42
66
6845
68756
—
48
57
6833
68659
153
487
6600
66591
278
1402
5519
55150
Hordeolum
H00.00 [2000502235]
H00.00 [2000502235]
8.6e-01
2.5e+00
2.5e+00
1.0e+50
1.8e+00
9.0e-01
7.0e-01
cases:0.71%
controls:0.30%
cases:1.21%
controls:0.10%
cases:0.20%
controls:0.02%
cases:0.13%
controls:0.00%
cases:0.09%
controls:0.01%
cases:0.28%
controls:0.11%
cases:0.86%
controls:0.43%
49
209
6836
68600
83
71
6804
68751
14
11
6873
68811
9
0
6878
68822
6
10
6875
68706
19
77
6734
67001
50
243
5747
56309
dexamethasone
S01BA01 [21603618]
S01BA01 [21603618]
6.1e-01
1.4e+00
1.7e+00
—
2.1e+00
1.0e+00
5.9e-01
cases:4.27%
controls:2.37%
cases:3.63%
controls:0.92%
cases:0.77%
controls:0.14%
—
—
cases:0.92%
controls:0.11%
cases:2.75%
controls:0.99%
cases:5.66%
controls:3.21%
294
1634
6591
67175
250
630
6637
68192
53
95
6834
68727
—
63
79
6818
68637
186
662
6567
66416
328
1817
5469
54735
dexamethasone
S03BA01 [21605201]
S03BA01 [21605201]
6.1e-01
1.4e+00
1.7e+00
—
2.1e+00
1.0e+00
5.9e-01
cases:4.27%
controls:2.37%
cases:3.62%
controls:0.91%
cases:0.77%
controls:0.14%
—
—
cases:0.90%
controls:0.11%
cases:2.74%
controls:0.99%
cases:5.66%
controls:3.21%
294
1633
6591
67176
249
629
6638
68193
53
94
6834
68728
—
62
79
6819
68637
185
661
6568
66417
328
1817
5469
54735
Senile macular degeneration (atrophic)(exudative)
H35.31 [2000502315]
H35.31 [2000502315]
4.2e-01
7.6e-01
1.1e+00
3.6e+00
1.1e+00
8.6e-01
3.1e-01
cases:0.94%
controls:0.62%
cases:1.06%
controls:0.50%
cases:0.70%
controls:0.24%
cases:0.36%
controls:0.01%
cases:0.67%
controls:0.22%
cases:1.23%
controls:0.52%
cases:1.35%
controls:0.99%
65
427
6820
68382
73
342
6814
68480
48
166
6839
68656
25
7
6862
68815
46
154
6835
68562
83
352
6670
66726
78
558
5719
55994
Removal of sutures
SPAT1153 [2001700254]
SPAT1153 [2001700254]
3.5e-01
7.3e-01
1.3e+00
—
3.4e+00
9.9e-01
5.2e-01
cases:7.65%
controls:5.54%
cases:3.03%
controls:1.48%
cases:0.52%
controls:0.15%
—
—
cases:4.68%
controls:0.16%
cases:3.75%
controls:1.43%
cases:8.78%
controls:5.42%
527
3809
6358
65000
209
1018
6678
67804
36
100
6851
68722
—
322
111
6559
68605
253
961
6500
66117
509
3067
5288
53485
Seborrhoeic keratosis
L82 [45548208]
L82 [45548208]
6.8e-01
1.0e+00
2.0e+00
—
1.9e+00
9.3e-01
7.9e-01
cases:4.14%
controls:2.14%
cases:2.13%
controls:0.80%
cases:0.48%
controls:0.07%
—
—
cases:0.54%
controls:0.08%
cases:2.22%
controls:0.89%
cases:7.12%
controls:3.35%
285
1475
6600
67334
147
550
6740
68272
33
47
6854
68775
—
37
54
6844
68662
150
597
6603
66481
413
1894
5384
54658
Basocellular carcinoma of the skin on another or unspecified part of the face
C44.31 [2000500792]
C44.31 [2000500792]
6.9e-01
1.0e+00
1.5e+00
—
1.6e+00
1.3e+00
9.9e-01
cases:1.57%
controls:0.79%
cases:0.99%
controls:0.35%
cases:0.28%
controls:0.06%
—
—
cases:0.42%
controls:0.09%
cases:1.42%
controls:0.38%
cases:2.78%
controls:1.05%
108
543
6777
68266
68
243
6819
68579
19
44
6868
68778
—
29
59
6852
68657
96
254
6657
66824
161
596
5636
55956
Besnier prurigo
L20.0 [45562534]
L20.0 [45562534]
7.0e-01
1.0e+00
1.7e+00
—
1.8e+00
9.8e-01
7.8e-01
cases:1.10%
controls:0.55%
cases:0.60%
controls:0.22%
cases:0.19%
controls:0.03%
—
—
cases:0.23%
controls:0.04%
cases:0.67%
controls:0.25%
cases:1.40%
controls:0.65%
76
381
6809
68428
41
150
6846
68672
13
24
6874
68798
—
16
27
6865
68689
45
168
6708
66910
81
366
5716
56186
Sedation and analgesia
WX002 [2001310758]
WX002 [2001310758]
2.6e-01
8.0e-01
2.0e+00
—
1.9e+00
1.3e+00
6.1e-01
cases:3.44%
controls:2.68%
cases:1.54%
controls:0.70%
cases:0.33%
controls:0.05%
—
—
cases:0.42%
controls:0.06%
cases:2.22%
controls:0.59%
cases:4.12%
controls:2.29%
237
1843
6648
66966
106
481
6781
68341
23
32
6864
68790
—
29
43
6852
68673
150
397
6603
66681
239
1293
5558
55259
AZATHIOPRINE - yes
AZATHIOPRINE-1 [2002330220]
AZATHIOPRINE-1 [2002330220]
2.4e+00
1.8e+00
—
—
—
2.3e+00
2.1e+00
cases:0.19%
controls:0.02%
cases:0.07%
controls:0.01%
—
—
—
—
—
—
cases:0.12%
controls:0.01%
cases:0.12%
controls:0.01%
13
12
6872
68797
5
8
6882
68814
—
—
—
8
8
6745
67070
7
8
5790
56544
Dry eye syndrome
H04.10 [2000502254]
H04.10 [2000502254]
5.6e-01
1.1e+00
1.7e+00
—
1.7e+00
1.0e+00
7.0e-01
cases:2.08%
controls:1.20%
cases:1.36%
controls:0.48%
cases:0.33%
controls:0.06%
—
—
cases:0.41%
controls:0.07%
cases:1.42%
controls:0.52%
cases:3.57%
controls:1.81%
143
823
6742
67986
94
328
6793
68494
23
41
6864
68781
—
28
50
6853
68666
96
347
6657
66731
207
1026
5590
55526
Other specified counselling
Z71.8 [45581061]
Z71.8 [45581061]
2.8e-01
4.4e-01
6.5e-01
4.1e+00
6.9e-01
3.8e-01
2.4e-01
cases:4.58%
controls:3.51%
cases:2.87%
controls:1.87%
cases:0.51%
controls:0.27%
cases:0.42%
controls:0.01%
cases:0.51%
controls:0.25%
cases:3.15%
controls:2.18%
cases:7.94%
controls:6.36%
315
2417
6570
66392
198
1290
6689
67532
35
183
6852
68639
29
5
6858
68817
35
175
6846
68541
213
1459
6540
65619
460
3596
5337
52956
Intravenous sedation or analgesia without general anesthesia
WX006 [2001310762]
WX006 [2001310762]
8.1e-01
6.4e-01
2.1e+00
—
2.5e+00
1.3e+00
1.5e-01
cases:0.38%
controls:0.17%
cases:0.39%
controls:0.21%
cases:0.17%
controls:0.02%
—
—
cases:0.20%
controls:0.02%
cases:0.81%
controls:0.23%
cases:1.05%
controls:0.91%
26
116
6859
68693
27
143
6860
68679
12
15
6875
68807
—
14
11
6867
68705
55
155
6698
66923
61
513
5736
56039
Other and unspecified skin changes
R23.8 [45573020]
R23.8 [45573020]
5.2e-01
1.5e+00
2.3e+00
—
1.1e+00
6.1e-01
6.5e-01
cases:3.60%
controls:2.17%
cases:4.04%
controls:0.89%
cases:1.02%
controls:0.10%
—
—
cases:0.28%
controls:0.10%
cases:1.76%
controls:0.97%
cases:6.62%
controls:3.56%
248
1490
6637
67319
278
615
6609
68207
70
70
6817
68752
—
19
66
6862
68650
119
648
6634
66430
384
2013
5413
54539
Otolaryngology
4 [38004449]
4 [38004449]
4.2e-01
5.4e-01
7.8e-01
3.0e+00
8.1e-01
6.1e-01
4.7e-01
cases:15.86%
controls:11.05%
cases:6.71%
controls:4.04%
cases:1.36%
controls:0.63%
cases:0.77%
controls:0.04%
cases:1.28%
controls:0.57%
cases:7.14%
controls:4.00%
cases:17.68%
controls:11.87%
1092
7606
5793
61203
462
2777
6425
66045
94
432
6793
68390
53
27
6834
68795
88
392
6793
68324
482
2683
6271
64395
1025
6712
4772
49840
Other senile cataract
H25.8 [45605644]
H25.8 [45605644]
8.1e-02
6.8e-01
1.2e+00
3.9e+00
7.3e-01
7.7e-01
2.4e-01
cases:1.51%
controls:1.40%
cases:0.96%
controls:0.49%
cases:0.22%
controls:0.07%
cases:0.45%
controls:0.01%
cases:0.16%
controls:0.08%
cases:1.08%
controls:0.50%
cases:2.17%
controls:1.72%
104
960
6781
67849
66
337
6821
68485
15
45
6872
68777
31
6
6856
68816
11
53
6870
68663
73
337
6680
66741
126
971
5671
55581
Neoplasm of uncertain or unknown behaviour: Skin
D48.5 [45586113]
D48.5 [45586113]
6.3e-01
1.7e+00
2.6e+00
—
1.5e+00
9.2e-01
7.0e-01
cases:1.05%
controls:0.56%
cases:1.12%
controls:0.20%
cases:0.32%
controls:0.02%
—
—
cases:0.13%
controls:0.03%
cases:0.59%
controls:0.24%
cases:1.76%
controls:0.88%
72
385
6813
68424
77
141
6810
68681
22
16
6865
68806
—
9
21
6872
68695
40
159
6713
66919
102
497
5695
56055
dexamethasone; oral, parenteral
H02AB02 [21602730]
H02AB02 [21602730]
5.0e-01
1.2e+00
1.4e+00
—
1.9e+00
9.6e-01
5.1e-01
cases:3.66%
controls:2.25%
cases:3.17%
controls:0.94%
cases:0.62%
controls:0.15%
—
—
cases:0.78%
controls:0.12%
cases:2.43%
controls:0.95%
cases:4.90%
controls:3.01%
252
1547
6633
67262
218
650
6669
68172
43
106
6844
68716
—
54
80
6827
68636
164
636
6589
66442
284
1701
5513
54851
Benign neoplasm: Skin of other and unspecified parts of face
D23.3 [45595740]
D23.3 [45595740]
6.9e-01
1.4e+00
2.1e+00
—
—
1.9e+00
1.0e+00
cases:0.41%
controls:0.20%
cases:0.25%
controls:0.06%
cases:0.09%
controls:0.01%
—
—
—
—
cases:0.30%
controls:0.04%
cases:0.64%
controls:0.23%
28
141
6857
68668
17
44
6870
68778
6
7
6881
68815
—
—
20
29
6733
67049
37
128
5760
56424
Basocellular carcinoma of the skin on the torso
C44.51 [2000500800]
C44.51 [2000500800]
6.0e-01
1.2e+00
2.4e+00
—
1.6e+00
1.1e+00
1.1e+00
cases:0.54%
controls:0.30%
cases:0.30%
controls:0.09%
cases:0.13%
controls:0.01%
—
—
cases:0.10%
controls:0.02%
cases:0.39%
controls:0.13%
cases:1.09%
controls:0.37%
37
203
6848
68606
21
63
6866
68759
9
8
6878
68814
—
7
14
6874
68702
26
86
6727
66992
63
210
5734
56342
Supplier / Service Provider
OMOP5117446 [33004]
OMOP5117446 [33004]
-6.9e-01
-5.2e-01
-3.8e-01
—
2.4e+00
2.4e+00
2.8e+00
cases:14.76%
controls:25.58%
cases:4.59%
controls:7.49%
cases:0.51%
controls:0.74%
—
—
cases:0.68%
controls:0.06%
cases:5.21%
controls:0.49%
cases:15.99%
controls:1.14%
1016
17600
5869
51209
316
5152
6571
63670
35
509
6852
68313
—
47
43
6834
68673
352
327
6401
66751
927
647
4870
55905
Examination of eyes and vision
Z01.0 [45566391]
Z01.0 [45566391]
3.0e-01
1.0e+00
1.8e+00
—
1.9e+00
1.1e+00
3.4e-01
cases:3.09%
controls:2.30%
cases:2.24%
controls:0.82%
cases:0.76%
controls:0.12%
—
—
cases:0.70%
controls:0.11%
cases:2.50%
controls:0.86%
cases:4.30%
controls:3.08%
213
1583
6672
67226
154
567
6733
68255
52
86
6835
68736
—
48
75
6833
68641
169
579
6584
66499
249
1744
5548
54808
Sleep apnoea
G47.3 [45562094]
G47.3 [45562094]
3.9e-01
4.8e-01
6.1e-01
3.1e+00
7.5e-01
4.6e-01
5.1e-01
cases:6.09%
controls:4.20%
cases:4.24%
controls:2.67%
cases:0.93%
controls:0.51%
cases:0.62%
controls:0.03%
cases:1.13%
controls:0.54%
cases:4.40%
controls:2.81%
cases:8.33%
controls:5.18%
419
2891
6466
65918
292
1838
6595
66984
64
350
6823
68472
43
19
6844
68803
78
370
6803
68346
297
1884
6456
65194
483
2930
5314
53622
Oncology Clinic/Center
261QX0200X [38004268]
261QX0200X [38004268]
1.8e-01
5.5e-01
1.8e+00
—
2.7e+00
5.8e-01
4.6e-01
cases:6.78%
controls:5.72%
cases:2.73%
controls:1.59%
cases:0.86%
controls:0.15%
—
—
cases:2.22%
controls:0.15%
cases:2.43%
controls:1.38%
cases:8.47%
controls:5.51%
467
3936
6418
64873
188
1097
6699
67725
59
102
6828
68720
—
153
100
6728
68616
164
925
6589
66153
491
3118
5306
53434
Day surgery
ZXD20 [2001311388]
ZXD20 [2001311388]
3.2e-01
8.2e-01
1.4e+00
1.0e+50
2.2e+00
1.3e+00
5.2e-01
cases:1.67%
controls:1.22%
cases:0.58%
controls:0.26%
cases:0.15%
controls:0.03%
cases:0.39%
controls:0.00%
cases:0.28%
controls:0.03%
cases:0.99%
controls:0.29%
cases:1.85%
controls:1.11%
115
837
6770
67972
40
176
6847
68646
10
24
6877
68798
27
0
6860
68822
19
21
6862
68695
67
192
6686
66886
107
627
5690
55925
Chronic conjunctivitis
H10.4 [45533218]
H10.4 [45533218]
6.9e-01
2.1e+00
—
1.0e+50
1.0e+50
2.5e+00
1.6e+00
cases:0.09%
controls:0.04%
cases:0.13%
controls:0.02%
—
—
cases:0.07%
controls:0.00%
cases:0.07%
controls:0.00%
cases:0.16%
controls:0.01%
cases:0.28%
controls:0.06%
6
30
6879
68779
9
11
6878
68811
—
5
0
6882
68822
5
0
6876
68716
11
9
6742
67069
16
32
5781
56520
Scheduled procedure
ZXD10 [2001311387]
ZXD10 [2001311387]
4.0e-01
6.3e-01
1.1e+00
—
1.8e+00
1.3e+00
8.6e-01
cases:9.30%
controls:6.41%
cases:3.14%
controls:1.69%
cases:0.49%
controls:0.16%
—
—
cases:0.96%
controls:0.16%
cases:4.62%
controls:1.25%
cases:9.99%
controls:4.47%
640
4409
6245
64400
216
1165
6671
67657
34
110
6853
68712
—
66
110
6815
68606
312
841
6441
66237
579
2528
5218
54024
Cryotherapy
ZXC50 [2001311370]
ZXC50 [2001311370]
4.3e-01
9.0e-01
2.6e+00
1.0e+50
—
1.6e+00
1.0e+00
cases:0.49%
controls:0.32%
cases:0.29%
controls:0.12%
cases:0.12%
controls:0.01%
cases:0.13%
controls:0.00%
—
—
cases:0.65%
controls:0.13%
cases:0.95%
controls:0.34%
34
221
6851
68588
20
81
6867
68741
8
6
6879
68816
9
0
6878
68822
—
44
86
6709
66992
55
192
5742
56360
One hour or less
ZXE00 [2001311394]
ZXE00 [2001311394]
3.6e-01
6.4e-01
1.0e+00
—
2.0e+00
1.3e+00
8.0e-01
cases:8.44%
controls:6.04%
cases:3.02%
controls:1.61%
cases:0.41%
controls:0.15%
—
—
cases:1.00%
controls:0.14%
cases:4.71%
controls:1.35%
cases:9.54%
controls:4.51%
581
4153
6304
64656
208
1111
6679
67711
28
101
6859
68721
—
69
98
6812
68618
318
907
6435
66171
553
2553
5244
53999
Eyelid symptom/complaint
F16 [2002000407]
F16 [2002000407]
6.9e-01
2.2e+00
2.3e+00
—
—
7.7e-01
8.2e-01
cases:0.93%
controls:0.47%
cases:0.99%
controls:0.11%
cases:0.17%
controls:0.02%
—
—
—
—
cases:0.33%
controls:0.15%
cases:1.21%
controls:0.54%
64
323
6821
68486
68
73
6819
68749
12
12
6875
68810
—
—
22
101
6731
66977
70
304
5727
56248
antibiotics in combination with other drugs
S01AA20 [21603571]
S01AA20 [21603571]
4.0e-01
1.2e+00
1.5e+00
—
1.5e+00
8.2e-01
3.8e-01
cases:11.36%
controls:7.91%
cases:8.04%
controls:2.47%
cases:1.31%
controls:0.29%
—
—
cases:1.37%
controls:0.30%
cases:5.75%
controls:2.62%
cases:12.82%
controls:9.14%
782
5444
6103
63365
554
1697
6333
67125
90
200
6797
68622
—
94
204
6787
68512
388
1755
6365
65323
743
5171
5054
51381
hydrocortisone
S01BA02 [21603619]
S01BA02 [21603619]
7.8e-01
1.1e+00
1.5e+00
—
2.1e+00
1.0e+00
7.1e-01
cases:0.54%
controls:0.25%
cases:0.39%
controls:0.13%
cases:0.09%
controls:0.02%
—
—
cases:0.15%
controls:0.02%
cases:0.46%
controls:0.17%
cases:0.95%
controls:0.47%
37
170
6848
68639
27
87
6860
68735
6
14
6881
68808
—
10
12
6871
68704
31
114
6722
66964
55
264
5742
56288
hydrocortisone
S01CB03 [21603666]
S01CB03 [21603666]
7.8e-01
1.1e+00
1.5e+00
—
2.1e+00
1.0e+00
7.1e-01
cases:0.54%
controls:0.25%
cases:0.39%
controls:0.13%
cases:0.09%
controls:0.02%
—
—
cases:0.15%
controls:0.02%
cases:0.46%
controls:0.17%
cases:0.95%
controls:0.47%
37
170
6848
68639
27
87
6860
68735
6
14
6881
68808
—
10
12
6871
68704
31
114
6722
66964
55
264
5742
56288
Biopsy of skin and subcutaneous tissue
TQX10 [2001310152]
TQX10 [2001310152]
6.9e-01
1.0e+00
1.5e+00
1.0e+50
1.6e+00
1.4e+00
1.1e+00
cases:2.06%
controls:1.05%
cases:0.93%
controls:0.33%
cases:0.16%
controls:0.04%
cases:0.51%
controls:0.00%
cases:0.10%
controls:0.02%
cases:1.13%
controls:0.27%
cases:2.83%
controls:0.97%
142
721
6743
68088
64
229
6823
68593
11
25
6876
68797
35
0
6852
68822
7
14
6874
68702
76
181
6677
66897
164
549
5633
56003
Photography of fundus of eye
XCK10 [2001301381]
XCK10 [2001301381]
2.6e-01
1.0e+00
1.8e+00
—
1.4e+00
1.0e+00
4.3e-01
cases:2.40%
controls:1.86%
cases:1.66%
controls:0.61%
cases:0.35%
controls:0.06%
—
—
cases:0.20%
controls:0.05%
cases:1.61%
controls:0.57%
cases:2.74%
controls:1.80%
165
1281
6720
67528
114
417
6773
68405
24
38
6863
68784
—
14
35
6867
68681
109
384
6644
66694
159
1018
5638
55534
Right side
ZXA00 [2001311346]
ZXA00 [2001311346]
2.2e-01
5.6e-01
1.2e+00
—
2.2e+00
1.0e+00
4.7e-01
cases:4.94%
controls:4.01%
cases:1.76%
controls:1.01%
cases:0.29%
controls:0.09%
—
—
cases:0.83%
controls:0.09%
cases:2.55%
controls:0.91%
cases:5.35%
controls:3.42%
340
2762
6545
66047
121
698
6766
68124
20
60
6867
68762
—
57
63
6824
68653
172
611
6581
66467
310
1934
5487
54618
Excision of other lesion extending through all layers of skin in head or neck
QAE10 [2001309784]
QAE10 [2001309784]
5.5e-01
9.6e-01
1.4e+00
—
2.0e+00
1.2e+00
8.6e-01
cases:1.70%
controls:0.99%
cases:0.76%
controls:0.29%
cases:0.12%
controls:0.03%
—
—
cases:0.19%
controls:0.02%
cases:1.02%
controls:0.32%
cases:2.50%
controls:1.07%
117
680
6768
68129
52
199
6835
68623
8
20
6879
68802
—
13
17
6868
68699
69
214
6684
66864
145
605
5652
55947
Remowal of suture of skin
TQW40 [2001310146]
TQW40 [2001310146]
2.0e-01
1.0e-01
—
—
2.7e+00
1.9e+00
8.7e-01
cases:0.83%
controls:0.68%
cases:0.22%
controls:0.20%
—
—
—
—
cases:0.20%
controls:0.01%
cases:1.01%
controls:0.15%
cases:1.40%
controls:0.59%
57
468
6828
68341
15
135
6872
68687
—
—
14
9
6867
68707
68
99
6685
66979
81
334
5716
56218
Outpatient Hospital
22 [8756]
22 [8756]
2.4e-01
2.3e-01
-2.5e-01
3.7e+00
5.3e-01
3.8e-01
3.6e-01
cases:30.31%
controls:25.42%
cases:9.08%
controls:7.33%
cases:0.71%
controls:0.91%
cases:1.44%
controls:0.03%
cases:1.41%
controls:0.83%
cases:9.14%
controls:6.45%
cases:25.81%
controls:19.47%
2087
17494
4798
51315
625
5048
6262
63774
49
628
6838
68194
99
24
6788
68798
97
571
6784
68145
617
4324
6136
62754
1496
11013
4301
45539
Basal cell carcinoma, NOS, of eyelid
8090/3-C44.1 [44499798]
8090/3-C44.1 [44499798]
1.9e+00
3.5e+00
1.0e+50
1.0e+50
1.0e+50
—
1.2e+00
cases:0.13%
controls:0.02%
cases:0.35%
controls:0.01%
cases:0.45%
controls:0.00%
cases:0.13%
controls:0.00%
cases:1.13%
controls:0.00%
—
—
cases:0.09%
controls:0.03%
9
13
6876
68796
24
7
6863
68815
31
0
6856
68822
9
0
6878
68822
78
0
6803
68716
—
5
15
5792
56537
Naevus/mole
S82 [2002001046]
S82 [2002001046]
5.5e-01
1.3e+00
1.4e+00
—
1.6e+00
3.1e-01
6.2e-01
cases:2.59%
controls:1.51%
cases:1.58%
controls:0.43%
cases:0.22%
controls:0.05%
—
—
cases:0.23%
controls:0.05%
cases:0.65%
controls:0.48%
cases:3.48%
controls:1.91%
178
1039
6707
67770
109
295
6778
68527
15
37
6872
68785
—
16
33
6865
68683
44
320
6709
66758
202
1078
5595
55474
Prolonged inflammation in the edge of the eyelid
H01.80 [2000502240]
H01.80 [2000502240]
1.1e+00
2.1e+00
—
1.0e+50
—
2.2e+00
1.1e+00
cases:0.16%
controls:0.05%
cases:0.16%
controls:0.02%
—
—
cases:0.16%
controls:0.00%
—
—
cases:0.24%
controls:0.03%
cases:0.36%
controls:0.12%
11
36
6874
68773
11
13
6876
68809
—
11
0
6876
68822
—
16
18
6737
67060
21
69
5776
56483
FEV1
20150-9 [3024653]
20150-9 [3024653]
7.4e-01
9.0e-01
9.0e-01
—
1.2e+00
1.2e+00
1.4e+00
cases:3.91%
controls:1.90%
cases:1.36%
controls:0.56%
cases:0.17%
controls:0.07%
—
—
cases:0.19%
controls:0.06%
cases:1.54%
controls:0.49%
cases:4.40%
controls:1.14%
269
1304
6616
67505
94
386
6793
68436
12
49
6875
68773
—
13
39
6868
68677
104
327
6649
66751
255
647
5542
55905
FEV1/FVC
19926-5 [3011505]
19926-5 [3011505]
7.4e-01
9.0e-01
9.0e-01
—
1.2e+00
1.2e+00
1.4e+00
cases:3.91%
controls:1.90%
cases:1.36%
controls:0.56%
cases:0.17%
controls:0.07%
—
—
cases:0.19%
controls:0.06%
cases:1.54%
controls:0.49%
cases:4.40%
controls:1.14%
269
1304
6616
67505
94
386
6793
68436
12
49
6875
68773
—
13
39
6868
68677
104
327
6649
66751
255
647
5542
55905
Forced vital capacity [Volume] Respiratory system
19870-5 [3020158]
19870-5 [3020158]
7.4e-01
9.0e-01
9.0e-01
—
1.2e+00
1.2e+00
1.4e+00
cases:3.91%
controls:1.90%
cases:1.36%
controls:0.56%
cases:0.17%
controls:0.07%
—
—
cases:0.19%
controls:0.06%
cases:1.54%
controls:0.49%
cases:4.40%
controls:1.14%
269
1304
6616
67505
94
386
6793
68436
12
49
6875
68773
—
13
39
6868
68677
104
327
6649
66751
255
647
5542
55905
Actinic keratosis
L57.0 [45591640]
L57.0 [45591640]
6.6e-01
8.4e-01
1.1e+00
—
9.9e-01
9.7e-01
8.5e-01
cases:2.80%
controls:1.47%
cases:1.86%
controls:0.81%
cases:0.29%
controls:0.10%
—
—
cases:0.39%
controls:0.15%
cases:2.18%
controls:0.84%
cases:4.76%
controls:2.09%
193
1010
6692
67799
128
558
6759
68264
20
69
6867
68753
—
27
100
6854
68616
147
561
6606
66517
276
1182
5521
55370
Left side
ZXA05 [2001311347]
ZXA05 [2001311347]
1.7e-01
6.7e-01
9.6e-01
—
2.1e+00
1.1e+00
4.0e-01
cases:4.27%
controls:3.63%
cases:1.79%
controls:0.92%
cases:0.25%
controls:0.09%
—
—
cases:0.71%
controls:0.08%
cases:2.43%
controls:0.79%
cases:4.85%
controls:3.30%
294
2497
6591
66312
123
632
6764
68190
17
65
6870
68757
—
49
58
6832
68658
164
532
6589
66546
281
1866
5516
54686
Localized swelling, mass and lump, head
R22.0 [45548955]
R22.0 [45548955]
3.3e-01
2.2e+00
2.3e+00
—
—
5.4e-01
7.6e-01
cases:0.32%
controls:0.23%
cases:0.52%
controls:0.06%
cases:0.10%
controls:0.01%
—
—
—
—
cases:0.13%
controls:0.08%
cases:0.64%
controls:0.30%
22
159
6863
68650
36
39
6851
68783
7
7
6880
68815
—
—
9
52
6744
67026
37
169
5760
56383
Pharmacy visit
OMOP4822462 [581458]
OMOP4822462 [581458]
5.3e-01
5.4e-01
3.2e-01
2.4e+00
2.3e-01
6.0e-01
7.1e-01
cases:96.70%
controls:94.55%
cases:91.84%
controls:86.74%
cases:57.67%
controls:49.75%
cases:21.94%
controls:2.60%
cases:55.56%
controls:49.93%
cases:92.58%
controls:87.23%
cases:97.93%
controls:95.87%
6658
65056
227
3753
6325
59696
562
9126
3972
34241
2915
34581
1511
1792
5376
67030
3823
34309
3058
34407
6252
58514
501
8564
5677
54217
120
2335
Photography of eye
CD2S4 [2001301069]
CD2S4 [2001301069]
—
2.8e+00
1.0e+50
—
—
2.4e+00
—
—
—
cases:0.29%
controls:0.02%
cases:0.10%
controls:0.00%
—
—
—
—
cases:0.16%
controls:0.01%
—
—
—
20
12
6867
68810
7
0
6880
68822
—
—
11
10
6742
67068
—
Keratoconus
H18.6 [45591282]
H18.6 [45591282]
1.3e+00
1.8e+00
—
—
—
2.0e+00
1.4e+00
cases:0.16%
controls:0.05%
cases:0.10%
controls:0.02%
—
—
—
—
—
—
cases:0.15%
controls:0.02%
cases:0.17%
controls:0.04%
11
31
6874
68778
7
12
6880
68810
—
—
—
10
13
6743
67065
10
24
5787
56528
lodoxamide
S01GX05 [21605089]
S01GX05 [21605089]
1.4e+00
1.5e+00
—
—
—
2.1e+00
1.7e+00
cases:0.28%
controls:0.07%
cases:0.09%
controls:0.02%
—
—
—
—
—
—
cases:0.18%
controls:0.02%
cases:0.28%
controls:0.05%
19
47
6866
68762
6
14
6881
68808
—
—
—
12
14
6741
67064
16
30
5781
56522
Bilateral
ZXA10 [2001311348]
ZXA10 [2001311348]
2.5e-01
9.6e-01
1.2e+00
—
1.3e+00
9.8e-01
4.5e-01
cases:3.05%
controls:2.39%
cases:1.57%
controls:0.60%
cases:0.23%
controls:0.07%
—
—
cases:0.32%
controls:0.09%
cases:1.55%
controls:0.59%
cases:3.64%
controls:2.36%
210
1646
6675
67163
108
416
6779
68406
16
46
6871
68776
—
22
60
6859
68656
105
396
6648
66682
211
1336
5586
55216
Excision of redundant skin of eyelid
CBB10 [2001300923]
CBB10 [2001300923]
8.0e-01
1.9e+00
—
1.0e+50
—
2.4e+00
4.2e-01
cases:0.42%
controls:0.19%
cases:0.16%
controls:0.02%
—
—
cases:0.25%
controls:0.00%
—
—
cases:0.37%
controls:0.03%
cases:0.31%
controls:0.20%
29
130
6856
68679
11
16
6876
68806
—
17
0
6870
68822
—
25
22
6728
67056
18
115
5779
56437
Laceration/cut
S18 [2002000983]
S18 [2002000983]
2.5e-01
4.0e-01
7.6e-01
8.7e-01
2.5e+00
7.7e-01
4.6e-01
cases:9.82%
controls:7.85%
cases:4.41%
controls:3.00%
cases:0.81%
controls:0.38%
cases:0.07%
controls:0.03%
cases:4.96%
controls:0.42%
cases:6.16%
controls:2.94%
cases:14.89%
controls:9.94%
676
5402
6209
63407
304
2067
6583
66755
56
264
6831
68558
5
21
6882
68801
341
288
6540
68428
416
1970
6337
65108
863
5620
4934
50932
Blepharitis/stye/chalazion
F72 [2002000455]
F72 [2002000455]
1.4e+00
2.7e+00
—
—
—
6.9e-01
1.1e+00
cases:0.54%
controls:0.14%
cases:0.57%
controls:0.04%
—
—
—
—
—
—
cases:0.10%
controls:0.05%
cases:0.41%
controls:0.14%
37
93
6848
68716
39
26
6848
68796
—
—
—
7
35
6746
67043
24
82
5773
56470
Glaucoma suspect
H40.0 [45567051]
H40.0 [45567051]
3.7e-01
7.4e-01
1.2e+00
1.0e+50
1.7e+00
7.9e-01
4.1e-01
cases:1.48%
controls:1.03%
cases:0.87%
controls:0.42%
cases:0.20%
controls:0.06%
cases:0.32%
controls:0.00%
cases:0.22%
controls:0.04%
cases:0.95%
controls:0.43%
cases:1.97%
controls:1.32%
102
707
6783
68102
60
287
6827
68535
14
44
6873
68778
22
0
6865
68822
15
28
6866
68688
64
291
6689
66787
114
744
5683
55808
Foreign body in skin
S15 [2002000980]
S15 [2002000980]
5.4e-01
1.1e+00
—
—
2.9e+00
7.1e-01
5.8e-01
cases:1.03%
controls:0.60%
cases:0.49%
controls:0.17%
—
—
—
—
cases:0.35%
controls:0.02%
cases:0.37%
controls:0.18%
cases:1.21%
controls:0.68%
71
416
6814
68393
34
114
6853
68708
—
—
24
13
6857
68703
25
122
6728
66956
70
384
5727
56168
Noninfectious dermatoses of eyelid
H01.1 [45591215]
H01.1 [45591215]
7.8e-01
3.6e+00
1.0e+50
—
—
—
1.5e+00
cases:0.07%
controls:0.03%
cases:0.26%
controls:0.01%
cases:0.07%
controls:0.00%
—
—
—
—
—
—
cases:0.19%
controls:0.04%
5
23
6880
68786
18
5
6869
68817
5
0
6882
68822
—
—
—
11
24
5786
56528
Eye and orbita extensive MRI examination with high intensity magnet
CA1CG [2001300869]
CA1CG [2001300869]
—
—
—
—
—
2.9e+00
2.1e+00
—
—
—
—
—
—
—
—
—
—
cases:0.16%
controls:0.01%
cases:0.24%
controls:0.03%
—
—
—
—
—
11
6
6742
67072
14
17
5783
56535
ciclosporin; oral, parenteral
L04AD01 [21603924]
L04AD01 [21603924]
8.9e-01
1.1e+00
1.1e+00
—
9.6e-01
9.6e-01
8.9e-01
cases:0.68%
controls:0.28%
cases:0.61%
controls:0.21%
cases:0.20%
controls:0.07%
—
—
cases:0.19%
controls:0.07%
cases:0.53%
controls:0.20%
cases:0.62%
controls:0.26%
47
194
6838
68615
42
143
6845
68679
14
47
6873
68775
—
13
50
6868
68666
36
137
6717
66941
36
145
5761
56407
Investigative irrigation of lacrimal passages
XCC00 [2001301014]
XCC00 [2001301014]
2.6e-01
1.9e+00
—
1.0e+50
—
1.7e+00
1.2e+00
cases:0.10%
controls:0.08%
cases:0.19%
controls:0.03%
—
—
cases:0.39%
controls:0.00%
—
—
cases:0.22%
controls:0.04%
cases:0.31%
controls:0.10%
7
54
6878
68755
13
19
6874
68803
—
27
0
6860
68822
—
15
27
6738
67051
18
54
5779
56498
golimumab; parenteral
L04AB06 [21603913]
L04AB06 [21603913]
1.3e+00
1.7e+00
1.8e+00
—
—
1.0e+00
5.3e-01
cases:0.20%
controls:0.05%
cases:0.17%
controls:0.03%
cases:0.12%
controls:0.02%
—
—
—
—
cases:0.13%
controls:0.05%
cases:0.14%
controls:0.08%
14
37
6871
68772
12
23
6875
68799
8
13
6879
68809
—
—
9
33
6744
67045
8
46
5789
56506
Observation for other suspected diseases and conditions
Z03.8 [45585798]
Z03.8 [45585798]
6.6e-01
1.1e+00
2.1e+00
—
—
9.5e-01
8.5e-01
cases:0.70%
controls:0.36%
cases:0.26%
controls:0.09%
cases:0.09%
controls:0.01%
—
—
—
—
cases:0.21%
controls:0.08%
cases:0.60%
controls:0.26%
48
250
6837
68559
18
61
6869
68761
6
7
6881
68815
—
—
14
54
6739
67024
35
146
5762
56406
Case Management Agency
251B00000X [38004193]
251B00000X [38004193]
1.0e-01
1.9e-01
4.0e-01
3.1e+00
5.8e-01
2.0e-01
1.3e-01
cases:61.47%
controls:59.03%
cases:57.76%
controls:52.98%
cases:29.13%
controls:21.66%
cases:25.45%
controls:1.46%
cases:33.32%
controls:21.84%
cases:60.68%
controls:55.80%
cases:75.64%
controls:73.25%
4232
40618
2653
28191
3978
36465
2909
32357
2006
14909
4881
53913
1753
1003
5134
67819
2293
15008
4588
53708
4098
37429
2655
29649
4385
41422
1412
15130
cromoglicic acid
S01GX01 [21605085]
S01GX01 [21605085]
3.7e-01
8.9e-01
1.2e+00
—
9.2e-01
7.1e-01
6.8e-01
cases:4.34%
controls:3.03%
cases:2.87%
controls:1.20%
cases:0.54%
controls:0.17%
—
—
cases:0.42%
controls:0.17%
cases:2.32%
controls:1.16%
cases:5.33%
controls:2.76%
299
2087
6586
66722
198
826
6689
67996
37
116
6850
68706
—
29
116
6852
68600
157
778
6596
66300
309
1561
5488
54991
azathioprine; oral, parenteral
L04AX01 [21603927]
L04AX01 [21603927]
8.3e-01
9.5e-01
4.7e-01
—
9.4e-01
9.9e-01
1.0e+00
cases:1.31%
controls:0.57%
cases:1.00%
controls:0.39%
cases:0.19%
controls:0.12%
—
—
cases:0.28%
controls:0.11%
cases:0.93%
controls:0.35%
cases:1.31%
controls:0.48%
90
394
6795
68415
69
268
6818
68554
13
81
6874
68741
—
19
74
6862
68642
63
234
6690
66844
76
271
5721
56281
prednisolone
S03BA02 [21605202]
S03BA02 [21605202]
3.9e-01
9.3e-01
1.2e+00
—
1.2e+00
5.8e-01
4.8e-01
cases:2.48%
controls:1.69%
cases:1.55%
controls:0.62%
cases:0.29%
controls:0.09%
—
—
cases:0.35%
controls:0.11%
cases:1.11%
controls:0.62%
cases:3.07%
controls:1.91%
171
1166
6714
67643
107
424
6780
68398
20
63
6867
68759
—
24
74
6857
68642
75
418
6678
66660
178
1082
5619
55470
prednisolone
S01BA04 [21603621]
S01BA04 [21603621]
3.9e-01
9.3e-01
1.2e+00
—
1.2e+00
5.8e-01
4.8e-01
cases:2.48%
controls:1.69%
cases:1.55%
controls:0.62%
cases:0.29%
controls:0.09%
—
—
cases:0.35%
controls:0.11%
cases:1.11%
controls:0.62%
cases:3.07%
controls:1.91%
171
1166
6714
67643
107
424
6780
68398
20
63
6867
68759
—
24
74
6857
68642
75
418
6678
66660
178
1082
5619
55470
levofloxacin
S01AE05 [43534860]
S01AE05 [43534860]
2.7e-01
9.5e-01
1.2e+00
1.0e+50
1.2e+00
7.4e-01
3.5e-01
cases:2.48%
controls:1.90%
cases:1.76%
controls:0.68%
cases:0.22%
controls:0.07%
cases:0.17%
controls:0.00%
cases:0.28%
controls:0.08%
cases:1.45%
controls:0.70%
cases:3.74%
controls:2.68%
171
1307
6714
67502
121
471
6766
68351
15
47
6872
68775
12
0
6875
68822
19
57
6862
68659
98
470
6655
66608
217
1515
5580
55037
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
8090/3-C44.3 [44499724]
8090/3-C44.3 [44499724]
5.5e-01
4.8e-01
—
—
3.2e+00
1.5e+00
4.4e-01
cases:0.39%
controls:0.23%
cases:0.09%
controls:0.05%
—
—
—
—
cases:0.25%
controls:0.01%
cases:0.16%
controls:0.04%
cases:0.35%
controls:0.22%
27
156
6858
68653
6
37
6881
68785
—
—
17
7
6864
68709
11
25
6742
67053
20
126
5777
56426
Melanocytic naevi
D22 [45595739]
D22 [45595739]
3.3e-01
1.1e+00
2.6e+00
—
—
4.6e-01
9.6e-01
cases:0.49%
controls:0.36%
cases:0.39%
controls:0.14%
cases:0.12%
controls:0.01%
—
—
—
—
cases:0.22%
controls:0.14%
cases:1.17%
controls:0.45%
34
245
6851
68564
27
93
6860
68729
8
6
6879
68816
—
—
15
94
6738
66984
68
255
5729
56297
Skin symptom/complaint other
S29 [2002000993]
S29 [2002000993]
3.6e-01
5.9e-01
1.2e+00
—
1.5e+00
5.7e-01
4.0e-01
cases:3.30%
controls:2.33%
cases:1.48%
controls:0.82%
cases:0.30%
controls:0.09%
—
—
cases:0.54%
controls:0.12%
cases:1.58%
controls:0.90%
cases:4.93%
controls:3.37%
227
1605
6658
67204
102
567
6785
68255
21
65
6866
68757
—
37
81
6844
68635
107
603
6646
66475
286
1908
5511
54644
Hyperplasia of prostate
N40 [45563015]
N40 [45563015]
2.9e-01
3.5e-01
3.7e-01
3.2e+00
4.2e-01
3.3e-01
4.0e-01
cases:4.42%
controls:3.35%
cases:2.21%
controls:1.56%
cases:0.36%
controls:0.25%
cases:0.26%
controls:0.01%
cases:0.36%
controls:0.24%
cases:2.22%
controls:1.61%
cases:6.14%
controls:4.20%
304
2302
6581
66507
152
1075
6735
67747
25
173
6862
68649
18
7
6869
68815
25
165
6856
68551
150
1082
6603
65996
356
2377
5441
54175
Blepharoconjunctivitis
H10.5 [45600848]
H10.5 [45600848]
9.9e-01
2.3e+00
—
—
—
1.1e+00
1.3e+00
cases:0.31%
controls:0.11%
cases:0.22%
controls:0.02%
—
—
—
—
—
—
cases:0.12%
controls:0.04%
cases:0.50%
controls:0.13%
21
78
6864
68731
15
15
6872
68807
—
—
—
8
27
6745
67051
29
76
5768
56476
Other healthcare associate professional
Z3229 [2001311561]
Z3229 [2001311561]
3.6e-01
7.5e-01
2.3e+00
1.0e+50
3.6e-01
7.7e-01
4.7e-01
cases:1.53%
controls:1.07%
cases:0.70%
controls:0.33%
cases:0.28%
controls:0.03%
cases:0.52%
controls:0.00%
cases:0.07%
controls:0.05%
cases:0.62%
controls:0.29%
cases:1.47%
controls:0.92%
105
738
6780
68071
48
227
6839
68595
19
20
6868
68802
36
0
6851
68822
5
35
6876
68681
42
194
6711
66884
85
521
5712
56031
cefalexin; oral
J01DB01 [21602870]
J01DB01 [21602870]
3.4e-01
4.3e-01
4.6e-01
2.0e+00
5.8e-01
3.9e-01
3.4e-01
cases:35.57%
controls:28.26%
cases:13.05%
controls:8.86%
cases:1.58%
controls:1.01%
cases:0.20%
controls:0.03%
cases:1.67%
controls:0.94%
cases:12.26%
controls:8.64%
cases:34.43%
controls:27.19%
2449
19447
4436
49362
899
6101
5988
62721
109
692
6778
68130
14
19
6873
68803
115
647
6766
68069
828
5796
5925
61282
1996
15379
3801
41173
Inpatient Visit
IP [9201]
IP [9201]
3.7e-02
5.2e-02
-5.4e-01
4.2e+00
1.8e-02
1.3e-01
3.3e-01
cases:5.68%
controls:5.48%
cases:2.57%
controls:2.44%
cases:0.16%
controls:0.27%
cases:0.67%
controls:0.01%
cases:0.31%
controls:0.30%
cases:2.77%
controls:2.45%
cases:10.42%
controls:7.69%
391
3773
6494
65036
177
1681
6710
67141
11
189
6876
68633
46
7
6841
68815
21
206
6860
68510
187
1643
6566
65435
604
4350
5193
52202
Pure hypercholesterolaemia
E78.01 [2000501514]
E78.01 [2000501514]
1.8e-01
1.8e-01
2.9e-01
3.7e+00
7.6e-01
1.7e-01
1.0e-01
cases:3.97%
controls:3.32%
cases:2.15%
controls:1.79%
cases:0.44%
controls:0.33%
cases:0.73%
controls:0.02%
cases:0.62%
controls:0.29%
cases:2.28%
controls:1.93%
cases:6.37%
controls:5.77%
273
2287
6612
66522
148
1234
6739
67588
30
224
6857
68598
50
12
6837
68810
43
201
6838
68515
154
1294
6599
65784
369
3264
5428
53288
Melanocytic naevi of other and unspecified parts of face
D22.3 [45542687]
D22.3 [45542687]
8.8e-01
2.1e+00
—
—
—
1.5e+00
8.0e-01
cases:0.32%
controls:0.13%
cases:0.28%
controls:0.03%
—
—
—
—
—
—
cases:0.15%
controls:0.03%
cases:0.29%
controls:0.13%
22
91
6863
68718
19
24
6868
68798
—
—
—
10
22
6743
67056
17
75
5780
56477
Resection of lax skin in upper eyelid
CBB11 [2001300924]
CBB11 [2001300924]
5.3e-01
1.2e+00
—
—
—
2.4e+00
7.7e-01
cases:0.38%
controls:0.22%
cases:0.22%
controls:0.07%
—
—
—
—
—
—
cases:0.56%
controls:0.05%
cases:0.60%
controls:0.28%
26
153
6859
68656
15
47
6872
68775
—
—
—
38
36
6715
67042
35
159
5762
56393
Crohn disease of small intestine
K50.0 [45596324]
K50.0 [45596324]
1.2e+00
9.5e-01
—
—
—
1.0e+00
1.1e+00
cases:0.42%
controls:0.13%
cases:0.25%
controls:0.10%
—
—
—
—
—
—
cases:0.28%
controls:0.10%
cases:0.43%
controls:0.14%
29
90
6856
68719
17
66
6870
68756
—
—
—
19
67
6734
67011
25
82
5772
56470
Office Visit
OMOP4822458 [581477]
OMOP4822458 [581477]
1.5e-01
1.5e-01
4.2e-01
3.2e+00
6.2e-01
2.4e-01
2.5e-01
cases:9.64%
controls:8.45%
cases:2.89%
controls:2.50%
cases:0.44%
controls:0.29%
cases:0.32%
controls:0.01%
cases:0.58%
controls:0.31%
cases:2.93%
controls:2.33%
cases:9.13%
controls:7.22%
664
5814
6221
62995
199
1719
6688
67103
30
197
6857
68625
22
9
6865
68813
40
216
6841
68500
198
1563
6555
65515
529
4085
5268
52467
Essential (primary) hypertension
I10 [45591453]
I10 [45591453]
1.7e-01
2.1e-01
1.8e-01
2.9e+00
4.9e-01
2.4e-01
2.2e-01
cases:21.48%
controls:18.75%
cases:11.60%
controls:9.57%
cases:1.93%
controls:1.62%
cases:1.63%
controls:0.09%
cases:2.57%
controls:1.59%
cases:12.63%
controls:10.19%
cases:29.57%
controls:25.20%
1479
12900
5406
55909
799
6588
6088
62234
133
1113
6754
67709
112
65
6775
68757
177
1096
6704
67620
853
6834
5900
60244
1714
14253
4083
42299
FEV1 --post bronchodilation
20155-8 [3023550]
20155-8 [3023550]
7.6e-01
9.4e-01
8.4e-01
—
1.3e+00
1.1e+00
1.4e+00
cases:3.53%
controls:1.69%
cases:1.18%
controls:0.46%
cases:0.13%
controls:0.06%
—
—
cases:0.16%
controls:0.05%
cases:1.16%
controls:0.38%
cases:3.88%
controls:1.03%
243
1162
6642
67647
81
318
6806
68504
9
39
6878
68783
—
11
31
6870
68685
78
255
6675
66823
225
584
5572
55968
FEV1/FVC --post bronchodilation
69970-2 [42868459]
69970-2 [42868459]
7.6e-01
9.4e-01
8.4e-01
—
1.3e+00
1.1e+00
1.4e+00
cases:3.53%
controls:1.69%
cases:1.18%
controls:0.46%
cases:0.13%
controls:0.06%
—
—
cases:0.16%
controls:0.05%
cases:1.16%
controls:0.38%
cases:3.88%
controls:1.03%
243
1162
6642
67647
81
318
6806
68504
9
39
6878
68783
—
11
31
6870
68685
78
255
6675
66823
225
584
5572
55968
FVC percent change Respiratory system
69982-7 [42868471]
69982-7 [42868471]
7.6e-01
9.4e-01
8.4e-01
—
1.3e+00
1.1e+00
1.4e+00
cases:3.53%
controls:1.69%
cases:1.18%
controls:0.46%
cases:0.13%
controls:0.06%
—
—
cases:0.16%
controls:0.05%
cases:1.16%
controls:0.38%
cases:3.88%
controls:1.03%
243
1162
6642
67647
81
318
6806
68504
9
39
6878
68783
—
11
31
6870
68685
78
255
6675
66823
225
584
5572
55968
FEV1 percent change
69983-5 [42868472]
69983-5 [42868472]
7.6e-01
9.4e-01
8.4e-01
—
1.3e+00
1.1e+00
1.4e+00
cases:3.53%
controls:1.69%
cases:1.18%
controls:0.46%
cases:0.13%
controls:0.06%
—
—
cases:0.16%
controls:0.05%
cases:1.16%
controls:0.38%
cases:3.88%
controls:1.03%
243
1162
6642
67647
81
318
6806
68504
9
39
6878
68783
—
11
31
6870
68685
78
255
6675
66823
225
584
5572
55968
Forced vital capacity [Volume] Respiratory system --post bronchodilation
19875-4 [3001668]
19875-4 [3001668]
7.6e-01
9.4e-01
8.4e-01
—
1.3e+00
1.1e+00
1.4e+00
cases:3.53%
controls:1.69%
cases:1.18%
controls:0.46%
cases:0.13%
controls:0.06%
—
—
cases:0.16%
controls:0.05%
cases:1.16%
controls:0.38%
cases:3.88%
controls:1.03%
243
1162
6642
67647
81
318
6806
68504
9
39
6878
68783
—
11
31
6870
68685
78
255
6675
66823
225
584
5572
55968
Laboratory Visit
OMOP4822461 [32036]
OMOP4822461 [32036]
6.4e-02
1.4e-01
2.1e-01
3.2e+00
3.2e-01
1.9e-01
9.5e-02
cases:38.88%
controls:37.37%
cases:38.64%
controls:35.31%
cases:13.58%
controls:11.29%
cases:14.36%
controls:0.67%
cases:14.77%
controls:11.17%
cases:41.64%
controls:37.21%
cases:56.06%
controls:53.70%
2677
25711
4208
43098
2661
24302
4226
44520
935
7770
5952
61052
989
461
5898
68361
1016
7674
5865
61042
2812
24958
3941
42120
3250
30369
2547
26183
Corneal ulcer
H16.0 [45557339]
H16.0 [45557339]
5.7e-01
1.1e+00
1.6e+00
1.0e+50
1.6e+00
8.8e-01
4.1e-01
cases:0.64%
controls:0.36%
cases:0.38%
controls:0.12%
cases:0.09%
controls:0.02%
cases:0.07%
controls:0.00%
cases:0.13%
controls:0.03%
cases:0.33%
controls:0.14%
cases:0.67%
controls:0.45%
44
249
6841
68560
26
83
6861
68739
6
12
6881
68810
5
0
6882
68822
9
19
6872
68697
22
91
6731
66987
39
252
5758
56300
Ankylosing spondylitis
M45 [45591841]
M45 [45591841]
6.7e-01
1.0e+00
1.3e+00
—
1.6e+00
8.0e-01
5.2e-01
cases:0.54%
controls:0.27%
cases:0.38%
controls:0.14%
cases:0.12%
controls:0.03%
—
—
cases:0.12%
controls:0.02%
cases:0.34%
controls:0.15%
cases:0.48%
controls:0.29%
37
189
6848
68620
26
94
6861
68728
8
21
6879
68801
—
8
16
6873
68700
23
103
6730
66975
28
163
5769
56389
Conjunctival surface anesthesia
WX100 [2001310764]
WX100 [2001310764]
2.0e-01
9.9e-01
8.6e-01
1.0e+50
1.2e+00
1.3e+00
4.5e-01
cases:1.70%
controls:1.40%
cases:1.25%
controls:0.47%
cases:0.12%
controls:0.05%
cases:1.58%
controls:0.00%
cases:0.19%
controls:0.06%
cases:1.61%
controls:0.45%
cases:2.83%
controls:1.82%
117
965
6768
67844
86
321
6801
68501
8
34
6879
68788
109
0
6778
68822
13
38
6868
68678
109
299
6644
66779
164
1027
5633
55525
ANTIHYPERTENSIVE_DRUG - yes
ANTIHYPERTENSIVE_DRUG-1 [2002330215]
ANTIHYPERTENSIVE_DRUG-1 [2002330215]
8.7e-01
1.0e+00
—
—
—
1.1e+00
9.3e-01
cases:0.45%
controls:0.19%
cases:0.38%
controls:0.14%
—
—
—
—
—
—
cases:0.37%
controls:0.12%
cases:0.50%
controls:0.20%
31
130
6854
68679
26
94
6861
68728
—
—
—
25
80
6728
66998
29
112
5768
56440
Other specified disorders of eyelid
H02.8 [45595984]
H02.8 [45595984]
—
3.9e+00
—
1.0e+50
—
1.8e+00
1.2e+00
—
—
cases:0.44%
controls:0.01%
—
—
cases:0.07%
controls:0.00%
—
—
cases:0.07%
controls:0.01%
cases:0.16%
controls:0.05%
—
30
6
6857
68816
—
5
0
6882
68822
—
5
8
6748
67070
9
26
5788
56526
Photography of eyelids and eyebrows
CB9S4 [2001301011]
CB9S4 [2001301011]
1.9e+00
—
—
1.0e+50
—
—
2.0e+00
cases:0.10%
controls:0.02%
—
—
—
—
cases:0.45%
controls:0.00%
—
—
—
—
cases:0.12%
controls:0.02%
7
11
6878
68798
—
—
31
0
6856
68822
—
—
7
9
5790
56543
Emergency Room Visit
ER [9203]
ER [9203]
2.7e-01
2.8e-01
8.3e-02
2.3e+00
3.8e-01
2.8e-01
3.5e-01
cases:38.29%
controls:32.22%
cases:14.40%
controls:11.29%
cases:1.60%
controls:1.47%
cases:0.70%
controls:0.07%
cases:1.99%
controls:1.37%
cases:13.96%
controls:10.90%
cases:38.07%
controls:30.30%
2636
22167
4249
46642
992
7767
5895
61055
110
1013
6777
67809
48
48
6839
68774
137
938
6744
67778
943
7309
5810
59769
2207
17135
3590
39417
Asthma, unspecified
J45.9 [45562456]
J45.9 [45562456]
2.4e-01
2.0e-01
3.7e-01
2.9e+00
4.3e-01
3.9e-01
3.4e-01
cases:4.11%
controls:3.28%
cases:2.02%
controls:1.66%
cases:0.44%
controls:0.30%
cases:0.33%
controls:0.02%
cases:0.45%
controls:0.29%
cases:2.53%
controls:1.74%
cases:5.78%
controls:4.19%
283
2255
6602
66554
139
1140
6748
67682
30
207
6857
68615
23
13
6864
68809
31
201
6850
68515
171
1165
6582
65913
335
2372
5462
54180
Lagophthalmos
H02.2 [45576626]
H02.2 [45576626]
1.3e+00
1.9e+00
—
—
—
—
1.9e+00
cases:0.07%
controls:0.02%
cases:0.10%
controls:0.01%
—
—
—
—
—
—
—
—
cases:0.14%
controls:0.02%
5
14
6880
68795
7
10
6880
68812
—
—
—
—
8
12
5789
56540
CICLOSPORIN - yes
CICLOSPORIN-1 [2002330221]
CICLOSPORIN-1 [2002330221]
1.2e+00
1.3e+00
—
—
—
1.0e+00
1.3e+00
cases:0.20%
controls:0.06%
cases:0.16%
controls:0.04%
—
—
—
—
—
—
cases:0.10%
controls:0.04%
cases:0.22%
controls:0.06%
14
44
6871
68765
11
29
6876
68793
—
—
—
7
25
6746
67053
13
34
5784
56518
Destruction of lesion of head or neck
QAA25 [2001309763]
QAA25 [2001309763]
7.6e-01
1.1e+00
—
1.0e+50
—
1.2e+00
7.8e-01
cases:0.57%
controls:0.26%
cases:0.33%
controls:0.11%
—
—
cases:0.09%
controls:0.00%
—
—
cases:0.43%
controls:0.13%
cases:0.78%
controls:0.36%
39
182
6846
68627
23
77
6864
68745
—
6
0
6881
68822
—
29
90
6724
66988
45
202
5752
56350
Carcinoma in situ: Skin of lower limb, including hip
D04.7 [45590975]
D04.7 [45590975]
1.8e+00
—
—
—
—
2.0e+00
1.0e+00
cases:0.16%
controls:0.03%
—
—
—
—
—
—
—
—
cases:0.09%
controls:0.01%
cases:0.10%
controls:0.04%
11
19
6874
68790
—
—
—
—
6
8
6747
67070
6
21
5791
56531
Pathology report gross observation
24419-4 [3002256]
24419-4 [3002256]
2.5e-01
-6.6e-02
6.3e-01
1.0e+50
1.9e+00
1.2e+00
6.4e-01
cases:2.67%
controls:2.10%
cases:0.71%
controls:0.76%
cases:0.13%
controls:0.07%
cases:0.51%
controls:0.00%
cases:0.33%
controls:0.05%
cases:1.88%
controls:0.59%
cases:4.05%
controls:2.19%
184
1446
6701
67363
49
523
6838
68299
9
48
6878
68774
35
0
6852
68822
23
33
6858
68683
127
395
6626
66683
235
1237
5562
55315
Skin texture symptom/complaint
S21 [2002000986]
S21 [2002000986]
3.7e-01
7.6e-01
6.9e-01
—
1.4e+00
7.0e-01
4.9e-01
cases:2.32%
controls:1.62%
cases:1.32%
controls:0.62%
cases:0.16%
controls:0.08%
—
—
cases:0.32%
controls:0.08%
cases:1.23%
controls:0.62%
cases:3.73%
controls:2.32%
160
1116
6725
67693
91
428
6796
68394
11
55
6876
68767
—
22
57
6859
68659
83
414
6670
66664
216
1313
5581
55239
Dermatological photography
XQ848 [2001310110]
XQ848 [2001310110]
4.6e-01
1.4e+00
—
—
—
1.2e+00
9.8e-01
cases:0.45%
controls:0.28%
cases:0.36%
controls:0.09%
—
—
—
—
—
—
cases:0.31%
controls:0.10%
cases:0.79%
controls:0.30%
31
195
6854
68614
25
59
6862
68763
—
—
—
21
65
6732
67013
46
170
5751
56382
Destruction of lesion of skin of trunk
QBA25 [2001309832]
QBA25 [2001309832]
1.2e+00
1.1e+00
—
—
—
1.4e+00
9.1e-01
cases:0.39%
controls:0.12%
cases:0.09%
controls:0.03%
—
—
—
—
—
—
cases:0.24%
controls:0.06%
cases:0.52%
controls:0.21%
27
83
6858
68726
6
20
6881
68802
—
—
—
16
38
6737
67040
30
118
5767
56434
Haemangioma, any site
D18.0 [45586089]
D18.0 [45586089]
9.7e-01
1.3e+00
—
—
—
9.4e-01
1.2e+00
cases:0.44%
controls:0.17%
cases:0.23%
controls:0.06%
—
—
—
—
—
—
cases:0.15%
controls:0.06%
cases:0.64%
controls:0.19%
30
114
6855
68695
16
42
6871
68780
—
—
—
10
39
6743
67039
37
108
5760
56444
Spinal stenosis
M48.0 [45557888]
M48.0 [45557888]
1.8e-01
1.2e-01
5.4e-02
2.6e+00
2.2e-01
3.8e-01
5.5e-01
cases:2.41%
controls:2.03%
cases:1.12%
controls:0.99%
cases:0.22%
controls:0.21%
cases:0.12%
controls:0.01%
cases:0.26%
controls:0.21%
cases:1.45%
controls:1.00%
cases:4.16%
controls:2.43%
166
1397
6719
67412
77
680
6810
68142
15
142
6872
68680
8
6
6879
68816
18
144
6863
68572
98
672
6655
66406
241
1377
5556
55175
Naevus, non-neoplastic
I78.1 [45533504]
I78.1 [45533504]
8.8e-01
1.7e+00
—
—
—
1.2e+00
9.2e-01
cases:0.39%
controls:0.16%
cases:0.22%
controls:0.04%
—
—
—
—
—
—
cases:0.10%
controls:0.03%
cases:0.38%
controls:0.15%
27
112
6858
68697
15
27
6872
68795
—
—
—
7
22
6746
67056
22
86
5775
56466
Trichilemmal cyst
L72.1 [45596386]
L72.1 [45596386]
6.6e-01
1.1e+00
1.0e+00
1.0e+50
9.6e-01
1.0e+00
7.6e-01
cases:1.10%
controls:0.57%
cases:0.61%
controls:0.21%
cases:0.07%
controls:0.03%
cases:0.13%
controls:0.00%
cases:0.09%
controls:0.03%
cases:0.46%
controls:0.17%
cases:1.52%
controls:0.72%
76
393
6809
68416
42
144
6845
68678
5
18
6882
68804
9
0
6878
68822
6
23
6875
68693
31
114
6722
66964
88
406
5709
56146
Presence of intraocular lens
Z96.1 [45585885]
Z96.1 [45585885]
1.2e-01
7.0e-01
9.9e-01
—
1.0e+00
4.5e-01
3.4e-01
cases:2.05%
controls:1.82%
cases:1.77%
controls:0.89%
cases:0.33%
controls:0.12%
—
—
cases:0.35%
controls:0.13%
cases:1.44%
controls:0.92%
cases:3.97%
controls:2.85%
141
1253
6744
67556
122
611
6765
68211
23
86
6864
68736
—
24
88
6857
68628
97
616
6656
66462
230
1611
5567
54941
Use of laser
ZXC10 [2001311360]
ZXC10 [2001311360]
6.9e-02
—
—
—
—
2.1e+00
1.4e+00
cases:0.13%
controls:0.12%
—
—
—
—
—
—
—
—
cases:0.13%
controls:0.02%
cases:0.33%
controls:0.08%
9
84
6876
68725
—
—
—
—
9
11
6744
67067
19
47
5778
56505
Stenosis and insufficiency of lacrimal passages
H04.5 [45581556]
H04.5 [45581556]
8.5e-01
1.3e+00
2.3e+00
1.0e+50
—
1.3e+00
4.4e-01
cases:0.41%
controls:0.17%
cases:0.32%
controls:0.09%
cases:0.07%
controls:0.01%
cases:0.25%
controls:0.00%
—
—
cases:0.34%
controls:0.09%
cases:0.36%
controls:0.23%
28
120
6857
68689
22
61
6865
68761
5
5
6882
68817
17
0
6870
68822
—
23
62
6730
67016
21
132
5776
56420
Flexible laryngoscopy
UDQ12 [2001301827]
UDQ12 [2001301827]
3.4e-01
6.5e-01
—
—
2.0e+00
8.3e-01
5.6e-01
cases:0.77%
controls:0.55%
cases:0.29%
controls:0.15%
—
—
—
—
cases:0.09%
controls:0.01%
cases:0.34%
controls:0.15%
cases:0.97%
controls:0.56%
53
379
6832
68430
20
104
6867
68718
—
—
6
8
6875
68708
23
100
6730
66978
56
314
5741
56238
Plastic And Reconstructive Surgery
24 [38004467]
24 [38004467]
3.1e-01
4.2e-01
4.7e-01
—
1.1e+00
9.2e-01
5.6e-01
cases:3.89%
controls:2.89%
cases:1.68%
controls:1.12%
cases:0.32%
controls:0.20%
—
—
cases:0.58%
controls:0.19%
cases:2.65%
controls:1.08%
cases:5.11%
controls:2.98%
268
1990
6617
66819
116
769
6771
68053
22
138
6865
68684
—
40
129
6841
68587
179
722
6574
66356
296
1684
5501
54868
Puncture of vitreous body with injection of medication
CKD05 [2001301407]
CKD05 [2001301407]
3.3e-01
7.3e-01
8.4e-01
—
1.1e+00
6.7e-01
1.1e-01
cases:0.94%
controls:0.68%
cases:0.94%
controls:0.46%
cases:0.45%
controls:0.19%
—
—
cases:0.52%
controls:0.18%
cases:0.99%
controls:0.51%
cases:1.16%
controls:1.04%
65
467
6820
68342
65
315
6822
68507
31
134
6856
68688
—
36
124
6845
68592
67
342
6686
66736
67
586
5730
55966
Benign lipomatous neoplasm, unspecified
D17.9 [45537896]
D17.9 [45537896]
1.3e+00
—
—
—
—
2.0e+00
1.0e+00
cases:0.22%
controls:0.06%
—
—
—
—
—
—
—
—
cases:0.10%
controls:0.01%
cases:0.19%
controls:0.07%
15
43
6870
68766
—
—
—
—
7
9
6746
67069
11
39
5786
56513
hypromellose
S01KA02 [21605115]
S01KA02 [21605115]
5.0e-01
6.7e-01
6.5e-01
—
8.4e-01
6.8e-01
6.0e-01
cases:4.23%
controls:2.61%
cases:2.18%
controls:1.13%
cases:0.41%
controls:0.21%
—
—
cases:0.48%
controls:0.21%
cases:2.27%
controls:1.16%
cases:5.28%
controls:2.97%
291
1793
6594
67016
150
777
6737
68045
28
146
6859
68676
—
33
142
6848
68574
153
777
6600
66301
306
1678
5491
54874
Insulin [Units/volume] in Serum or Plasma
20448-7 [3016244]
20448-7 [3016244]
4.1e-01
—
-1.0e+50
—
—
1.9e+00
1.3e+00
cases:0.12%
controls:0.08%
—
—
cases:0.00%
controls:0.01%
—
—
—
—
cases:0.10%
controls:0.01%
cases:0.22%
controls:0.06%
8
53
6877
68756
—
0
5
6887
68817
—
—
7
10
6746
67068
13
33
5784
56519
Obesity due to excess calories
E66.01 [2000501501]
E66.01 [2000501501]
4.9e-01
6.0e-01
1.0e+00
—
8.8e-01
6.6e-01
4.2e-01
cases:1.50%
controls:0.92%
cases:0.81%
controls:0.45%
cases:0.23%
controls:0.08%
—
—
cases:0.20%
controls:0.08%
cases:0.95%
controls:0.49%
cases:1.90%
controls:1.26%
103
636
6782
68173
56
307
6831
68515
16
58
6871
68764
—
14
58
6867
68658
64
330
6689
66748
110
712
5687
55840
Inflammation of eyelid, unspecified
H01.9 [45557271]
H01.9 [45557271]
1.2e+00
2.0e+00
—
—
—
1.4e+00
2.9e-01
cases:0.19%
controls:0.06%
cases:0.13%
controls:0.02%
—
—
—
—
—
—
cases:0.07%
controls:0.02%
cases:0.17%
controls:0.13%
13
41
6872
68768
9
12
6878
68810
—
—
—
5
12
6748
67066
10
73
5787
56479
Malignant tumor of the skin on another or unspecified part of the face without histology
C44.30 [2000500791]
C44.30 [2000500791]
6.2e-01
9.5e-01
—
—
1.0e+50
1.9e+00
1.3e+00
cases:0.20%
controls:0.11%
cases:0.10%
controls:0.04%
—
—
—
—
cases:0.09%
controls:0.00%
cases:0.16%
controls:0.03%
cases:0.36%
controls:0.10%
14
75
6871
68734
7
27
6880
68795
—
—
6
0
6875
68716
11
17
6742
67061
21
58
5776
56494
Optical coherence tomography (OCT) of ocular fundus
CK2X4 [2001301456]
CK2X4 [2001301456]
2.5e-01
9.1e-01
7.8e-01
—
1.0e+00
7.4e-01
4.5e-01
cases:1.45%
controls:1.14%
cases:1.26%
controls:0.51%
cases:0.22%
controls:0.10%
—
—
cases:0.25%
controls:0.09%
cases:1.20%
controls:0.58%
cases:2.57%
controls:1.66%
100
782
6785
68027
87
352
6800
68470
15
69
6872
68753
—
17
61
6864
68655
81
386
6672
66692
149
939
5648
55613
Diverticular disease of large intestine without perforation or abscess
K57.3 [45567316]
K57.3 [45567316]
3.7e-01
1.8e-01
8.5e-01
—
9.2e-01
4.5e-01
5.0e-01
cases:3.98%
controls:2.77%
cases:1.28%
controls:1.07%
cases:0.32%
controls:0.14%
—
—
cases:0.41%
controls:0.16%
cases:1.72%
controls:1.10%
cases:5.71%
controls:3.55%
274
1906
6611
66903
88
736
6799
68086
22
94
6865
68728
—
28
112
6853
68604
116
737
6637
66341
331
2008
5466
54544
More than one and less than three hours
ZXE10 [2001311401]
ZXE10 [2001311401]
2.8e-01
4.1e-01
5.9e-01
—
9.0e-01
8.8e-01
6.0e-01
cases:7.39%
controls:5.70%
cases:2.12%
controls:1.42%
cases:0.25%
controls:0.14%
—
—
cases:0.28%
controls:0.11%
cases:2.64%
controls:1.11%
cases:7.26%
controls:4.12%
509
3919
6376
64890
146
978
6741
67844
17
94
6870
68728
—
19
77
6862
68639
178
742
6575
66336
421
2329
5376
54223
mesalazine; oral, rectal
A07EC02 [21600664]
A07EC02 [21600664]
5.1e-01
6.2e-01
5.9e-01
—
8.3e-01
5.8e-01
5.2e-01
cases:1.48%
controls:0.89%
cases:1.26%
controls:0.68%
cases:0.46%
controls:0.26%
—
—
cases:0.52%
controls:0.23%
cases:1.21%
controls:0.68%
cases:1.45%
controls:0.87%
102
615
6783
68194
87
471
6800
68351
32
178
6855
68644
—
36
158
6845
68558
82
457
6671
66621
84
490
5713
56062
Attention to surgical dressings and sutures
Z48.0 [45609943]
Z48.0 [45609943]
-1.9e-01
5.8e-01
—
—
3.0e+00
5.1e-01
-2.2e-01
cases:0.29%
controls:0.35%
cases:0.25%
controls:0.14%
—
—
—
—
cases:0.31%
controls:0.01%
cases:0.25%
controls:0.15%
cases:0.50%
controls:0.62%
20
242
6865
68567
17
95
6870
68727
—
—
21
10
6860
68706
17
101
6736
66977
29
353
5768
56199
Cervical spine MRI examination with high intensity magnet
NA1BG [2001306990]
NA1BG [2001306990]
5.1e-01
8.2e-01
-1.0e+50
—
—
1.1e+00
6.0e-01
cases:0.77%
controls:0.47%
cases:0.30%
controls:0.14%
cases:0.00%
controls:0.02%
—
—
—
—
cases:0.33%
controls:0.11%
cases:0.79%
controls:0.43%
53
320
6832
68489
21
93
6866
68729
0
11
6887
68811
—
—
22
73
6731
67005
46
246
5751
56306
General Surgery
2 [38004447]
2 [38004447]
2.1e-01
1.7e-01
-1.4e-01
2.2e+00
3.2e-01
2.3e-01
2.0e-01
cases:22.70%
controls:19.28%
cases:6.98%
controls:5.94%
cases:0.77%
controls:0.88%
cases:0.45%
controls:0.05%
cases:1.05%
controls:0.77%
cases:6.97%
controls:5.60%
cases:18.46%
controls:15.70%
1563
13265
5322
55544
481
4088
6406
64734
53
607
6834
68215
31
34
6856
68788
72
526
6809
68190
471
3758
6282
63320
1070
8879
4727
47673
Cardiac arrhythmia NOS
K80 [2002000607]
K80 [2002000607]
4.1e-01
3.0e-01
—
—
1.5e+00
6.3e-01
4.6e-01
cases:1.32%
controls:0.88%
cases:0.41%
controls:0.30%
—
—
—
—
cases:0.13%
controls:0.03%
cases:0.55%
controls:0.29%
cases:1.78%
controls:1.12%
91
607
6794
68202
28
208
6859
68614
—
—
9
20
6872
68696
37
196
6716
66882
103
636
5694
55916
Lump/swelling localized
S04 [2002000969]
S04 [2002000969]
3.9e-01
8.8e-01
1.7e+00
—
1.2e+00
5.2e-01
3.3e-01
cases:1.58%
controls:1.08%
cases:0.86%
controls:0.36%
cases:0.17%
controls:0.03%
—
—
cases:0.09%
controls:0.03%
cases:0.52%
controls:0.31%
cases:1.88%
controls:1.35%
109
745
6776
68064
59
245
6828
68577
12
22
6875
68800
—
6
18
6875
68698
35
208
6718
66870
109
766
5688
55786
Type 2 diabetes mellitus, without complications
E11.9 [45561952]
E11.9 [45561952]
-1.9e-02
1.3e-01
1.9e-01
2.9e+00
4.5e-01
8.0e-02
9.8e-02
cases:5.69%
controls:5.80%
cases:3.44%
controls:3.03%
cases:0.65%
controls:0.54%
cases:0.46%
controls:0.02%
cases:0.80%
controls:0.51%
cases:3.60%
controls:3.33%
cases:8.61%
controls:7.87%
392
3990
6493
64819
237
2087
6650
66735
45
374
6842
68448
32
17
6855
68805
55
350
6826
68366
243
2235
6510
64843
499
4451
5298
52101
betamethasone
S03BA03 [21605203]
S03BA03 [21605203]
5.1e-01
4.9e-01
3.6e-01
—
9.4e-01
4.9e-01
5.0e-01
cases:3.53%
controls:2.16%
cases:1.51%
controls:0.93%
cases:0.15%
controls:0.10%
—
—
cases:0.31%
controls:0.12%
cases:1.47%
controls:0.90%
cases:3.52%
controls:2.17%
243
1483
6642
67326
104
639
6783
68183
10
70
6877
68752
—
21
82
6860
68634
99
605
6654
66473
204
1229
5593
55323
Kidney transplant status
Z94.0 [45566477]
Z94.0 [45566477]
7.6e-01
9.2e-01
8.5e-01
—
8.9e-01
9.5e-01
1.0e+00
cases:0.32%
controls:0.15%
cases:0.36%
controls:0.15%
cases:0.16%
controls:0.07%
—
—
cases:0.15%
controls:0.06%
cases:0.40%
controls:0.16%
cases:0.45%
controls:0.16%
22
103
6863
68706
25
100
6862
68722
11
47
6876
68775
—
10
41
6871
68675
27
104
6726
66974
26
90
5771
56462
colestyramine; oral
C10AC01 [21601876]
C10AC01 [21601876]
7.2e-01
8.7e-01
—
—
—
1.1e+00
1.0e+00
cases:0.49%
controls:0.24%
cases:0.25%
controls:0.10%
—
—
—
—
—
—
cases:0.33%
controls:0.11%
cases:0.67%
controls:0.25%
34
165
6851
68644
17
71
6870
68751
—
—
—
22
72
6731
67006
39
139
5758
56413
fusidic acid; ointment
D06AX01 [21602062]
D06AX01 [21602062]
4.8e-01
4.5e-01
9.3e-01
—
3.8e-01
4.5e-01
5.4e-01
cases:4.84%
controls:3.04%
cases:1.48%
controls:0.95%
cases:0.26%
controls:0.10%
—
—
cases:0.15%
controls:0.10%
cases:1.55%
controls:1.00%
cases:5.92%
controls:3.55%
333
2091
6552
66718
102
655
6785
68167
18
71
6869
68751
—
10
68
6871
68648
105
671
6648
66407
343
2005
5454
54547
fusidic acid
D09AA02 [21602265]
D09AA02 [21602265]
4.8e-01
4.5e-01
9.3e-01
—
3.8e-01
4.5e-01
5.4e-01
cases:4.84%
controls:3.04%
cases:1.48%
controls:0.95%
cases:0.26%
controls:0.10%
—
—
cases:0.15%
controls:0.10%
cases:1.55%
controls:1.00%
cases:5.92%
controls:3.55%
333
2091
6552
66718
102
655
6785
68167
18
71
6869
68751
—
10
68
6871
68648
105
671
6648
66407
343
2005
5454
54547
Other minor procedure on skin
TQW99 [2001310150]
TQW99 [2001310150]
6.2e-01
5.6e-01
—
—
1.6e+00
1.2e+00
1.0e+00
cases:0.83%
controls:0.45%
cases:0.28%
controls:0.16%
—
—
—
—
cases:0.10%
controls:0.02%
cases:0.46%
controls:0.14%
cases:1.26%
controls:0.45%
57
307
6828
68502
19
109
6868
68713
—
—
7
14
6874
68702
31
94
6722
66984
73
256
5724
56296
Congenital non-neoplastic naevus
Q82.58 [2000503507]
Q82.58 [2000503507]
4.6e-01
2.8e+00
—
—
—
—
1.1e+00
cases:0.09%
controls:0.06%
cases:0.15%
controls:0.01%
—
—
—
—
—
—
—
—
cases:0.14%
controls:0.05%
6
38
6879
68771
10
6
6877
68816
—
—
—
—
8
26
5789
56526
Chronic atrial fibrillation
I48.2 [45591467]
I48.2 [45591467]
1.7e-01
7.0e-01
5.4e-01
2.8e+00
9.2e-01
5.1e-01
1.5e-01
cases:0.19%
controls:0.16%
cases:0.35%
controls:0.17%
cases:0.09%
controls:0.05%
cases:0.15%
controls:0.01%
cases:0.13%
controls:0.05%
cases:0.40%
controls:0.24%
cases:0.74%
controls:0.64%
13
110
6872
68699
24
119
6863
68703
6
35
6881
68787
10
6
6877
68816
9
36
6872
68680
27
162
6726
66916
43
363
5754
56189
Conjunctivitis, unspecified
H10.9 [45591253]
H10.9 [45591253]
4.9e-01
8.6e-01
1.9e+00
—
1.7e+00
2.1e-01
2.4e-01
cases:0.73%
controls:0.45%
cases:0.39%
controls:0.17%
cases:0.10%
controls:0.01%
—
—
cases:0.10%
controls:0.02%
cases:0.22%
controls:0.18%
cases:0.91%
controls:0.72%
50
307
6835
68502
27
114
6860
68708
7
10
6880
68812
—
7
13
6874
68703
15
121
6738
66957
53
409
5744
56143
Other operation on eyelid for malposition
CBN99 [2001301006]
CBN99 [2001301006]
—
—
—
—
—
2.8e+00
6.0e-01
—
—
—
—
—
—
—
—
—
—
cases:0.12%
controls:0.01%
cases:0.10%
controls:0.06%
—
—
—
—
—
8
5
6745
67073
6
32
5791
56520
Flap of skin
ZZR00 [2001311677]
ZZR00 [2001311677]
5.4e-01
7.8e-01
—
—
—
1.8e+00
9.5e-01
cases:0.31%
controls:0.18%
cases:0.10%
controls:0.05%
—
—
—
—
—
—
cases:0.28%
controls:0.05%
cases:0.41%
controls:0.16%
21
122
6864
68687
7
32
6880
68790
—
—
—
19
31
6734
67047
24
91
5773
56461
Medical observation and evaluation for suspected diseases and conditions, ruled out
Z03 [45552058]
Z03 [45552058]
4.5e-01
8.4e-01
1.2e+00
—
—
8.0e-01
6.4e-01
cases:1.37%
controls:0.87%
cases:0.55%
controls:0.24%
cases:0.09%
controls:0.03%
—
—
—
—
cases:0.53%
controls:0.24%
cases:1.60%
controls:0.85%
94
601
6791
68208
38
164
6849
68658
6
18
6881
68804
—
—
36
161
6717
66917
93
481
5704
56071
Arthrocentesis, unspecified region, unspecified region
TNX10 [2001308560]
TNX10 [2001308560]
6.9e-01
6.2e-01
—
—
—
7.2e-01
7.0e-01
cases:1.50%
controls:0.76%
cases:0.51%
controls:0.27%
—
—
—
—
—
—
cases:0.52%
controls:0.25%
cases:1.33%
controls:0.66%
103
521
6782
68288
35
188
6852
68634
—
—
—
35
169
6718
66909
77
375
5720
56177
Deposits [accretions] on teeth betel
K03.65 [2000502690]
K03.65 [2000502690]
3.3e-01
4.9e-01
1.2e+00
—
—
3.9e-01
3.8e-01
cases:3.79%
controls:2.76%
cases:1.35%
controls:0.84%
cases:0.26%
controls:0.08%
—
—
—
—
cases:1.32%
controls:0.90%
cases:4.76%
controls:3.30%
261
1896
6624
66913
93
575
6794
68247
18
57
6869
68765
—
—
89
603
6664
66475
276
1866
5521
54686
Intubation of lacrimal canaliculus/duct
TCC30 [2001301047]
TCC30 [2001301047]
1.3e+00
—
—
—
—
2.7e+00
5.9e-01
cases:0.16%
controls:0.05%
—
—
—
—
—
—
—
—
cases:0.25%
controls:0.02%
cases:0.09%
controls:0.05%
11
31
6874
68778
—
—
—
—
17
11
6736
67067
5
27
5792
56525
Eye discharge
F03 [2002000401]
F03 [2002000401]
4.5e-01
9.3e-01
1.8e+00
—
—
7.3e-01
3.1e-01
cases:0.94%
controls:0.61%
cases:0.55%
controls:0.22%
cases:0.13%
controls:0.02%
—
—
—
—
cases:0.36%
controls:0.17%
cases:1.09%
controls:0.80%
65
417
6820
68392
38
151
6849
68671
9
15
6878
68807
—
—
24
115
6729
66963
63
454
5734
56098
Carcinoma in situ: Skin of trunk
D04.5 [45576373]
D04.5 [45576373]
—
1.4e+00
—
—
—
1.5e+00
1.3e+00
—
—
cases:0.10%
controls:0.02%
—
—
—
—
—
—
cases:0.15%
controls:0.03%
cases:0.26%
controls:0.07%
—
7
17
6880
68805
—
—
—
10
23
6743
67055
15
42
5782
56510
Plain photography of ocular fundus
CK2S4 [2001301455]
CK2S4 [2001301455]
1.6e-01
1.1e+00
7.4e-01
—
1.0e+00
1.1e+00
5.7e-01
cases:0.77%
controls:0.66%
cases:0.87%
controls:0.30%
cases:0.12%
controls:0.06%
—
—
cases:0.15%
controls:0.05%
cases:0.92%
controls:0.32%
cases:1.55%
controls:0.89%
53
454
6832
68355
60
206
6827
68616
8
38
6879
68784
—
10
36
6871
68680
62
215
6691
66863
90
502
5707
56050
Xanthelasma of eyelid
H02.6 [45547786]
H02.6 [45547786]
—
—
—
—
—
—
2.7e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.16%
controls:0.01%
—
—
—
—
—
—
9
6
5788
56546
Use of chemical agents
ZXC20 [2001311366]
ZXC20 [2001311366]
7.2e-01
5.3e-01
—
—
—
1.5e+00
1.2e+00
cases:0.33%
controls:0.16%
cases:0.10%
controls:0.06%
—
—
—
—
—
—
cases:0.15%
controls:0.03%
cases:0.38%
controls:0.12%
23
112
6862
68697
7
41
6880
68781
—
—
—
10
22
6743
67056
22
67
5775
56485
Type 2 diabetes mellitus, with unspecified complications
E11.8 [45561951]
E11.8 [45561951]
-8.6e-02
2.5e-01
4.7e-01
2.7e+00
7.4e-02
-4.8e-02
3.1e-02
cases:1.22%
controls:1.33%
cases:0.93%
controls:0.72%
cases:0.23%
controls:0.15%
cases:0.15%
controls:0.01%
cases:0.16%
controls:0.15%
cases:0.84%
controls:0.89%
cases:2.43%
controls:2.36%
84
914
6801
67895
64
497
6823
68325
16
100
6871
68722
10
7
6877
68815
11
102
6870
68614
57
594
6696
66484
141
1334
5656
55218
Acute and unspecified inflammation of lacrimal passages
H04.3 [45547794]
H04.3 [45547794]
—
2.6e+00
—
—
—
—
4.9e-01
—
—
cases:0.10%
controls:0.01%
—
—
—
—
—
—
—
—
cases:0.09%
controls:0.05%
—
7
5
6880
68817
—
—
—
—
5
30
5792
56522
ibuprofen
R02AX02 [1588667]
R02AX02 [1588667]
2.7e-01
2.2e-01
1.7e-01
1.6e+00
7.1e-02
3.0e-01
2.6e-01
cases:39.29%
controls:33.11%
cases:17.50%
controls:14.56%
cases:2.50%
controls:2.11%
cases:0.35%
controls:0.07%
cases:2.27%
controls:2.11%
cases:18.29%
controls:14.27%
cases:38.57%
controls:32.64%
2705
22780
4180
46029
1205
10022
5682
58800
172
1452
6715
67370
24
51
6863
68771
156
1453
6725
67263
1235
9572
5518
57506
2236
18458
3561
38094
ibuprofen; oral, parenteral, rectal
M01AE01 [21603967]
M01AE01 [21603967]
2.7e-01
2.2e-01
1.7e-01
1.6e+00
7.1e-02
3.0e-01
2.6e-01
cases:39.29%
controls:33.11%
cases:17.50%
controls:14.56%
cases:2.50%
controls:2.11%
cases:0.35%
controls:0.07%
cases:2.27%
controls:2.11%
cases:18.29%
controls:14.27%
cases:38.57%
controls:32.64%
2705
22780
4180
46029
1205
10022
5682
58800
172
1452
6715
67370
24
51
6863
68771
156
1453
6725
67263
1235
9572
5518
57506
2236
18458
3561
38094
Hypothyroidism, unspecified
E03.9 [45537945]
E03.9 [45537945]
-3.7e-02
3.7e-03
-1.1e-01
2.6e+00
-1.6e-01
-1.0e-01
1.6e-01
cases:1.95%
controls:2.02%
cases:1.00%
controls:1.00%
cases:0.15%
controls:0.16%
cases:0.12%
controls:0.01%
cases:0.17%
controls:0.21%
cases:0.95%
controls:1.05%
cases:3.50%
controls:3.01%
134
1388
6751
67421
69
687
6818
68135
10
112
6877
68710
8
6
6879
68816
12
141
6869
68575
64
703
6689
66375
203
1703
5594
54849
Scoliosis, unspecified
M41.9 [45591832]
M41.9 [45591832]
1.1e+00
1.5e+00
-1.0e+50
—
—
1.0e+00
5.9e-01
cases:0.28%
controls:0.10%
cases:0.17%
controls:0.04%
cases:0.00%
controls:0.01%
—
—
—
—
cases:0.09%
controls:0.03%
cases:0.24%
controls:0.13%
19
66
6866
68743
12
26
6875
68796
0
5
6887
68817
—
—
6
22
6747
67056
14
76
5783
56476
Gastroenterology
10 [38004455]
10 [38004455]
4.1e-01
3.8e-01
3.5e-01
—
6.7e-01
5.9e-01
5.2e-01
cases:7.57%
controls:5.16%
cases:3.17%
controls:2.18%
cases:0.57%
controls:0.40%
—
—
cases:0.77%
controls:0.39%
cases:3.70%
controls:2.09%
cases:9.80%
controls:6.06%
521
3552
6364
65257
218
1499
6669
67323
39
274
6848
68548
—
53
271
6828
68445
250
1403
6503
65675
568
3429
5229
53123
Fall on same level from slipping, tripping and stumbling
W01 [45756243]
W01 [45756243]
4.3e-02
-3.0e-02
-4.3e-01
2.6e+00
-1.3e-02
-9.7e-03
7.0e-02
cases:4.30%
controls:4.13%
cases:1.50%
controls:1.54%
cases:0.15%
controls:0.22%
cases:0.13%
controls:0.01%
cases:0.25%
controls:0.25%
cases:1.58%
controls:1.60%
cases:6.43%
controls:6.02%
296
2839
6589
65970
103
1060
6784
67762
10
154
6877
68668
9
7
6878
68815
17
172
6864
68544
107
1073
6646
66005
373
3407
5424
53145
Other specified inflammation of eyelids
H01.89 [2000502241]
H01.89 [2000502241]
1.0e+00
2.6e+00
—
—
—
—
1.3e+00
cases:0.09%
controls:0.03%
cases:0.13%
controls:0.01%
—
—
—
—
—
—
—
—
cases:0.16%
controls:0.04%
6
22
6879
68787
9
7
6878
68815
—
—
—
—
9
23
5788
56529
Mouth breathing
R06.5 [45573006]
R06.5 [45573006]
4.8e-01
7.9e-01
—
—
—
7.6e-01
5.2e-01
cases:1.12%
controls:0.69%
cases:0.42%
controls:0.19%
—
—
—
—
—
—
cases:0.36%
controls:0.17%
cases:0.97%
controls:0.57%
77
477
6808
68332
29
132
6858
68690
—
—
—
24
112
6729
66966
56
325
5741
56227
Panorama tomography of teeth and jaws or similar X-ray examination
EB1HA [2001301913]
EB1HA [2001301913]
3.2e-01
3.7e-01
1.0e+00
—
4.7e-01
3.9e-01
4.5e-01
cases:9.03%
controls:6.74%
cases:2.66%
controls:1.86%
cases:0.39%
controls:0.14%
—
—
cases:0.22%
controls:0.14%
cases:2.61%
controls:1.78%
cases:10.14%
controls:6.71%
622
4641
6263
64168
183
1277
6704
67545
27
99
6860
68723
—
15
94
6866
68622
176
1195
6577
65883
588
3792
5209
52760
Other specified chronic obstructive pulmonary disease
J44.8 [45586673]
J44.8 [45586673]
2.8e-02
4.5e-02
-3.1e-01
2.5e+00
3.8e-01
-1.4e-01
9.1e-02
cases:1.73%
controls:1.68%
cases:1.09%
controls:1.04%
cases:0.17%
controls:0.24%
cases:0.16%
controls:0.01%
cases:0.29%
controls:0.20%
cases:0.99%
controls:1.14%
cases:2.43%
controls:2.22%
119
1157
6766
67652
75
717
6812
68105
12
164
6875
68658
11
9
6876
68813
20
137
6861
68579
67
764
6686
66314
141
1258
5656
55294
Other excision or destruction of lesion of eyelid
CBB99 [2001300937]
CBB99 [2001300937]
—
—
—
1.0e+50
—
—
2.5e+00
—
—
—
—
—
—
cases:2.25%
controls:0.00%
—
—
—
—
cases:0.17%
controls:0.01%
—
—
—
155
0
6732
68822
—
—
10
8
5787
56544
Person consulting for explanation of investigation findings
Z71.2 [45552100]
Z71.2 [45552100]
3.1e-01
3.9e-01
8.3e-01
-1.0e+50
6.7e-01
5.3e-01
4.3e-01
cases:5.26%
controls:3.90%
cases:2.48%
controls:1.70%
cases:0.45%
controls:0.20%
cases:0.00%
controls:0.01%
cases:0.41%
controls:0.21%
cases:3.14%
controls:1.87%
cases:8.35%
controls:5.62%
362
2684
6523
66125
171
1167
6716
67655
31
135
6856
68687
0
6
6887
68816
28
144
6853
68572
212
1256
6541
65822
484
3176
5313
53376
Plastic repair of levator aponeurosis of eyelid
CBJ30 [2001300983]
CBJ30 [2001300983]
—
—
—
—
—
2.5e+00
1.2e+00
—
—
—
—
—
—
—
—
—
—
cases:0.09%
controls:0.01%
cases:0.12%
controls:0.04%
—
—
—
—
—
6
5
6747
67073
7
20
5790
56532
General anesthesia, balanced
WX408 [2001310808]
WX408 [2001310808]
3.5e-01
4.5e-01
1.5e-01
—
8.6e-02
8.7e-01
8.1e-01
cases:4.84%
controls:3.47%
cases:1.39%
controls:0.89%
cases:0.10%
controls:0.09%
—
—
cases:0.09%
controls:0.08%
cases:1.51%
controls:0.64%
cases:5.26%
controls:2.42%
333
2387
6552
66422
96
613
6791
68209
7
60
6880
68762
—
6
55
6875
68661
102
430
6651
66648
305
1369
5492
55183
Photography of conjunctiva
CF2S4 [2001301141]
CF2S4 [2001301141]
—
—
—
1.0e+50
—
—
2.5e+00
—
—
—
—
—
—
cases:0.12%
controls:0.00%
—
—
—
—
cases:0.10%
controls:0.01%
—
—
—
8
0
6879
68822
—
—
6
5
5791
56547
Benign neoplasm: Orbit, unspecified
D31.6 [45566682]
D31.6 [45566682]
—
—
—
—
—
—
2.5e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.10%
controls:0.01%
—
—
—
—
—
—
6
5
5791
56547
Extensive MRI examination of neck vasculature with high intensity magnet
PA6CG [2001308703]
PA6CG [2001308703]
—
—
—
—
—
—
2.5e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.10%
controls:0.01%
—
—
—
—
—
—
6
5
5791
56547
Sequelae of cerebral infarction
I69.3 [45533476]
I69.3 [45533476]
-3.3e-02
-9.9e-02
5.8e-02
2.5e+00
4.1e-01
-6.7e-02
5.2e-02
cases:0.89%
controls:0.92%
cases:0.48%
controls:0.53%
cases:0.10%
controls:0.10%
cases:0.10%
controls:0.01%
cases:0.15%
controls:0.10%
cases:0.58%
controls:0.62%
cases:1.71%
controls:1.62%
61
630
6824
68179
33
364
6854
68458
7
66
6880
68756
7
6
6880
68816
10
66
6871
68650
39
414
6714
66664
99
918
5698
55634
Hudhorn
L85.80 [2000502969]
L85.80 [2000502969]
1.4e+00
2.5e+00
—
—
—
—
1.3e+00
cases:0.12%
controls:0.03%
cases:0.10%
controls:0.01%
—
—
—
—
—
—
—
—
cases:0.16%
controls:0.04%
8
19
6877
68790
7
6
6880
68816
—
—
—
—
9
23
5788
56529
carbamide
D02AE01 [21601975]
D02AE01 [21601975]
6.7e-01
6.9e-01
8.2e-01
—
1.1e+00
1.0e+00
7.4e-01
cases:1.05%
controls:0.54%
cases:0.41%
controls:0.20%
cases:0.07%
controls:0.03%
—
—
cases:0.07%
controls:0.02%
cases:0.52%
controls:0.18%
cases:1.00%
controls:0.48%
72
370
6813
68439
28
141
6859
68681
5
22
6882
68800
—
5
17
6876
68699
35
123
6718
66955
58
271
5739
56281
Correction of lax skin and resection of herniated fat in upper eyelid
CBB21 [2001300930]
CBB21 [2001300930]
—
—
—
1.0e+50
—
2.5e+00
8.0e-01
—
—
—
—
—
—
cases:0.15%
controls:0.00%
—
—
cases:0.10%
controls:0.01%
cases:0.09%
controls:0.04%
—
—
—
10
0
6877
68822
—
7
6
6746
67072
5
22
5792
56530
Resection of levator muscle of eyelid
CBJ40 [2001300984]
CBJ40 [2001300984]
6.9e-01
1.6e+00
—
—
—
2.5e+00
1.4e+00
cases:0.09%
controls:0.04%
cases:0.09%
controls:0.02%
—
—
—
—
—
—
cases:0.10%
controls:0.01%
cases:0.14%
controls:0.04%
6
30
6879
68779
6
12
6881
68810
—
—
—
7
6
6746
67072
8
20
5789
56532
Other disorders of vitreous body
H43.8 [45533329]
H43.8 [45533329]
3.7e-01
8.1e-01
1.3e+00
—
7.3e-01
5.7e-01
2.7e-01
cases:1.42%
controls:0.99%
cases:0.73%
controls:0.32%
cases:0.17%
controls:0.05%
—
—
cases:0.09%
controls:0.04%
cases:0.58%
controls:0.33%
cases:1.67%
controls:1.29%
98
680
6787
68129
50
223
6837
68599
12
34
6875
68788
—
6
29
6875
68687
39
220
6714
66858
97
728
5700
55824
Hordeolum and chalazion
H00 [45755391]
H00 [45755391]
8.3e-01
2.4e+00
—
—
—
—
8.7e-01
cases:0.12%
controls:0.05%
cases:0.23%
controls:0.02%
—
—
—
—
—
—
—
—
cases:0.19%
controls:0.08%
8
35
6877
68774
16
14
6871
68808
—
—
—
—
11
45
5786
56507
Atherosclerotic heart disease
I25.1 [45596196]
I25.1 [45596196]
2.9e-02
-2.0e-02
1.3e-01
2.4e+00
3.4e-01
5.1e-02
1.5e-01
cases:4.81%
controls:4.68%
cases:2.45%
controls:2.50%
cases:0.46%
controls:0.41%
cases:0.39%
controls:0.03%
cases:0.65%
controls:0.47%
cases:2.80%
controls:2.66%
cases:7.26%
controls:6.30%
331
3218
6554
65591
169
1722
6718
67100
32
282
6855
68540
27
24
6860
68798
45
320
6836
68396
189
1786
6564
65292
421
3562
5376
52990
Disorder of skin and subcutaneous tissue, unspecified
L98.9 [45562566]
L98.9 [45562566]
1.3e+00
1.3e+00
—
—
—
1.3e+00
1.1e+00
cases:0.26%
controls:0.07%
cases:0.12%
controls:0.03%
—
—
—
—
—
—
cases:0.07%
controls:0.02%
cases:0.29%
controls:0.10%
18
50
6867
68759
8
21
6879
68801
—
—
—
5
13
6748
67065
17
54
5780
56498
Upper respiratory infection acute
R74 [2002000942]
R74 [2002000942]
3.4e-01
3.3e-01
9.1e-01
—
4.4e-01
4.0e-01
4.1e-01
cases:5.50%
controls:3.97%
cases:1.90%
controls:1.37%
cases:0.33%
controls:0.14%
—
—
cases:0.26%
controls:0.17%
cases:2.09%
controls:1.41%
cases:7.07%
controls:4.79%
379
2732
6506
66077
131
942
6756
67880
23
93
6864
68729
—
18
116
6863
68600
141
944
6612
66134
410
2708
5387
53844
Atherosclerosis of arteries of extremities
I70.2 [45538421]
I70.2 [45538421]
-2.4e-02
-6.0e-02
3.8e-01
2.4e+00
-6.6e-02
3.0e-01
2.0e-01
cases:1.45%
controls:1.49%
cases:0.77%
controls:0.82%
cases:0.30%
controls:0.21%
cases:0.17%
controls:0.02%
cases:0.17%
controls:0.19%
cases:1.17%
controls:0.87%
cases:2.38%
controls:1.96%
100
1023
6785
67786
53
562
6834
68260
21
144
6866
68678
12
11
6875
68811
12
128
6869
68588
79
585
6674
66493
138
1106
5659
55446
Hand/finger symptom/complaint
L12 [2002000636]
L12 [2002000636]
2.1e-01
2.5e-01
1.2e+00
—
5.7e-01
6.5e-01
5.0e-01
cases:2.21%
controls:1.80%
cases:0.77%
controls:0.60%
cases:0.20%
controls:0.06%
—
—
cases:0.13%
controls:0.07%
cases:1.18%
controls:0.62%
cases:3.78%
controls:2.32%
152
1240
6733
67569
53
415
6834
68407
14
41
6873
68781
—
9
51
6872
68665
80
418
6673
66660
219
1310
5578
55242
Impingement syndrome of shoulder
M75.4 [45553266]
M75.4 [45553266]
3.2e-01
9.7e-01
9.2e-01
—
—
7.9e-01
6.2e-01
cases:0.90%
controls:0.66%
cases:0.46%
controls:0.18%
cases:0.07%
controls:0.03%
—
—
—
—
cases:0.33%
controls:0.15%
cases:1.00%
controls:0.54%
62
451
6823
68358
32
122
6855
68700
5
20
6882
68802
—
—
22
99
6731
66979
58
307
5739
56245
Periodontal treatment by dental hygienist, extensive
SDE03 [2001310351]
SDE03 [2001310351]
3.9e-01
7.7e-01
8.4e-01
—
—
6.4e-01
5.6e-01
cases:4.69%
controls:3.23%
cases:1.52%
controls:0.71%
cases:0.19%
controls:0.08%
—
—
—
—
cases:1.42%
controls:0.75%
cases:4.85%
controls:2.84%
323
2224
6562
66585
105
488
6782
68334
13
56
6874
68766
—
—
96
504
6657
66574
281
1605
5516
54947
Acute conjunctivitis, unspecified
H10.3 [45566958]
H10.3 [45566958]
6.4e-01
1.1e+00
—
—
—
6.5e-01
6.2e-01
cases:0.92%
controls:0.48%
cases:0.45%
controls:0.15%
—
—
—
—
—
—
cases:0.30%
controls:0.16%
cases:1.21%
controls:0.66%
63
332
6822
68477
31
104
6856
68718
—
—
—
20
104
6733
66974
70
371
5727
56181
Epilation of cilia by electrolysis
CBG00 [2001300965]
CBG00 [2001300965]
—
—
—
—
—
—
2.4e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.24%
controls:0.02%
—
—
—
—
—
—
14
13
5783
56539
Conjunctivitis
H10 [45581570]
H10 [45581570]
7.6e-01
1.0e+00
1.9e+00
—
—
5.0e-01
5.8e-01
cases:0.94%
controls:0.44%
cases:0.42%
controls:0.15%
cases:0.09%
controls:0.01%
—
—
—
—
cases:0.28%
controls:0.17%
cases:1.10%
controls:0.62%
65
306
6820
68503
29
106
6858
68716
6
9
6881
68813
—
—
19
115
6734
66963
64
350
5733
56202
Hypertrophy of breast
N62 [45577538]
N62 [45577538]
4.6e-01
6.8e-01
—
—
1.6e+00
1.2e+00
1.1e+00
cases:0.57%
controls:0.36%
cases:0.20%
controls:0.10%
—
—
—
—
cases:0.07%
controls:0.01%
cases:0.31%
controls:0.09%
cases:0.88%
controls:0.29%
39
246
6846
68563
14
71
6873
68751
—
—
5
10
6876
68706
21
61
6732
67017
51
164
5746
56388
metronidazole; oral, rectal
P01AB01 [21604857]
P01AB01 [21604857]
3.1e-01
4.1e-01
-2.7e-01
—
7.8e-01
4.6e-01
3.9e-01
cases:9.16%
controls:6.90%
cases:2.67%
controls:1.79%
cases:0.17%
controls:0.23%
—
—
cases:0.36%
controls:0.17%
cases:2.74%
controls:1.74%
cases:8.92%
controls:6.23%
631
4748
6254
64061
184
1234
6703
67588
12
157
6875
68665
—
25
115
6856
68601
185
1170
6568
65908
517
3523
5280
53029
Phakoemulsification with implantation of artificial lens in posterior chamber
CJE20 [2001301342]
CJE20 [2001301342]
3.0e-02
8.5e-01
8.2e-01
—
7.1e-01
4.7e-01
2.0e-01
cases:4.85%
controls:4.72%
cases:3.25%
controls:1.42%
cases:0.30%
controls:0.14%
—
—
cases:0.29%
controls:0.14%
cases:2.28%
controls:1.43%
cases:7.14%
controls:5.94%
334
3245
6551
65564
224
979
6663
67843
21
93
6866
68729
—
20
98
6861
68618
154
960
6599
66118
414
3357
5383
53195
azelastine; nasal
R01AC03 [21605035]
R01AC03 [21605035]
3.3e-01
4.7e-01
6.2e-01
—
7.9e-01
3.4e-01
3.8e-01
cases:4.34%
controls:3.15%
cases:2.61%
controls:1.64%
cases:0.45%
controls:0.24%
—
—
cases:0.55%
controls:0.25%
cases:2.41%
controls:1.73%
cases:6.05%
controls:4.21%
299
2170
6586
66639
180
1132
6707
67690
31
167
6856
68655
—
38
173
6843
68543
163
1159
6590
65919
351
2380
5446
54172
testosterone; oral, parenteral, rectal, sublingual, transdermal
G03BA03 [21602510]
G03BA03 [21602510]
4.4e-01
6.0e-01
1.1e+00
—
7.7e-01
5.5e-01
5.7e-01
cases:0.87%
controls:0.56%
cases:0.64%
controls:0.35%
cases:0.25%
controls:0.08%
—
—
cases:0.23%
controls:0.11%
cases:0.62%
controls:0.36%
cases:0.90%
controls:0.51%
60
386
6825
68423
44
243
6843
68579
17
54
6870
68768
—
16
74
6865
68642
42
241
6711
66837
52
288
5745
56264
Other seropositive rheumatoid arthritis
M05.8 [45538634]
M05.8 [45538634]
4.9e-02
2.0e-01
1.0e-01
2.3e+00
1.7e-01
1.8e-01
1.7e-01
cases:1.39%
controls:1.33%
cases:1.15%
controls:0.94%
cases:0.29%
controls:0.26%
cases:0.09%
controls:0.01%
cases:0.33%
controls:0.28%
cases:1.16%
controls:0.97%
cases:1.73%
controls:1.46%
96
914
6789
67895
79
650
6808
68172
20
180
6867
68642
6
6
6881
68816
23
193
6858
68523
78
649
6675
66429
100
827
5697
55725
General and Unspecified, Follow-up encounter unspecified
A63 [2002000197]
A63 [2002000197]
—
2.3e+00
—
—
—
—
-1.0e+50
—
—
cases:0.09%
controls:0.01%
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.02%
—
6
6
6881
68816
—
—
—
—
0
11
5797
56541
fluticasone, combinations
R01AD58 [43534837]
R01AD58 [43534837]
3.2e-01
4.7e-01
5.9e-01
—
7.9e-01
3.4e-01
3.7e-01
cases:4.28%
controls:3.14%
cases:2.60%
controls:1.64%
cases:0.44%
controls:0.24%
—
—
cases:0.55%
controls:0.25%
cases:2.40%
controls:1.72%
cases:5.99%
controls:4.20%
295
2160
6590
66649
179
1130
6708
67692
30
167
6857
68655
—
38
173
6843
68543
162
1157
6591
65921
347
2373
5450
54179
Physiotherapist
Z3226 [2001311560]
Z3226 [2001311560]
3.2e-01
6.8e-01
—
—
—
5.4e-01
7.5e-01
cases:3.21%
controls:2.36%
cases:1.18%
controls:0.60%
—
—
—
—
—
—
cases:1.01%
controls:0.59%
cases:3.80%
controls:1.83%
221
1623
6664
67186
81
414
6806
68408
—
—
—
68
394
6685
66684
220
1035
5577
55517
Biopsy of conjunctiva
CFA20 [2001301120]
CFA20 [2001301120]
—
—
—
1.0e+50
1.0e+50
1.0e+50
2.3e+00
—
—
—
—
—
—
cases:0.26%
controls:0.00%
cases:0.10%
controls:0.00%
cases:0.13%
controls:0.00%
cases:0.14%
controls:0.01%
—
—
—
18
0
6869
68822
7
0
6874
68716
9
0
6744
67078
8
8
5789
56544
Basal cell carcinoma, NOS, of skin of upper limb and shoulder
8090/3-C44.6 [36564323]
8090/3-C44.6 [36564323]
—
—
—
—
—
—
2.3e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.12%
controls:0.01%
—
—
—
—
—
—
7
7
5790
56545
Excision of tarsus and skin
CBN50 [2001301004]
CBN50 [2001301004]
—
—
—
—
—
—
2.3e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.12%
controls:0.01%
—
—
—
—
—
—
7
7
5790
56545
Eye appearance abnormal
F15 [2002000406]
F15 [2002000406]
—
—
—
—
—
—
2.3e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.12%
controls:0.01%
—
—
—
—
—
—
7
7
5790
56545
Osseous and subluxation stenosis of intervertebral foramina
M99.6 [45562996]
M99.6 [45562996]
—
-1.0e+50
—
—
—
—
2.3e+00
—
—
cases:0.00%
controls:0.01%
—
—
—
—
—
—
—
—
cases:0.10%
controls:0.01%
—
0
6
6887
68816
—
—
—
—
6
6
5791
56546
Laser therapy or photocoagulation of skin of head or neck
QAA40 [2001309765]
QAA40 [2001309765]
—
—
—
—
—
—
2.3e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.10%
controls:0.01%
—
—
—
—
—
—
6
6
5791
56546
Closure of loop enterostomy without resection
JFG00 [2001304957]
JFG00 [2001304957]
-1.0e+50
—
—
—
—
—
2.3e+00
cases:0.00%
controls:0.03%
—
—
—
—
—
—
—
—
—
—
cases:0.10%
controls:0.01%
0
18
6885
68791
—
—
—
—
—
6
6
5791
56546
Graft of patients own bone
ZZH20 [2001311640]
ZZH20 [2001311640]
—
—
—
—
—
—
2.3e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.10%
controls:0.01%
—
—
—
—
—
—
6
6
5791
56546
desonide
D07AB08 [21602112]
D07AB08 [21602112]
4.4e-01
6.1e-01
4.1e-01
—
9.6e-01
6.8e-01
5.4e-01
cases:2.51%
controls:1.63%
cases:0.91%
controls:0.50%
cases:0.09%
controls:0.06%
—
—
cases:0.16%
controls:0.06%
cases:0.96%
controls:0.49%
cases:2.74%
controls:1.61%
173
1121
6712
67688
63
344
6824
68478
6
40
6881
68782
—
11
42
6870
68674
65
330
6688
66748
159
911
5638
55641
Other specified urinary incontinence
N39.4 [45577525]
N39.4 [45577525]
3.6e-01
5.2e-01
5.8e-01
—
1.4e+00
3.1e-01
1.6e-01
cases:1.48%
controls:1.04%
cases:0.80%
controls:0.48%
cases:0.17%
controls:0.10%
—
—
cases:0.31%
controls:0.08%
cases:0.74%
controls:0.54%
cases:1.85%
controls:1.58%
102
714
6783
68095
55
328
6832
68494
12
67
6875
68755
—
21
54
6860
68662
50
365
6703
66713
107
893
5690
55659
Lumbar spine MRI examination with high intensity magnet
NA3BG [2001307034]
NA3BG [2001307034]
4.9e-01
5.0e-01
—
—
—
8.6e-01
8.9e-01
cases:1.73%
controls:1.06%
cases:0.52%
controls:0.32%
—
—
—
—
—
—
cases:0.70%
controls:0.30%
cases:2.57%
controls:1.08%
119
730
6766
68079
36
219
6851
68603
—
—
—
47
199
6706
66879
149
609
5648
55943
Very extensive MRI examination of brain with high intensity magnet
AA1DG [2001300120]
AA1DG [2001300120]
-6.8e-03
4.9e-01
—
—
—
1.2e+00
1.0e+00
cases:0.23%
controls:0.23%
cases:0.10%
controls:0.06%
—
—
—
—
—
—
cases:0.21%
controls:0.06%
cases:0.52%
controls:0.19%
16
161
6869
68648
7
43
6880
68779
—
—
—
14
42
6739
67036
30
105
5767
56447
mometasone; nasal
R01AD09 [21605051]
R01AD09 [21605051]
3.5e-01
5.0e-01
6.1e-01
—
1.8e-01
3.9e-01
3.7e-01
cases:11.59%
controls:8.46%
cases:5.47%
controls:3.38%
cases:0.94%
controls:0.51%
—
—
cases:0.61%
controls:0.51%
cases:4.96%
controls:3.41%
cases:11.82%
controls:8.51%
798
5819
6087
62990
377
2325
6510
66497
65
353
6822
68469
—
42
350
6839
68366
335
2287
6418
64791
685
4812
5112
51740
Gastro-oesophageal reflux disease with oesophagitis
K21.0 [45543296]
K21.0 [45543296]
4.2e-01
4.8e-01
1.1e+00
—
1.3e+00
3.7e-01
4.6e-01
cases:1.66%
controls:1.09%
cases:0.55%
controls:0.34%
cases:0.13%
controls:0.04%
—
—
cases:0.20%
controls:0.05%
cases:0.52%
controls:0.36%
cases:1.90%
controls:1.20%
114
750
6771
68059
38
236
6849
68586
9
30
6878
68792
—
14
37
6867
68679
35
241
6718
66837
110
681
5687
55871
Excision of lesion of eyelid and reconstruction using graft or flap
CBB50 [2001300936]
CBB50 [2001300936]
1.4e+00
—
—
1.0e+50
—
—
2.2e+00
cases:0.12%
controls:0.03%
—
—
—
—
cases:0.22%
controls:0.00%
—
—
—
—
cases:0.26%
controls:0.03%
8
20
6877
68789
—
—
15
0
6872
68822
—
—
15
16
5782
56536
oxytetracycline
S01AA04 [21603557]
S01AA04 [21603557]
8.5e-01
1.4e+00
—
—
—
4.4e-01
5.5e-01
cases:0.41%
controls:0.17%
cases:0.20%
controls:0.05%
—
—
—
—
—
—
cases:0.07%
controls:0.05%
cases:0.36%
controls:0.21%
28
120
6857
68689
14
36
6873
68786
—
—
—
5
32
6748
67046
21
118
5776
56434
fludrocortisone and antiinfectives
S03CA05 [21605209]
S03CA05 [21605209]
8.5e-01
1.4e+00
—
—
—
4.4e-01
5.5e-01
cases:0.41%
controls:0.17%
cases:0.20%
controls:0.05%
—
—
—
—
—
—
cases:0.07%
controls:0.05%
cases:0.36%
controls:0.21%
28
120
6857
68689
14
36
6873
68786
—
—
—
5
32
6748
67046
21
118
5776
56434
fludrocortisone and antiinfectives
S02CA07 [21605179]
S02CA07 [21605179]
8.5e-01
1.4e+00
—
—
—
4.4e-01
5.5e-01
cases:0.41%
controls:0.17%
cases:0.20%
controls:0.05%
—
—
—
—
—
—
cases:0.07%
controls:0.05%
cases:0.36%
controls:0.21%
28
120
6857
68689
14
36
6873
68786
—
—
—
5
32
6748
67046
21
118
5776
56434
polymyxin B
S01AA18 [21603569]
S01AA18 [21603569]
8.5e-01
1.4e+00
—
—
—
4.4e-01
5.5e-01
cases:0.41%
controls:0.17%
cases:0.20%
controls:0.05%
—
—
—
—
—
—
cases:0.07%
controls:0.05%
cases:0.36%
controls:0.21%
28
120
6857
68689
14
36
6873
68786
—
—
—
5
32
6748
67046
21
118
5776
56434
analgesics and anesthetics - combinations
S02DA30 [21605185]
S02DA30 [21605185]
8.5e-01
1.4e+00
—
—
—
4.4e-01
5.5e-01
cases:0.41%
controls:0.17%
cases:0.20%
controls:0.05%
—
—
—
—
—
—
cases:0.07%
controls:0.05%
cases:0.36%
controls:0.21%
28
120
6857
68689
14
36
6873
68786
—
—
—
5
32
6748
67046
21
118
5776
56434
polymyxin B
S03AA03 [21605192]
S03AA03 [21605192]
8.5e-01
1.4e+00
—
—
—
4.4e-01
5.5e-01
cases:0.41%
controls:0.17%
cases:0.20%
controls:0.05%
—
—
—
—
—
—
cases:0.07%
controls:0.05%
cases:0.36%
controls:0.21%
28
120
6857
68689
14
36
6873
68786
—
—
—
5
32
6748
67046
21
118
5776
56434
oxytetracycline
D06AA03 [21602059]
D06AA03 [21602059]
8.5e-01
1.4e+00
—
—
—
4.4e-01
5.5e-01
cases:0.41%
controls:0.17%
cases:0.20%
controls:0.05%
—
—
—
—
—
—
cases:0.07%
controls:0.05%
cases:0.36%
controls:0.21%
28
120
6857
68689
14
36
6873
68786
—
—
—
5
32
6748
67046
21
118
5776
56434
antiinfectives, combinations
S02AA30 [21605163]
S02AA30 [21605163]
8.5e-01
1.4e+00
—
—
—
4.4e-01
5.5e-01
cases:0.41%
controls:0.17%
cases:0.20%
controls:0.05%
—
—
—
—
—
—
cases:0.07%
controls:0.05%
cases:0.36%
controls:0.21%
28
120
6857
68689
14
36
6873
68786
—
—
—
5
32
6748
67046
21
118
5776
56434
antiinfectives, combinations
S03AA30 [21605198]
S03AA30 [21605198]
8.5e-01
1.4e+00
—
—
—
4.4e-01
5.5e-01
cases:0.41%
controls:0.17%
cases:0.20%
controls:0.05%
—
—
—
—
—
—
cases:0.07%
controls:0.05%
cases:0.36%
controls:0.21%
28
120
6857
68689
14
36
6873
68786
—
—
—
5
32
6748
67046
21
118
5776
56434
polymyxin B
S02AA11 [21605157]
S02AA11 [21605157]
8.5e-01
1.4e+00
—
—
—
4.4e-01
5.5e-01
cases:0.41%
controls:0.17%
cases:0.20%
controls:0.05%
—
—
—
—
—
—
cases:0.07%
controls:0.05%
cases:0.36%
controls:0.21%
28
120
6857
68689
14
36
6873
68786
—
—
—
5
32
6748
67046
21
118
5776
56434
Dermatoscopy
XQ845 [2001310108]
XQ845 [2001310108]
7.5e-01
1.1e+00
—
—
—
1.1e+00
6.4e-01
cases:0.25%
controls:0.12%
cases:0.22%
controls:0.07%
—
—
—
—
—
—
cases:0.30%
controls:0.10%
cases:0.50%
controls:0.27%
17
80
6868
68729
15
50
6872
68772
—
—
—
20
66
6733
67012
29
150
5768
56402
Chronic kidney disease, unspecified
N18.9 [45553438]
N18.9 [45553438]
1.6e-03
9.2e-02
-2.9e-01
2.2e+00
3.1e-01
-2.2e-01
1.9e-01
cases:0.65%
controls:0.65%
cases:0.49%
controls:0.45%
cases:0.10%
controls:0.14%
cases:0.12%
controls:0.01%
cases:0.17%
controls:0.13%
cases:0.43%
controls:0.54%
cases:1.41%
controls:1.17%
45
449
6840
68360
34
310
6853
68512
7
93
6880
68729
8
9
6879
68813
12
88
6869
68628
29
359
6724
66719
82
660
5715
55892
Preretinal fibrosis of the macula
H35.38 [2000502318]
H35.38 [2000502318]
2.9e-01
7.0e-01
7.6e-01
—
1.5e+00
5.9e-01
3.2e-01
cases:0.51%
controls:0.38%
cases:0.42%
controls:0.21%
cases:0.09%
controls:0.04%
—
—
cases:0.16%
controls:0.04%
cases:0.36%
controls:0.20%
cases:0.78%
controls:0.57%
35
261
6850
68548
29
144
6858
68678
6
28
6881
68794
—
11
25
6870
68691
24
132
6729
66946
45
320
5752
56232
General health counselling
SPAT1312 [2001700413]
SPAT1312 [2001700413]
2.4e-01
4.3e-01
4.1e-01
-1.0e+50
8.3e-01
3.6e-01
3.2e-01
cases:6.94%
controls:5.53%
cases:3.01%
controls:1.98%
cases:0.33%
controls:0.22%
cases:0.00%
controls:0.01%
cases:0.54%
controls:0.23%
cases:2.74%
controls:1.93%
cases:8.50%
controls:6.34%
478
3804
6407
65005
207
1363
6680
67459
23
153
6864
68669
0
10
6887
68812
37
161
6844
68555
185
1295
6568
65783
493
3584
5304
52968
Correction of lax skin of eyelid and resection of herniated fat
CBB20 [2001300929]
CBB20 [2001300929]
-2.0e-01
1.8e+00
—
1.0e+50
—
2.2e+00
2.5e-01
cases:0.07%
controls:0.09%
cases:0.09%
controls:0.01%
—
—
cases:0.17%
controls:0.00%
—
—
cases:0.12%
controls:0.01%
cases:0.09%
controls:0.07%
5
61
6880
68748
6
10
6881
68812
—
12
0
6875
68822
—
8
9
6745
67069
5
38
5792
56514
Peripheral retinal degeneration
H35.4 [45596075]
H35.4 [45596075]
—
—
—
—
—
2.2e+00
6.7e-01
—
—
—
—
—
—
—
—
—
—
cases:0.12%
controls:0.01%
cases:0.10%
controls:0.05%
—
—
—
—
—
8
9
6745
67069
6
30
5791
56522
Verruca simplex
B07.9 [2000500357]
B07.9 [2000500357]
5.1e-01
1.3e+00
2.3e+00
—
—
9.6e-01
8.3e-01
cases:0.36%
controls:0.22%
cases:0.30%
controls:0.08%
cases:0.07%
controls:0.01%
—
—
—
—
cases:0.22%
controls:0.08%
cases:0.78%
controls:0.34%
25
151
6860
68658
21
55
6866
68767
5
5
6882
68817
—
—
15
57
6738
67021
45
192
5752
56360
imidazoles/triazoles in combination with corticosteroids
D01AC20 [21601936]
D01AC20 [21601936]
3.6e-01
5.7e-01
7.2e-01
—
4.8e-01
3.0e-01
5.0e-01
cases:5.58%
controls:3.96%
cases:2.41%
controls:1.37%
cases:0.41%
controls:0.20%
—
—
cases:0.29%
controls:0.18%
cases:1.87%
controls:1.39%
cases:6.45%
controls:4.01%
384
2725
6501
66084
166
946
6721
67876
28
136
6859
68686
—
20
124
6861
68592
126
930
6627
66148
374
2265
5423
54287
Benign neoplasm: Skin, unspecified
D23.9 [45557064]
D23.9 [45557064]
7.6e-01
2.2e+00
—
—
—
9.8e-01
7.3e-01
cases:0.31%
controls:0.14%
cases:0.36%
controls:0.04%
—
—
—
—
—
—
cases:0.18%
controls:0.07%
cases:0.43%
controls:0.21%
21
98
6864
68711
25
29
6862
68793
—
—
—
12
45
6741
67033
25
118
5772
56434
Foreign body on external eye
T15 [45536466]
T15 [45536466]
2.1e+00
-1.0e+50
—
—
—
—
—
cases:0.09%
controls:0.01%
cases:0.00%
controls:0.01%
—
—
—
—
—
—
—
—
—
—
6
7
6879
68802
0
5
6887
68817
—
—
—
—
—
Disorder of eye and adnexa, unspecified
H57.9 [45552726]
H57.9 [45552726]
—
2.1e+00
—
—
—
—
8.6e-01
—
—
cases:0.09%
controls:0.01%
—
—
—
—
—
—
—
—
cases:0.14%
controls:0.06%
—
6
7
6881
68815
—
—
—
—
8
33
5789
56519
Excision and repair of surgical scar in trunk
QBE30 [2001309857]
QBE30 [2001309857]
—
—
—
—
—
—
2.1e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.12%
controls:0.01%
—
—
—
—
—
—
7
8
5790
56544
paracetamol; oral, parenteral, rectal
N02BE01 [21604344]
N02BE01 [21604344]
1.9e-01
1.4e-01
-1.5e-02
1.2e+00
-4.2e-02
2.4e-01
3.4e-01
cases:38.23%
controls:33.84%
cases:21.08%
controls:18.81%
cases:3.57%
controls:3.62%
cases:0.45%
controls:0.13%
cases:3.47%
controls:3.62%
cases:23.80%
controls:19.64%
cases:49.20%
controls:40.85%
2632
23287
4253
45522
1452
12944
5435
55878
246
2494
6641
66328
31
91
6856
68731
239
2485
6642
66231
1607
13176
5146
53902
2852
23100
2945
33452
Cryotherapy for trichiasis
CBG10 [2001300966]
CBG10 [2001300966]
—
—
—
—
—
1.0e+50
2.1e+00
—
—
—
—
—
—
—
—
—
—
cases:0.12%
controls:0.00%
cases:0.10%
controls:0.01%
—
—
—
—
—
8
0
6745
67078
6
7
5791
56545
Ultrasound examination of uterus and parametria
LC2AE [2001306543]
LC2AE [2001306543]
6.4e-01
7.8e-01
—
—
—
5.2e-01
6.9e-01
cases:1.28%
controls:0.68%
cases:0.41%
controls:0.19%
—
—
—
—
—
—
cases:0.31%
controls:0.18%
cases:1.24%
controls:0.63%
88
466
6797
68343
28
129
6859
68693
—
—
—
21
124
6732
66954
72
354
5725
56198
olopatadine
S01GX09 [21605093]
S01GX09 [21605093]
7.1e-01
1.4e+00
—
—
—
1.0e+00
6.5e-01
cases:0.42%
controls:0.21%
cases:0.36%
controls:0.09%
—
—
—
—
—
—
cases:0.18%
controls:0.06%
cases:0.41%
controls:0.22%
29
143
6856
68666
25
62
6862
68760
—
—
—
12
42
6741
67036
24
122
5773
56430
formoterol and fluticasone
R03AK11 [44819166]
R03AK11 [44819166]
7.0e-01
7.7e-01
9.9e-01
—
2.7e-01
6.6e-01
6.4e-01
cases:0.54%
controls:0.27%
cases:0.42%
controls:0.20%
cases:0.16%
controls:0.06%
—
—
cases:0.07%
controls:0.06%
cases:0.37%
controls:0.19%
cases:0.64%
controls:0.34%
37
185
6848
68624
29
135
6858
68687
11
41
6876
68781
—
5
38
6876
68678
25
129
6728
66949
37
191
5760
56361
methotrexate; oral, parenteral
L04AX03 [21603929]
L04AX03 [21603929]
2.0e-01
7.2e-02
-5.8e-02
1.8e+00
-2.6e-01
1.4e-01
3.2e-01
cases:2.64%
controls:2.17%
cases:1.87%
controls:1.75%
cases:0.60%
controls:0.63%
cases:0.10%
controls:0.02%
cases:0.49%
controls:0.64%
cases:2.03%
controls:1.77%
cases:3.19%
controls:2.34%
182
1496
6703
67313
129
1201
6758
67621
41
434
6846
68388
7
12
6880
68810
34
439
6847
68277
137
1188
6616
65890
185
1322
5612
55230
methotrexate
L01BA01 [21601423]
L01BA01 [21601423]
2.0e-01
7.2e-02
-5.8e-02
1.8e+00
-2.6e-01
1.4e-01
3.2e-01
cases:2.64%
controls:2.17%
cases:1.87%
controls:1.75%
cases:0.60%
controls:0.63%
cases:0.10%
controls:0.02%
cases:0.49%
controls:0.64%
cases:2.03%
controls:1.77%
cases:3.19%
controls:2.34%
182
1496
6703
67313
129
1201
6758
67621
41
434
6846
68388
7
12
6880
68810
34
439
6847
68277
137
1188
6616
65890
185
1322
5612
55230
methylprednisolone; oral, parenteral
H02AB04 [21602732]
H02AB04 [21602732]
4.3e-01
4.8e-01
3.8e-01
—
-7.4e-02
5.7e-01
6.1e-01
cases:3.02%
controls:2.00%
cases:1.15%
controls:0.71%
cases:0.19%
controls:0.13%
—
—
cases:0.12%
controls:0.13%
cases:1.14%
controls:0.65%
cases:2.79%
controls:1.54%
208
1373
6677
67436
79
492
6808
68330
13
89
6874
68733
—
8
86
6873
68630
77
436
6676
66642
162
872
5635
55680
Localized swelling, mass and lump, unspecified
R22.9 [45577788]
R22.9 [45577788]
3.6e-01
1.5e+00
1.4e+00
—
—
2.5e-01
6.1e-01
cases:1.03%
controls:0.72%
cases:1.09%
controls:0.26%
cases:0.12%
controls:0.03%
—
—
—
—
cases:0.36%
controls:0.28%
cases:1.79%
controls:0.98%
71
498
6814
68311
75
176
6812
68646
8
19
6879
68803
—
—
24
185
6729
66893
104
557
5693
55995
Knee and lower leg extensive MRI examination with high intensity magnet
NG1CG [2001308063]
NG1CG [2001308063]
1.0e+00
1.0e+00
—
—
—
—
1.0e+00
cases:0.26%
controls:0.09%
cases:0.10%
controls:0.04%
—
—
—
—
—
—
—
—
cases:0.29%
controls:0.10%
18
65
6867
68744
7
25
6880
68797
—
—
—
—
17
59
5780
56493
tacrolimus
D11AH01 [21602338]
D11AH01 [21602338]
5.2e-01
3.6e-01
—
—
7.3e-01
8.6e-01
6.7e-01
cases:1.13%
controls:0.68%
cases:0.46%
controls:0.32%
—
—
—
—
cases:0.09%
controls:0.04%
cases:0.77%
controls:0.33%
cases:1.71%
controls:0.88%
78
467
6807
68342
32
223
6855
68599
—
—
6
29
6875
68687
52
220
6701
66858
99
496
5698
56056
retinol
S01XA02 [21605128]
S01XA02 [21605128]
6.2e-01
8.6e-01
—
—
—
1.1e+00
9.2e-01
cases:0.45%
controls:0.24%
cases:0.23%
controls:0.10%
—
—
—
—
—
—
cases:0.27%
controls:0.09%
cases:0.67%
controls:0.27%
31
167
6854
68642
16
68
6871
68754
—
—
—
18
58
6735
67020
39
152
5758
56400
imiquimod
D06BB10 [21602092]
D06BB10 [21602092]
4.8e-01
9.7e-01
—
—
1.6e+00
1.1e+00
2.8e-01
cases:0.73%
controls:0.45%
cases:0.41%
controls:0.15%
—
—
—
—
cases:0.07%
controls:0.01%
cases:0.40%
controls:0.14%
cases:0.76%
controls:0.57%
50
310
6835
68499
28
106
6859
68716
—
—
5
10
6876
68706
27
92
6726
66986
44
325
5753
56227
Other nevus (non-neoplastic)
I78.19 [2000502539]
I78.19 [2000502539]
—
—
—
—
—
—
2.0e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.12%
controls:0.02%
—
—
—
—
—
—
7
9
5790
56543
Replacement of prosthetic implant in breast
HAD60 [2001303951]
HAD60 [2001303951]
2.0e+00
—
—
—
—
—
-1.0e+50
cases:0.09%
controls:0.01%
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.02%
6
8
6879
68801
—
—
—
—
—
0
9
5797
56543
Operation for ptosis of eyebrow
CBJ50 [2001300987]
CBJ50 [2001300987]
5.4e-01
—
—
—
—
2.0e+00
9.7e-01
cases:0.07%
controls:0.04%
—
—
—
—
—
—
—
—
cases:0.13%
controls:0.02%
cases:0.12%
controls:0.05%
5
29
6880
68780
—
—
—
—
9
12
6744
67066
7
26
5790
56526
Sarcoidosis, unspecified
D86.9 [45566717]
D86.9 [45566717]
4.8e-01
—
—
—
—
2.0e+00
1.3e+00
cases:0.07%
controls:0.05%
—
—
—
—
—
—
—
—
cases:0.09%
controls:0.01%
cases:0.14%
controls:0.04%
5
31
6880
68778
—
—
—
—
6
8
6747
67070
8
22
5789
56530
Eye pressure longterm registration
XCH05 [2001311083]
XCH05 [2001311083]
6.3e-01
1.3e+00
—
—
—
2.0e+00
—
cases:0.15%
controls:0.08%
cases:0.09%
controls:0.02%
—
—
—
—
—
—
cases:0.09%
controls:0.01%
—
—
10
53
6875
68756
6
16
6881
68806
—
—
—
6
8
6747
67070
—
Other minor procedure in eye surgery
TCW99 [2001301502]
TCW99 [2001301502]
-5.2e-01
3.6e-01
—
1.0e+50
—
2.0e+00
6.5e-03
cases:0.10%
controls:0.17%
cases:0.07%
controls:0.05%
—
—
cases:0.74%
controls:0.00%
—
—
cases:0.46%
controls:0.06%
cases:0.22%
controls:0.22%
7
118
6878
68691
5
35
6882
68787
—
51
0
6836
68822
—
31
42
6722
67036
13
126
5784
56426
Audiometric test
21727005 [4071702]
21727005 [4071702]
3.2e-01
6.0e-01
1.3e-01
—
—
6.5e-01
4.2e-01
cases:3.04%
controls:2.22%
cases:1.09%
controls:0.60%
cases:0.07%
controls:0.06%
—
—
—
—
cases:1.14%
controls:0.60%
cases:3.76%
controls:2.50%
209
1531
6676
67278
75
413
6812
68409
5
44
6882
68778
—
—
77
402
6676
66676
218
1413
5579
55139
dorzolamide
S01EC03 [21603695]
S01EC03 [21603695]
5.8e-01
4.9e-01
3.1e-01
—
7.8e-01
5.0e-01
4.3e-01
cases:1.18%
controls:0.66%
cases:0.84%
controls:0.52%
cases:0.23%
controls:0.17%
—
—
cases:0.32%
controls:0.15%
cases:0.89%
controls:0.54%
cases:1.28%
controls:0.84%
81
456
6804
68353
58
357
6829
68465
16
117
6871
68705
—
22
101
6859
68615
60
364
6693
66714
74
474
5723
56078
Other conjunctivitis
H10.8 [45562159]
H10.8 [45562159]
1.1e+00
2.0e+00
—
—
—
-1.0e+50
6.3e-01
cases:0.13%
controls:0.04%
cases:0.12%
controls:0.02%
—
—
—
—
—
—
cases:0.00%
controls:0.02%
cases:0.17%
controls:0.09%
9
30
6876
68779
8
11
6879
68811
—
—
—
0
11
6753
67067
10
52
5787
56500
Destruction of lesion of skin of upper limb
QCA25 [2001309893]
QCA25 [2001309893]
6.3e-01
1.5e+00
—
—
—
2.0e+00
9.2e-01
cases:0.09%
controls:0.05%
cases:0.09%
controls:0.02%
—
—
—
—
—
—
cases:0.12%
controls:0.02%
cases:0.16%
controls:0.06%
6
32
6879
68777
6
14
6881
68808
—
—
—
8
11
6745
67067
9
35
5788
56517
Observation for suspected disease or condition, unspecified
Z03.9 [45552062]
Z03.9 [45552062]
2.9e-01
3.2e-01
4.2e-01
—
9.2e-01
4.1e-01
3.6e-01
cases:3.65%
controls:2.75%
cases:1.28%
controls:0.93%
cases:0.17%
controls:0.11%
—
—
cases:0.25%
controls:0.10%
cases:1.41%
controls:0.94%
cases:4.24%
controls:3.01%
251
1890
6634
66919
88
641
6799
68181
12
79
6875
68743
—
17
68
6864
68648
95
628
6658
66450
246
1702
5551
54850
Neck ultrasound examination
EP1AE [2001302284]
EP1AE [2001302284]
4.7e-01
6.9e-01
1.4e+00
—
—
9.7e-01
5.4e-01
cases:0.87%
controls:0.55%
cases:0.33%
controls:0.17%
cases:0.07%
controls:0.02%
—
—
—
—
cases:0.49%
controls:0.19%
cases:0.83%
controls:0.48%
60
377
6825
68432
23
115
6864
68707
5
12
6882
68810
—
—
33
125
6720
66953
48
274
5749
56278
Acute pain
R52.0 [45573031]
R52.0 [45573031]
1.5e-01
1.2e+00
-1.0e+50
—
—
9.8e-01
7.3e-01
cases:0.23%
controls:0.20%
cases:0.17%
controls:0.05%
cases:0.00%
controls:0.01%
—
—
—
—
cases:0.16%
controls:0.06%
cases:0.47%
controls:0.22%
16
137
6869
68672
12
35
6875
68787
0
6
6887
68816
—
—
11
41
6742
67037
27
127
5770
56425
Ileoscopy through colon
UJF30 [2001305028]
UJF30 [2001305028]
5.2e-01
3.4e-01
9.6e-01
—
1.3e+00
6.8e-01
7.6e-01
cases:1.73%
controls:1.03%
cases:0.48%
controls:0.34%
cases:0.09%
controls:0.03%
—
—
cases:0.09%
controls:0.02%
cases:0.61%
controls:0.31%
cases:2.31%
controls:1.09%
119
710
6766
68099
33
234
6854
68588
6
23
6881
68799
—
6
17
6875
68699
41
207
6712
66871
134
619
5663
55933
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
C50.41 [2000501002]
C50.41 [2000501002]
-6.4e-02
-3.0e-02
1.9e-01
1.9e+00
2.4e-02
2.2e-02
1.1e-01
cases:1.06%
controls:1.13%
cases:0.80%
controls:0.82%
cases:0.23%
controls:0.19%
cases:0.10%
controls:0.01%
cases:0.23%
controls:0.23%
cases:0.74%
controls:0.72%
cases:1.29%
controls:1.16%
73
777
6812
68032
55
566
6832
68256
16
132
6871
68690
7
10
6880
68812
16
156
6865
68560
50
486
6703
66592
75
656
5722
55896
LabWAS
↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
6144
56341
1.76
49.70
6.3
5.7
1.90
1.95
mu/l
1.75
5711
51917
6287
58164
1.81
47.62
6.1
5.5
5.99
5.97
mmol/l
0.72
5787
53142
5281
46871
1.52
46.96
5.0
4.6
12.60
13.22
mm/h
2.55
4932
43762
6189
57047
1.75
46.82
7.5
6.8
39.70
39.57
mmol/mol
0.64
5776
53099
5485
49116
1.55
46.44
9.1
8.6
79.18
80.12
u/l
0.61
5199
46602
6418
59863
1.90
45.79
6.8
6.1
2.64
2.68
mmol/l
2.00
5994
55348
6626
62560
2.17
44.56
14.5
13.0
25.67
25.28
u/l
0.79
6456
60674
6545
61558
2.01
43.86
23.6
21.2
3.97
3.98
mmol/l
1.09
6453
60319
4825
42288
1.46
43.57
5.6
5.1
2315.67
2427.30
e6/l
0.04
55
600
6535
61463
1.99
43.31
23.3
21.0
139.67
139.67
mmol/l
0.00
6452
60333
6665
63185
2.22
42.46
26.1
23.3
78.42
77.72
umol/l
0.87
6608
62441
6379
59602
1.82
42.17
19.6
17.7
23.96
24.76
mg/l
1.11
5431
49780
6729
64084
2.39
41.65
30.4
27.0
133.70
133.39
g/l
1.02
6684
63392
6728
64076
2.39
41.55
30.2
26.8
4.45
4.43
e12/l
2.23
6575
62541
6727
64065
2.38
41.50
30.3
26.8
248.82
250.98
e9/l
1.98
6610
62751
6727
64073
2.38
41.34
30.1
26.7
91.37
91.42
fl
0.45
6682
63357
6727
64076
2.38
41.29
30.8
27.3
40.65
40.17
%
0.36
6680
63331
6727
64082
2.37
41.17
30.3
26.8
6.77
6.75
e9/l
0.20
6585
62538
3610
30237
1.40
40.60
2.4
2.2
97.35
96.43
pmol/l
0.50
1898
15644
6049
55915
1.61
39.14
4.8
4.4
1.32
1.28
mmol/l
3.86
5538
50927
6297
58870
1.71
38.15
5.8
5.3
4.56
4.63
mmol/l
5.55
5888
54639
6187
57597
1.65
37.84
19.1
17.4
77.31
77.67
ml/min/173m2
0.73
5785
53674
6256
58485
1.67
36.63
5.8
5.2
1.46
1.49
mmol/l
9.78
5811
53908
5318
48129
1.44
35.23
5.0
4.6
14.86
14.90
pmol/l
0.61
4872
44050
3892
33681
1.35
32.18
6.9
6.5
0.20
0.19
e9/l
2.27
3388
29176
3789
32751
1.34
31.05
6.7
6.3
0.04
0.04
e9/l
0.00
3222
27879
3993
34800
1.34
30.88
6.6
6.8
11.58
11.45
umol/l
0.24
3774
33193
3774
32643
1.34
30.57
6.6
6.3
0.60
0.59
e9/l
0.42
3206
27774
4172
36690
1.34
29.84
9.9
9.9
4.17
4.15
e9/l
0.26
3596
31722
3830
33322
1.33
29.16
6.7
6.4
1.92
1.88
e9/l
0.62
3338
29078
3539
30521
1.32
28.25
5.4
5.1
35.70
35.34
g/l
3.57
3314
28517
3505
30200
1.32
28.10
2.6
2.5
78.94
79.15
nmol/l
0.17
3138
27151
2748
22911
1.33
27.61
3.6
3.4
7.16
7.12
mmol/l
0.21
2295
19175
2655
22037
1.33
27.48
3.8
3.5
46.93
45.96
mg/l
0.08
1673
13795
3406
29419
1.31
25.96
3.4
3.1
115.68
130.94
ug/l
3.70
3165
27316
2680
22410
1.32
25.84
4.4
4.2
8.86
8.64
mg/mmol
0.08
1660
13688
4290
38371
1.31
24.56
5.3
5.1
6.69
6.73
mmol/l
0.87
4116
36519
3568
31271
1.29
23.23
17.1
16.2
1.29
1.27
inr
0.51
2952
26202
3526
30882
1.29
22.97
7.0
6.6
1.21
1.21
mmol/l
0.05
3248
28489
1975
16022
1.32
22.94
4.4
4.1
0.46
0.43
0.03
13
186
2087
17092
1.32
22.58
2.8
2.8
344.44
342.12
umol/l
0.47
1811
14904
3882
34526
1.28
21.90
4.6
4.2
1.94
0.16
estimate
0.60
678
6908
3871
34441
1.28
21.65
7.8
7.4
1.21
1.21
mmol/l
0.06
3394
29671
2790
23870
1.28
21.30
3.4
3.6
2.36
2.36
mmol/l
0.12
2480
21574
2151
17870
1.29
20.46
2.6
2.4
2.91
2.86
mg/l
0.46
1866
15456
3798
33855
1.27
20.28
4.5
4.2
0.00
0.00
estimate
1.60
696
7104
3417
30122
1.26
19.86
6.9
6.5
57.63
57.73
%
0.20
3242
28701
2483
21076
1.28
19.75
2.8
2.7
58.65
63.99
u/l
0.70
2277
19469
1504
11952
1.33
19.66
1.8
1.8
1155.58
1165.48
nmol/l
0.15
1125
9041
3470
30683
1.26
19.50
7.0
6.6
27.42
27.22
%
0.49
3276
28980
3825
34274
1.26
18.90
4.5
4.2
4.88
3.94
estimate
0.10
718
7342
2842
24614
1.26
18.84
4.6
4.1
105.19
111.72
e6/l
0.13
2020
17441
719
5088
1.46
18.84
1.5
1.5
—
—
—
0
0
1730
14089
1.30
18.82
3.0
3.0
2.46
2.46
mmol/l
0.27
1540
12634
3823
34277
1.25
18.69
2.8
2.8
—
—
—
0
0
799
5786
1.43
18.49
2.6
2.4
6.90
7.42
ug/l
0.17
689
5033
2500
21363
1.27
18.47
3.3
3.2
1493.84
1439.24
ng/l
0.22
2157
18603
2360
20083
1.26
17.91
1.7
1.7
20.78
20.44
nmol/l
0.49
1968
16933
1033
7918
1.36
16.94
2.6
2.3
137.76
139.60
ug/g
0.05
820
6265
2531
21830
1.25
16.80
3.9
3.5
75.53
74.76
e6/l
0.01
1939
16716
1011
7735
1.36
16.77
8.3
7.3
—
—
—
0
0
1938
16228
1.27
16.53
2.6
2.5
—
—
—
0
0
1982
16657
1.27
16.37
4.1
4.2
89.57
89.11
%
0.36
1941
16296
2455
21153
1.25
16.30
2.3
2.2
182.80
209.08
u/l
0.73
2313
19954
1725
14272
1.28
16.18
1.3
1.3
1.88
1.66
u/ml
0.20
405
3752
2212
18908
1.25
15.60
3.7
3.4
0.51
0.44
e6/l
0.34
1635
13958
1461
11917
1.29
15.21
3.4
3.1
1.07
1.48
e6/l
0.87
810
6419
3360
30086
1.23
15.17
2.9
2.8
—
—
estimate
—
0
0
1712
14277
1.26
14.82
1.7
1.8
1.26
1.31
mg/l
0.29
1308
11199
1503
12370
1.27
14.46
1.6
1.5
2.47
2.47
g/l
0.00
858
7386
1459
11982
1.28
14.26
1.4
1.3
27.01
33.78
iu/ml
1.60
432
3681
1597
13280
1.26
14.04
4.2
4.1
217.81
431.96
ng/l
1.67
1269
10742
1359
11165
1.27
13.11
1.3
1.3
11.50
12.29
u/ml
0.14
489
4244
5162
48685
1.23
12.56
26.1
22.8
331.32
331.37
g/l
0.14
5135
48411
1790
15237
1.24
12.54
3.0
2.8
5.96
5.80
e6/l
0.18
1629
13903
4289
39847
1.20
11.63
3.7
3.4
53.23
49.52
u/l
1.15
3951
37131
1130
9216
1.27
11.43
1.5
1.5
—
—
—
0
0
383
2656
1.47
11.10
1.9
2.0
—
—
—
0
0
1395
11697
1.24
11.04
2.0
2.0
—
—
—
0
0
2920
26303
1.19
10.97
2.0
1.9
1.38
1.34
mmol/l
1.82
2459
21794
2813
25298
1.19
10.67
4.3
4.0
58.71
72.67
ng/l
0.27
2016
18467
1946
16943
1.21
10.55
6.3
5.9
4.54
3.43
ug/l
0.59
1749
15242
806
6368
1.30
10.42
2.8
2.6
68.97
69.18
e9/l
0.06
598
4659
1153
9524
1.25
10.38
6.7
7.0
104.17
104.26
mmol/l
0.26
1153
9519
1085
8909
1.26
10.28
1.4
1.4
419.44
521.87
titre
1.74
249
2015
786
6221
1.30
10.02
6.8
7.3
1.30
1.33
mmol/l
0.25
774
6109
1583
13588
1.21
9.84
5.2
4.8
22.87
22.04
%
1.28
803
7032
830
6631
1.29
9.84
2.1
2.2
0.02
0.01
estimate
0.21
137
1292
1280
10787
1.23
9.51
3.6
3.2
3.25
2.82
e6/l
0.59
621
5275
432
3165
1.39
9.27
1.2
1.1
0.97
1.77
u/ml
—
10
35
979
8072
1.25
8.87
4.5
4.4
243.00
245.37
u/l
0.18
924
7642
413
3041
1.38
8.61
1.1
1.1
—
—
—
0
0
342
2458
1.41
8.24
1.8
1.8
—
—
—
0
0
2025
18022
1.17
8.11
3.2
3.2
0.18
0.06
0.67
38
486
1714
15046
1.18
8.10
5.0
4.5
1.02
1.12
kg/l
0.50
1138
10164
145
868
1.68
8.09
2.0
2.1
13.36
24.46
mg/l
5.43
42
308
789
6412
1.26
8.09
2.5
2.5
36.89
46.69
u/l
0.67
631
5399
249
1694
1.49
8.03
1.2
1.2
—
—
—
0
0
361
2632
1.39
8.01
1.4
1.4
—
—
—
0
0
583
4570
1.30
7.98
8.6
9.1
1.32
1.30
%
0.20
583
4544
2126
19020
1.17
7.94
4.9
4.4
0.00
0.00
estimate
0.13
661
6563
651
5183
1.28
7.90
1.8
1.7
—
—
—
0
0
249
1706
1.48
7.77
1.2
1.2
—
—
—
0
0
1172
9991
1.21
7.62
3.6
3.4
0.77
0.79
ug/l
0.23
821
6874
921
7691
1.23
7.36
2.6
2.7
8.28
8.58
umol/l
0.18
777
6738
1283
11064
1.20
7.34
2.6
2.6
2.35
2.30
g/l
2.30
1176
10202
1358
11835
1.18
6.85
2.7
2.6
12.55
12.54
umol/l
0.01
1261
10996
506
3979
1.29
6.78
2.4
2.3
12.25
12.74
nmol/l
0.71
435
3540
619
5003
1.26
6.64
3.1
2.9
10.50
10.54
g/l
0.07
563
4607
1185
10232
1.19
6.64
2.7
2.7
21.33
21.87
%
0.74
1101
9474
509
4018
1.29
6.62
1.3
1.3
77.82
54.39
au/ml
1.28
27
276
295
2159
1.38
6.46
1.5
1.4
249.05
271.40
ug/g
1.16
176
1293
689
5656
1.24
6.45
3.9
3.7
88.08
90.91
ng/l
0.34
582
4819
1202
10436
1.18
6.29
1.9
2.0
29.23
29.62
s
1.48
1179
10150
115
698
1.66
6.19
1.2
1.2
—
33.89
—
0
9
2314
21134
1.14
6.15
3.5
3.3
31.89
35.50
u/l
1.82
2160
19898
1057
9097
1.19
6.12
6.2
5.8
1.04
1.04
mmol/l
0.04
971
8438
644
5279
1.24
6.11
2.9
2.7
62.96
63.74
ml/min/173m2
0.21
283
2238
335
2525
1.34
6.10
4.5
3.3
43.68
51.82
mg/l
0.40
299
2147
470
3714
1.28
6.08
2.1
1.9
—
—
—
0
0
543
4370
1.26
6.06
2.5
2.4
18.53
22.68
au/ml
0.94
54
420
334
2526
1.34
5.96
4.5
3.3
53.08
74.82
mg/l
0.48
297
2147
548
4424
1.26
5.96
9.0
9.4
0.66
0.64
%
0.51
548
4397
937
7998
1.20
5.94
5.7
5.2
32.38
33.06
%
1.09
601
5189
239
1719
1.40
5.84
1.5
1.5
—
—
—
0
0
1016
8757
1.19
5.77
1.9
1.9
—
—
—
0
0
2733
25316
1.13
5.71
4.6
4.2
0.95
0.47
estimate
0.23
575
5828
486
3888
1.27
5.71
1.4
1.3
217.52
207.58
u/ml
0.11
445
3600
300
2252
1.35
5.64
4.6
3.2
6.33
3.62
ratio
0.53
193
1307
312
2359
1.34
5.60
3.2
3.9
24.84
24.93
mmol/l
0.19
285
2147
508
4096
1.26
5.59
2.2
2.0
—
—
—
0
0
283
2115
1.35
5.49
1.8
1.7
—
—
—
0
0
3004
28070
1.12
5.31
12.2
12.1
0.00
0.00
e9/l
0.93
2385
22780
1306
11583
1.16
5.15
3.0
3.3
0.82
0.81
mmol/l
1.96
1208
10895
734
6207
1.20
5.14
2.3
2.3
367.33
382.67
nmol/l
1.18
671
5731
945
8176
1.18
5.12
1.9
1.9
—
—
—
0
0
493
4025
1.24
4.89
3.7
3.9
24.44
24.31
mmol/l
0.46
488
3984
664
5594
1.21
4.85
2.4
2.5
0.37
0.48
e6/l
1.16
630
5372
227
1676
1.37
4.81
1.4
1.3
—
—
—
0
0
931
8100
1.17
4.70
7.1
7.4
1.04
1.00
mmol/l
0.13
773
6687
938
8166
1.17
4.70
7.1
7.4
12.53
12.29
kpa
0.73
906
7847
139
945
1.48
4.67
1.3
1.4
—
—
—
0
0
938
8171
1.17
4.67
7.1
7.5
5.07
5.10
kpa
0.55
905
7855
670
5671
1.20
4.66
2.8
3.0
223.79
200.29
ng/l
0.33
617
5197
91
563
1.62
4.65
1.5
1.5
—
—
—
0
0
91
563
1.62
4.65
1.5
1.5
—
—
—
0
0
91
563
1.62
4.65
1.5
1.5
—
—
—
0
0
175
1250
1.41
4.54
1.9
1.9
4.85
4.85
mmol/24h
0.00
155
1102
505
4170
1.23
4.52
8.4
9.2
24.44
24.31
mmol/l
0.43
492
4087
787
6777
1.18
4.51
7.8
8.2
119.82
120.05
g/l
0.12
769
6617
228
1714
1.34
4.34
1.3
1.3
—
—
—
0
0
233
1764
1.33
4.23
1.6
1.6
15351.36
12715.16
e6/l
0.26
160
1232
804
6973
1.17
4.23
3.8
3.7
5.78
5.82
kpa
0.52
787
6807
356
2854
1.26
4.19
3.2
2.3
2.78
2.93
g/l
2.25
315
2580
257
1977
1.31
4.18
1.7
1.5
0.42
5.83
iu/ml
0.87
47
379
835
7272
1.17
4.17
7.6
7.7
95.80
95.52
%
0.74
812
7018
342
2731
1.27
4.16
2.0
1.8
6.98
6.76
iu/ml
0.06
77
644
181
1322
1.38
4.15
1.8
1.9
40.10
43.39
nmol/l
1.24
167
1276
678
5811
1.18
4.11
3.1
3.1
4.60
4.48
kpa
0.74
663
5661
710
6110
1.18
4.11
3.1
2.6
66.57
66.13
g/l
0.85
627
5578
5058
49001
1.12
4.08
23.8
21.8
13.77
13.73
%
1.31
5007
48378
472
3917
1.22
4.05
2.2
1.9
1.32
1.37
g/l
0.15
419
3583
61
353
1.73
4.05
2.7
2.7
40.38
39.75
%
0.10
39
202
255
1969
1.31
4.05
2.2
1.8
—
—
—
0
0
487
4059
1.21
4.01
3.3
3.4
4.41
4.44
pmol/l
0.31
432
3613
407
3333
1.23
3.98
1.5
1.7
1.55
1.57
g/l
0.22
342
2875
525
4415
1.20
3.94
1.7
1.8
—
—
—
0
0
300
2381
1.27
3.86
1.6
1.6
24.39
18.68
u/ml
0.40
56
492
58
337
1.73
3.82
1.4
1.7
—
—
—
0
0
58
337
1.73
3.82
1.4
1.7
—
—
—
0
0
58
337
1.73
3.82
1.4
1.7
—
—
—
0
0
58
337
1.73
3.82
1.4
1.7
—
—
—
0
0
149
1072
1.40
3.78
1.8
1.5
0.81
0.75
g/l
0.25
122
824
710
6159
1.17
3.74
6.6
7.2
9.94
10.33
mmol/l
0.76
677
5886
776
6780
1.16
3.72
3.8
3.8
1.83
1.89
mmol/l
0.20
700
5958
372
3044
1.23
3.69
3.2
2.3
7.27
7.47
g/l
1.67
331
2767
371
3038
1.23
3.65
3.2
2.3
3.54
3.70
g/l
1.81
330
2766
126
886
1.43
3.64
1.4
1.4
—
—
—
0
0
325
2624
1.25
3.64
3.2
2.3
9.78
10.16
g/l
0.83
279
2319
371
3042
1.23
3.61
3.2
2.3
4.21
4.22
g/l
0.09
330
2767
309
2483
1.26
3.61
2.4
2.3
433.67
643.84
ug/l
0.83
286
2355
767
6713
1.16
3.60
2.3
2.2
0.22
0.21
g/l
3.02
725
6260
232
1801
1.30
3.58
1.2
1.2
101.67
153.82
titre
0.73
12
165
240
1874
1.29
3.55
2.3
2.4
3.69
3.59
g/l
0.54
229
1787
127
903
1.41
3.47
1.4
1.4
—
—
—
0
0
402
3339
1.22
3.47
2.2
2.2
0.05
0.27
estimate
0.42
108
1003
190
1442
1.33
3.46
1.6
1.6
—
—
—
0
0
140
1014
1.39
3.45
1.3
1.3
0.14
0.28
nmol/l
—
10
65
125
892
1.41
3.36
1.4
1.4
—
—
—
0
0
267
2134
1.26
3.30
3.3
2.3
0.00
0.00
g/l
0.42
230
1859
259
2065
1.26
3.27
1.3
1.3
—
—
—
0
0
196
1510
1.31
3.24
1.1
1.1
4.63
3.85
0.25
16
170
293
2374
1.24
3.22
2.4
1.9
—
—
—
0
0
85
572
1.49
3.13
2.6
2.2
759.32
880.89
mg
0.41
85
567
520
4474
1.18
3.07
3.5
3.7
5.04
5.16
kpa
3.48
487
4272
236
1877
1.27
3.06
1.7
2.1
95.88
92.45
%
1.77
227
1803
31
160
1.94
3.03
2.8
3.2
8.96
8.03
mg/l
0.35
25
128
101
709
1.43
3.02
1.2
1.2
—
—
—
0
0
279
2267
1.24
3.01
3.4
3.1
1109.24
463.09
mg/l
0.48
119
946
79
529
1.50
3.00
1.5
1.5
—
—
—
0
0
119
862
1.39
2.98
1.3
1.3
0.20
0.21
nmol/l
0.15
87
685
445
3790
1.19
2.97
3.2
3.5
1.75
1.93
mmol/l
0.46
319
2836
319
2634
1.22
2.96
3.4
2.4
0.89
0.87
g/l
0.03
269
2247
232
1854
1.26
2.91
4.9
4.0
3.88
3.88
mmol/l
0.07
232
1840
246
1980
1.25
2.90
3.4
2.3
0.00
0.00
g/l
-0.00
229
1855
271
2207
1.24
2.88
3.3
2.3
0.07
0.03
g/l
0.30
243
1977
10
27
3.71
2.87
1.4
2.6
3.65
2.56
mg/l
—
10
27
188
1467
1.29
2.87
3.8
2.7
63.67
60.67
%
1.13
188
1460
118
860
1.38
2.86
1.4
1.4
—
—
—
0
0
75
503
1.50
2.84
1.9
1.8
384.78
342.77
mu/l
0.29
54
397
157
1197
1.32
2.84
1.3
1.3
44.87
37.00
u/l
0.21
138
1032
118
863
1.37
2.81
1.4
1.4
—
—
—
0
0
163
1252
1.31
2.80
1.3
1.4
12.70
12.54
u/l
0.05
123
1012
203
1605
1.27
2.80
1.2
1.3
45.20
4.15
u/ml
—
5
100
75
505
1.49
2.80
1.0
1.1
—
—
—
0
0
234
1884
1.25
2.77
3.0
3.3
1.40
2.03
index
1.40
118
953
82
570
1.44
2.63
1.8
1.6
21.26
23.03
u/ml
0.16
19
112
275
2269
1.22
2.61
1.5
1.6
0.30
0.32
mg/l
0.18
112
1023
1053
9613
1.11
2.58
1.5
1.5
—
—
—
0
0
213
1713
1.25
2.57
1.3
1.2
—
—
—
0
0
116
860
1.35
2.57
2.4
2.3
1.19
1.21
g/24h
0.02
65
496
12
44
2.73
2.54
2.6
1.5
—
—
—
0
0
48
300
1.60
2.52
3.4
3.1
24.19
25.76
mu/l
0.12
43
288
842
7606
1.12
2.50
3.8
4.2
13.81
24.54
ug/l
1.21
684
6233
115
856
1.35
2.49
1.4
1.4
—
—
—
0
0
38
224
1.70
2.49
1.2
1.4
577.33
236.15
nmol/24h
0.48
38
224
41
247
1.66
2.48
1.1
1.1
—
—
—
0
0
33
187
1.77
2.48
1.4
1.6
9.78
9.33
ug/l
0.28
33
187
102
746
1.37
2.47
3.9
3.6
57.88
57.29
%
0.09
86
639
133
1014
1.32
2.46
2.0
1.9
202.25
200.05
pmol/l
0.09
122
961
230
1879
1.23
2.43
1.4
1.4
—
—
—
0
0
325
2752
1.19
2.38
2.1
1.9
42.09
39.58
u/l
1.17
292
2411
403
3478
1.17
2.36
1.4
1.5
—
—
—
0
0
40
244
1.64
2.33
1.4
1.8
—
—
—
0
0
40
244
1.64
2.33
1.4
1.8
—
—
—
0
0
287
2409
1.20
2.32
1.4
1.4
32.22
32.37
iu/l
0.02
240
2076
469
4103
1.15
2.30
1.2
1.2
137.46
137.23
u/ml
0.00
152
1527
215
1758
1.23
2.27
1.5
1.6
—
—
—
0
0
203
1652
1.24
2.25
2.0
1.6
—
—
—
0
0
245
2033
1.21
2.25
1.2
1.3
47.71
43.73
u/ml
—
8
106
491
4319
1.15
2.23
6.9
6.7
24.56
24.60
mmol/l
0.10
471
4135
287
2422
1.19
2.21
2.6
2.7
—
—
—
0
0
50
327
1.53
2.20
1.2
1.2
149.54
133.88
nmol/l
1.25
50
327
24
128
1.88
2.20
1.3
1.2
—
—
—
0
0
59
400
1.48
2.20
1.0
1.0
—
0.62
—
0
5
76
541
1.41
2.20
1.2
1.2
—
—
—
0
0
58
393
1.48
2.17
2.3
2.5
232.18
228.04
e6/l
0.05
51
342
25
137
1.83
2.12
2.6
2.4
7.14
7.21
mmol/l
0.06
18
83
92
681
1.36
2.12
4.1
3.6
—
—
—
0
0
15
68
2.21
2.10
1.1
1.0
—
—
—
0
0
41
260
1.58
2.08
1.4
1.2
—
—
—
0
0
39
245
1.60
2.06
1.4
1.9
—
—
—
0
0
213
1762
1.22
2.05
1.9
2.4
196.51
199.48
%
0.20
205
1676
499
5607
0.88
2.00
4.4
4.0
1.23
1.23
mmol/l
0.09
442
4833
56
384
1.46
2.00
2.3
2.3
1092.33
536.03
e6/l
0.42
49
314
131
1029
1.28
2.00
1.1
1.1
3.21
2.08
u/ml
0.38
63
540
264
2238
1.19
1.97
1.3
1.3
—
—
—
0
0
66
469
1.41
1.96
1.6
1.8
—
—
—
0
0
9
34
2.65
1.86
1.0
1.0
—
—
—
0
0
13
59
2.21
1.84
1.1
1.0
—
—
—
0
0
116
909
1.28
1.83
1.3
1.3
304.86
330.41
pmol/l
0.30
102
772
52
359
1.45
1.82
1.6
1.4
1.39
1.25
nmol/l
0.36
36
258
18
94
1.92
1.79
1.4
1.3
—
—
—
0
0
231
1954
1.19
1.79
2.0
1.7
0.24
0.24
g/l
0.02
215
1859
69
504
1.37
1.78
1.2
1.2
—
—
—
0
0
181
1498
1.21
1.78
1.4
1.4
—
—
—
0
0
77
575
1.34
1.73
1.3
1.2
109.99
108.58
pmol/l
0.09
77
575
41
273
1.50
1.73
1.4
1.4
139.64
199.37
pmol/l
0.98
41
273
157
1285
1.23
1.73
1.4
1.4
—
—
—
0
0
67
490
1.37
1.72
1.2
1.2
—
—
—
0
0
156
1277
1.23
1.71
1.3
1.4
—
—
—
0
0
111
874
1.27
1.71
1.1
1.1
5.31
4.08
u/ml
0.31
54
428
96
742
1.30
1.71
1.4
1.3
32.80
33.10
u/l
0.03
70
608
80
603
1.33
1.70
1.2
1.2
—
—
—
0
0
424
3771
1.13
1.70
2.9
4.0
49.00
68.54
u/ml
1.53
414
3634
92
708
1.30
1.69
1.1
1.1
4.63
2.84
u/ml
0.58
44
338
16
82
1.95
1.69
1.0
1.1
—
—
—
0
0
236
2013
1.18
1.68
1.9
1.7
1.22
1.19
g/l
0.67
223
1918
205
1728
1.19
1.68
1.4
1.5
—
—
—
0
0
24
141
1.70
1.67
1.2
1.3
108.81
71.30
mu/l
0.24
15
106
86
657
1.31
1.67
1.1
1.1
7.08
3.52
u/ml
0.65
36
278
162
1337
1.22
1.66
4.2
5.2
303.25
1652.81
iu/ml
0.57
20
183
180
1501
1.20
1.66
1.8
1.8
337.54
306.59
mu/l
0.41
169
1369
72
537
1.34
1.65
1.2
1.2
—
—
—
0
0
24
142
1.69
1.64
1.2
1.2
—
—
—
0
0
15
76
1.98
1.64
7.8
6.6
36.47
50.02
ug/min
0.63
15
57
118
943
1.26
1.63
1.1
1.1
12.62
18.63
au/ml
0.32
17
196
185
1550
1.20
1.62
3.4
3.3
0.76
0.83
nmol/l
1.52
151
1247
145
1186
1.23
1.62
1.5
1.6
—
—
—
0
0
223
1901
1.18
1.61
3.1
2.9
1.57
1.63
mg/l
0.52
212
1710
69
514
1.35
1.60
1.2
1.2
—
—
—
0
0
107
848
1.27
1.59
1.1
1.1
0.97
1.07
u/ml
0.07
38
345
69
515
1.34
1.59
1.2
1.2
—
—
—
0
0
10
43
2.33
1.58
1.4
1.8
—
—
—
0
0
65
482
1.35
1.56
1.4
1.4
70.00
58.38
titre
—
7
37
67
500
1.34
1.55
1.4
1.4
80.00
469.76
titre
—
5
42
79
606
1.31
1.52
1.1
1.1
0.51
0.25
u/ml
0.46
28
199
181
1526
1.19
1.51
1.1
1.1
6.19
8.58
eliau/ml
0.25
15
153
449
4042
1.12
1.50
8.1
9.7
15.89
15.82
%
0.22
430
3896
107
856
1.25
1.49
2.2
2.3
440.49
687.73
u/ml
0.18
107
844
49
350
1.40
1.48
1.1
1.1
—
—
—
0
0
101
803
1.26
1.48
1.1
1.1
4.21
2.84
—
10
113
172
1450
1.19
1.45
2.8
2.4
121.64
91.86
ug/min
0.37
111
843
99
789
1.26
1.43
1.1
1.1
2.46
1.51
u/ml
0.56
51
382
63
474
1.33
1.41
1.2
1.3
8.35
9.01
mmol/l
0.65
56
453
114
926
1.23
1.40
5.8
6.4
12.22
12.34
mg/l
0.10
100
863
159
1336
1.19
1.40
1.2
1.3
—
—
—
0
0
159
1336
1.19
1.40
1.2
1.3
—
—
—
0
0
153
1283
1.20
1.38
2.2
2.0
4026.42
4427.04
u/l
0.09
57
506
47
339
1.39
1.37
1.2
1.6
—
—
—
0
0
47
339
1.39
1.37
1.2
1.6
—
—
—
0
0
72
555
1.30
1.37
5.4
5.4
245.31
74.46
u/ml
0.63
17
177
56
416
1.35
1.36
1.3
1.2
—
—
—
0
0
128
1057
1.21
1.36
2.7
2.5
16359.08
1326.34
u/ml
0.44
13
61
45
324
1.39
1.33
1.4
1.2
199.32
293.05
u/l
1.09
38
296
36
249
1.45
1.32
1.2
1.3
—
—
—
0
0
96
776
1.24
1.26
1.5
1.4
277.56
276.54
mosm/kgh2o
0.15
75
590
180
1546
1.17
1.25
3.5
3.5
317.50
729.11
u/ml
0.88
165
1400
321
2870
1.12
1.25
1.9
1.6
9.48
20.22
iu/ml
1.37
12
74
55
414
1.33
1.25
1.3
1.2
—
—
—
0
0
24
154
1.56
1.25
1.1
1.2
226.50
313.99
pmol/l
1.13
16
111
219
1910
1.15
1.25
1.3
1.3
5.80
4.58
u/ml
0.16
18
181
201
1744
1.16
1.23
2.0
2.0
12.01
11.95
mg/l
0.04
189
1615
44
321
1.37
1.22
1.7
1.7
11.53
6.30
nmol/l
0.25
37
261
10
49
2.04
1.22
1.2
1.0
—
—
—
0
0
219
1915
1.15
1.21
1.3
1.3
10.54
7.26
u/ml
0.29
30
288
16
93
1.72
1.21
1.1
1.1
—
—
—
0
0
53
400
1.33
1.20
1.5
1.6
3.39
4.14
ug/l
0.32
38
315
666
6192
1.08
1.19
1.6
1.7
1.42
1.49
%
2.14
567
5373
59
453
1.31
1.19
2.3
2.0
—
—
—
0
0
6
26
2.31
1.18
1.2
1.1
278.50
263.88
nmol/l
—
6
26
55
419
1.32
1.17
1.3
1.2
—
—
—
0
0
27
182
1.49
1.15
1.4
1.8
—
—
—
0
0
107
886
1.21
1.15
1.1
1.2
2.77
4.92
u/ml
2.10
48
390
87
705
1.24
1.15
1.6
1.6
—
—
—
0
0
28
191
1.47
1.13
1.1
1.1
—
—
—
0
0
115
1370
0.84
1.12
4.1
3.6
29.47
27.40
mg/l
0.24
74
963
14
81
1.73
1.08
1.4
1.2
57.14
75.22
ng/l
—
9
56
98
810
1.21
1.08
1.4
1.4
—
—
—
0
0
41
547
0.75
1.07
1.9
2.2
2.67
1.66
u/field
0.60
27
290
40
296
1.35
1.05
1.1
1.2
—
—
—
0
0
23
337
0.68
1.05
1.8
2.5
204.30
203.73
u/l
0.02
23
332
288
2593
1.12
1.04
1.3
1.3
0.24
1.09
u/ml
3.29
21
234
60
472
1.27
1.04
1.3
1.3
1.06
1.58
u/ml
0.32
38
277
135
1155
1.17
1.03
3.8
3.6
1.24
1.60
%
0.68
118
1028
99
824
1.20
1.03
1.1
1.1
123.35
117.18
%
1.22
88
732
5
22
2.27
1.03
4.6
4.4
—
—
—
0
0
26
179
1.45
1.02
1.1
1.1
—
—
—
0
0
13
75
1.73
1.02
1.0
2.0
—
—
—
0
0
5
110
0.45
0.99
6.2
7.0
8.20
10.39
%
—
5
110
38
282
1.35
0.99
1.0
1.0
1.05
1.25
u/ml
0.09
12
64
81
664
1.22
0.99
1.2
1.3
1.57
1.51
nmol/l
0.19
71
599
145
1253
1.16
0.99
1.2
1.3
142.00
334.44
titre
—
10
108
74
601
1.23
0.99
1.5
1.6
—
—
—
0
0
42
317
1.33
0.99
1.2
1.5
—
—
—
0
0
0
29
0.00
0.97
0.0
1.0
—
—
—
0
0
80
658
1.22
0.96
1.6
1.6
—
—
—
0
0
49
381
1.29
0.95
6.8
6.8
12.12
130.63
ug/l
1.21
26
233
79
651
1.22
0.93
1.3
1.4
235450.57
111017.04
e6/l
0.43
46
430
43
329
1.31
0.93
1.2
1.1
1.05
1.06
ratio
0.24
36
262
6
27
2.22
0.93
1.0
1.1
—
—
—
0
0
8
142
0.56
0.93
6.5
7.7
5.90
5.45
kpa
—
8
142
144
1252
1.15
0.92
1.2
1.3
80.00
207.86
titre
—
5
28
6
28
2.14
0.91
1.0
1.0
0.11
0.34
u/ml
—
6
21
18
118
1.53
0.90
1.7
1.4
—
—
—
0
0
102
865
1.18
0.90
1.0
1.1
—
—
—
0
0
1481
14264
1.05
0.90
1.7
1.7
18432463.40
28174237.92
pmol/l
0.36
1199
11784
21
143
1.47
0.89
1.0
1.2
0.81
0.67
umol/24h
—
8
66
39
297
1.31
0.88
1.4
2.1
136.86
131.92
umol/l
0.03
21
164
19
277
0.69
0.87
19.7
17.4
1646.58
1387.27
nmol/l
1.04
19
271
22
312
0.70
0.87
1.2
1.3
92.20
61.79
%
—
5
39
28
203
1.38
0.87
1.5
1.2
0.29
0.31
g/l
0.54
21
161
22
153
1.44
0.85
1.0
1.1
—
—
—
0
0
169
1498
1.13
0.84
1.2
1.2
45.04
44.25
u/ml
0.02
12
158
89
752
1.19
0.83
1.6
1.4
0.52
0.34
nmol/l
0.87
61
546
315
2891
1.09
0.83
2.0
1.9
1.99
2.28
ug/l
0.20
274
2561
37
283
1.31
0.83
1.9
1.2
151.19
156.55
mmol/24h
0.18
37
283
8
46
1.74
0.82
4.5
6.2
11.88
8.11
%
—
8
46
61
498
1.23
0.82
1.2
1.2
297.50
145.36
titre
—
8
84
61
498
1.23
0.82
1.2
1.2
104.00
105.71
titre
—
5
14
202
1815
1.12
0.81
1.8
2.0
3.75
7.05
iu/l
0.50
73
723
94
801
1.18
0.81
1.5
1.6
50.69
58.72
%
1.11
54
496
157
1390
1.13
0.81
1.4
1.4
60.42
61.49
mmol/l
0.11
128
1118
463
4325
1.08
0.80
3.6
3.2
128.69
127.73
g/l
0.41
450
4191
6
33
1.82
0.79
1.2
1.1
—
—
—
0
0
122
1064
1.15
0.79
1.4
1.4
—
—
—
0
0
27
199
1.36
0.78
1.1
1.1
—
—
—
0
0
36
278
1.30
0.77
1.1
4.2
5490.68
813.28
mg/l
0.40
28
194
105
908
1.16
0.76
1.1
1.2
2.26
3.57
u/ml
1.17
35
323
77
649
1.19
0.76
1.3
1.5
—
—
—
0
0
52
422
1.23
0.75
2.2
2.0
17.54
17.23
nmol/l
0.09
47
396
23
166
1.39
0.75
1.3
1.2
—
—
—
0
0
7
38
1.84
0.73
1.0
1.2
54.29
71.26
ug/l
—
7
38
5
25
2.00
0.72
1.0
1.3
—
—
—
0
0
215
1955
1.10
0.72
1.4
1.7
4.33
4.46
mg/l
0.05
154
1487
43
345
1.25
0.70
1.1
1.1
—
—
—
0
0
76
647
1.18
0.69
3.4
2.9
—
—
—
0
0
21
152
1.38
0.69
1.0
1.0
12.37
11.40
u/ml
0.05
12
101
27
204
1.32
0.68
1.4
2.1
190.07
183.77
%
0.08
27
192
7
42
1.67
0.68
8.0
5.9
—
—
—
0
0
49
401
1.22
0.67
1.3
1.6
5.31
6.18
u/l
0.68
40
346
31
240
1.29
0.67
1.1
1.4
—
—
—
0
0
5
28
1.79
0.66
1.0
1.0
0.01
0.14
u/ml
—
5
28
53
439
1.21
0.65
1.4
1.5
62.53
59.41
ug/l
0.19
53
439
32
250
1.28
0.65
2.4
2.3
48.76
51.53
umol/l
0.24
27
215
23
171
1.35
0.65
2.3
2.8
2.46
2.06
ratio
0.44
17
152
27
206
1.31
0.65
2.1
1.6
0.36
0.40
ug/l
0.25
22
137
7
44
1.59
0.65
1.1
1.8
11.41
20.51
pmol/l
—
7
35
59
496
1.19
0.63
1.4
1.8
9.91
8.46
umol/l
0.14
44
351
28
217
1.29
0.61
2.7
2.8
28.26
28.63
umol/l
0.07
23
160
0
20
0.00
0.60
0.0
1.0
—
—
—
0
0
8
51
1.57
0.60
1.1
1.1
92.00
90.98
titre
—
8
51
0
21
0.00
0.60
0.0
5.8
—
369.14
—
0
21
0
22
0.00
0.59
0.0
1.2
—
1.08
—
0
13
58
491
1.18
0.59
1.0
1.0
295.36
292.08
mg/l
0.12
50
443
80
696
1.15
0.58
1.3
1.2
7.13
7.50
mmol/l
0.57
72
609
100
884
1.13
0.58
1.9
1.9
23.66
24.69
ug/l
0.10
100
868
47
392
1.20
0.56
1.6
1.7
—
—
—
0
0
6
36
1.67
0.56
2.3
2.1
—
—
—
0
0
29
229
1.27
0.56
1.1
1.0
94.65
93.96
%
0.05
23
168
8
55
1.46
0.56
1.0
1.1
8.88
15.35
u/l
—
8
55
132
1461
0.90
0.56
1.1
1.1
0.53
0.61
ratio
0.90
18
235
24
185
1.30
0.56
1.4
1.2
—
—
—
0
0
6
37
1.62
0.55
1.0
1.5
216.33
337.27
umol/24h
—
6
37
16
116
1.38
0.54
1.9
2.0
—
—
—
0
0
16
116
1.38
0.54
1.9
2.0
—
—
—
0
0
36
294
1.23
0.54
1.3
1.3
5.49
5.98
mmol/l
2.13
36
279
21
160
1.31
0.53
1.6
1.5
—
—
—
0
0
30
241
1.25
0.52
1.4
1.2
—
—
—
0
0
159
1456
1.09
0.51
1.3
1.3
220.61
220.75
miu/ml
0.00
76
630
29
233
1.25
0.50
2.2
2.7
0.62
0.61
mmol/l
0.36
29
233
43
509
0.84
0.49
1.4
1.4
13.09
13.14
u/l
0.01
43
488
133
1211
1.10
0.49
1.5
1.8
1.09
0.85
nmol/l
1.21
107
1026
80
902
0.89
0.49
1.1
1.1
39.04
13377.48
iu/ml
0.55
14
178
35
289
1.21
0.48
6.9
5.2
29.86
52.61
u/ml
—
7
46
7
47
1.49
0.47
1.0
1.2
—
—
—
0
0
12
85
1.41
0.46
1.3
1.1
—
—
—
0
0
51
439
1.16
0.46
1.0
1.1
7.97
9.56
iu/ml
—
9
116
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
251
2356
1.07
0.46
3.6
3.0
0.37
0.34
iu/ml
0.52
132
1296
100
902
1.11
0.45
1.8
2.3
32.99
32.48
pg
0.65
100
894
328
3107
1.06
0.45
3.6
3.4
25.33
25.22
mmol/l
0.27
315
3012
90
808
1.12
0.45
5.3
5.2
339.32
352.14
umol/l
0.38
85
708
55
478
1.15
0.44
2.7
2.3
784.07
632.08
ml
1.31
45
313
118
1293
0.91
0.44
3.0
3.8
25.44
35.56
u/ml
1.13
113
1260
11
152
0.72
0.44
1.2
1.1
—
—
—
0
0
7
51
1.37
0.44
1.1
1.3
43.14
1537.31
u/l
—
7
45
62
703
0.88
0.43
1.3
1.4
6.75
6.30
mmol/l
0.69
57
657
32
266
1.20
0.43
1.1
1.1
152.57
345.11
ng/l
—
7
71
11
78
1.41
0.43
1.2
1.1
—
—
—
0
0
72
640
1.13
0.43
1.1
1.1
94.07
95.68
%
0.26
67
595
137
1486
0.92
0.42
1.4
1.5
—
—
—
0
0
36
304
1.19
0.41
2.6
1.7
42.13
39.75
g/l
2.30
36
304
151
1398
1.08
0.41
2.0
2.6
33.92
33.31
umol/l
0.11
133
1256
27
222
1.22
0.40
1.2
1.1
—
—
—
0
0
23
186
1.24
0.40
1.3
1.3
43.23
34.04
%
0.40
13
126
81
730
1.11
0.39
1.1
1.1
2.30
3.42
eliau/ml
0.87
30
297
0
19
0.00
0.39
0.0
1.0
—
—
—
0
0
38
325
1.17
0.39
1.6
1.9
1.24
2.78
u/field
1.39
31
229
136
1466
0.93
0.37
6.4
7.2
104.96
105.06
mmol/l
0.08
118
1316
136
1465
0.93
0.37
6.4
7.1
11.25
11.25
mmol/l
0.00
118
1314
1802
17717
1.02
0.36
3.8
3.7
0.51
0.29
estimate
0.21
570
5631
5
77
0.65
0.35
1.2
1.1
—
—
—
0
0
158
1688
0.93
0.35
2.4
2.2
123.81
127.40
g/l
0.96
118
1299
70
632
1.11
0.34
1.2
1.3
—
—
—
0
0
275
2621
1.05
0.34
3.0
3.4
1760.57
2758.83
u/ml
0.30
242
2251
33
283
1.17
0.34
1.0
1.1
1263.94
1562.55
miu/ml
1.04
33
283
12
91
1.32
0.33
1.3
1.0
—
—
—
0
0
40
349
1.15
0.33
3.4
3.9
—
—
—
0
0
23
191
1.20
0.33
1.1
1.7
—
—
—
0
0
71
782
0.91
0.33
1.3
1.4
48780.13
60314.06
e6/l
0.23
45
428
39
341
1.14
0.32
1.3
1.4
—
—
—
0
0
39
341
1.14
0.32
1.3
1.4
—
—
—
0
0
23
192
1.20
0.32
1.1
1.3
159.46
119.09
nmol/l
0.50
15
136
89
819
1.09
0.31
1.9
1.8
90.38
89.54
%
1.11
89
808
26
221
1.18
0.30
1.3
1.2
40.21
38.62
g/l
0.27
13
105
21
250
0.84
0.30
2.1
2.1
356.58
4001.27
e6/l
0.59
12
168
38
430
0.88
0.29
1.5
1.5
6.27
6.85
u/l
0.13
30
347
285
2967
0.96
0.28
4.7
5.3
0.87
0.87
%
0.07
267
2810
9
116
0.78
0.27
1.0
1.1
11.29
37.62
iu/ml
—
9
116
8
66
1.21
0.26
2.3
2.6
0.63
0.62
u/field
—
8
66
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
28
321
0.87
0.26
1.2
1.1
—
—
—
0
0
70
760
0.92
0.26
1.3
1.2
54.71
62.45
u/l
1.00
62
665
86
925
0.93
0.26
1.4
1.6
—
—
—
0
0
130
1226
1.06
0.26
1.5
1.6
987.89
1034.00
mu/l
0.32
108
994
18
214
0.84
0.26
1.2
1.9
16493.57
21311.13
e6/l
—
7
111
33
291
1.13
0.26
1.3
1.4
—
1088053.77
—
0
13
9
73
1.23
0.25
1.1
1.1
—
—
—
0
0
19
160
1.19
0.25
1.2
1.1
720.00
897.22
titre
—
5
36
57
521
1.09
0.25
3.3
2.6
16.16
29.63
mg/l
5.71
45
378
82
881
0.93
0.24
1.3
1.5
2657.82
3366.62
e6/l
0.21
67
611
169
1612
1.05
0.23
1.2
1.3
529.14
555.64
mg/l
0.32
162
1530
69
639
1.08
0.23
1.1
1.1
—
4.59
—
0
9
12
147
0.82
0.23
1.0
2.0
2.47
2.15
ug/l
—
7
82
15
179
0.84
0.23
1.1
1.1
—
—
—
0
0
16
134
1.19
0.22
1.1
1.1
—
—
—
0
0
5
41
1.22
0.22
1.0
1.0
—
—
—
0
0
74
793
0.93
0.22
4.5
13.7
7.35
7.35
mmol/l
0.00
61
667
0
10
0.00
0.21
0.0
6.7
—
—
—
0
0
0
12
0.00
0.21
0.0
3.4
—
—
—
0
0
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
29
325
0.89
0.21
1.0
1.1
1.04
1.16
u/l
0.85
11
148
0
13
0.00
0.21
0.0
1.5
—
1.36
—
0
13
515
5269
0.98
0.21
2.0
2.0
3.50
3.39
ratio
1.11
395
4117
82
770
1.07
0.20
2.5
3.1
11.16
10.74
mmol/l
0.55
82
760
60
557
1.08
0.20
1.1
1.1
—
—
—
0
0
14
165
0.85
0.19
1.1
1.1
—
—
—
0
0
38
346
1.10
0.19
1.1
1.1
19.89
19.52
u/ml
0.02
14
139
31
279
1.11
0.19
1.5
1.5
29.57
29.50
umol/l
0.01
31
262
13
154
0.84
0.19
1.2
1.3
—
—
—
0
0
37
337
1.10
0.19
1.2
1.2
—
—
—
0
0
91
861
1.06
0.18
1.6
1.5
—
—
—
0
0
10
81
1.23
0.18
1.4
1.1
—
—
—
0
0
18
206
0.87
0.18
1.1
1.1
—
—
—
0
0
18
206
0.87
0.18
1.1
1.3
3.74
330.94
ug/l
—
10
99
40
368
1.09
0.17
1.1
1.1
—
1.55
—
0
7
5
67
0.75
0.17
1.0
1.0
—
—
—
0
0
5
67
0.75
0.17
1.0
1.1
—
—
—
0
0
148
1424
1.04
0.16
1.2
1.2
3.68
3.80
mmol/l
0.72
136
1343
13
152
0.85
0.16
4.2
2.3
3440.77
238.66
ug/l
0.43
13
152
135
1403
0.96
0.16
1.3
1.4
1352.37
1180.07
e6/l
0.07
103
1103
220
2137
1.03
0.15
1.3
1.4
—
—
—
0
0
22
197
1.12
0.15
1.2
1.2
20.02
10.31
pmol/l
—
7
72
62
657
0.94
0.15
1.5
1.4
1.19
1.19
ratio
0.01
30
390
62
657
0.94
0.15
1.5
1.4
0.90
0.94
ratio
0.44
30
388
62
657
0.94
0.15
1.5
1.4
0.93
1.16
ratio
2.06
30
388
9
80
1.13
0.15
1.3
1.5
—
—
—
0
0
12
102
1.18
0.15
2.5
1.9
67.10
50.99
pmol/l
0.23
12
85
41
441
0.93
0.15
1.3
1.5
13.03
12.98
umol/l
0.02
36
411
9
81
1.11
0.15
3.9
5.7
—
1975.83
—
0
6
32
295
1.09
0.14
3.4
3.3
1.78
1.33
%
0.50
32
295
198
1926
1.03
0.13
1.5
1.7
—
—
—
0
0
42
449
0.94
0.13
1.6
1.5
—
—
—
0
0
57
539
1.06
0.13
1.6
1.5
—
—
—
0
0
34
366
0.93
0.13
1.0
1.3
—
—
—
0
0
16
179
0.89
0.12
1.1
1.1
—
—
—
0
0
20
181
1.11
0.12
1.4
1.1
95.86
88.10
%
—
7
92
31
288
1.08
0.11
2.0
2.0
67.92
56.89
ug/l
0.49
31
281
134
1381
0.97
0.11
1.3
1.3
17.98
28.17
e6/l
0.55
96
1016
63
601
1.05
0.11
1.4
1.5
29.78
30.91
%
0.08
37
358
13
147
0.88
0.11
1.1
1.5
1.18
1.18
mmol/l
0.09
13
147
25
271
0.92
0.11
1.5
1.5
2.12
1.98
umol/l
0.39
25
248
62
649
0.95
0.11
1.5
1.4
—
—
—
0
0
141
1371
1.03
0.11
4.4
4.3
2.46
2.62
mmol/l
0.31
101
956
13
115
1.13
0.10
1.3
1.2
—
79.32
—
0
31
38
403
0.94
0.10
3.2
2.0
7.98
8.02
mmol/l
0.03
38
403
11
96
1.15
0.10
1.2
1.6
—
0.80
—
0
8
20
218
0.92
0.10
6.3
3.2
10.05
10.19
kpa
0.06
20
218
5
44
1.14
0.10
1.2
1.3
1.43
0.85
ml/s/173m2
—
5
31
15
135
1.11
0.09
2.7
3.2
53.33
143.12
ng/l
—
6
45
5
47
1.06
0.09
1.2
1.2
—
—
—
0
0
16
176
0.91
0.09
1.1
1.1
—
—
—
0
0
(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay
13
116
1.12
0.09
1.3
1.2
—
77.67
—
0
30
20
217
0.92
0.09
6.3
3.2
5.23
4.91
kpa
0.59
20
217
68
706
0.96
0.09
1.5
1.5
55.01
60.97
ug/l
0.54
51
575
42
399
1.05
0.09
1.6
1.5
—
—
—
0
0
50
478
1.05
0.09
1.1
1.0
303.79
327.77
ng/l
0.27
34
334
6
57
1.05
0.08
1.3
1.2
5.88
6.05
mmol/l
—
6
57
6
57
1.05
0.08
1.0
1.0
—
—
—
0
0
89
864
1.03
0.08
1.5
1.5
—
—
—
0
0
5
64
0.78
0.08
1.0
1.0
—
—
—
0
0
7
68
1.03
0.07
1.0
1.2
1.43
1.68
umol/24h
—
7
68
7
68
1.03
0.07
1.1
1.4
—
—
—
0
0
30
317
0.95
0.07
1.2
1.2
—
—
—
0
0
41
392
1.05
0.07
1.0
1.1
—
—
—
0
0
12
108
1.11
0.07
1.2
1.3
—
—
—
0
0
176
1729
1.02
0.07
1.6
1.8
—
30.85
—
0
5
31
326
0.95
0.07
1.6
2.2
104.68
98.17
%
0.53
31
308
54
559
0.97
0.06
1.6
1.5
—
—
—
0
0
29
305
0.95
0.06
1.1
1.1
—
—
—
0
0
88
859
1.02
0.06
1.1
1.1
1.56
1.53
g/l
0.21
76
775
49
506
0.97
0.05
1.4
1.3
—
—
—
0
0
691
6869
1.01
0.05
3.5
3.6
—
—
—
0
0
20
212
0.94
0.05
1.1
1.1
—
—
—
0
0
50
485
1.03
0.05
1.1
1.0
41.96
42.42
ng/l
0.02
34
333
11
101
1.09
0.04
1.5
1.6
—
—
—
0
0
381
3836
0.99
0.04
1.7
1.7
3.40
3.46
mmol/l
0.39
261
2705
320
3223
0.99
0.03
4.4
5.1
1.65
1.59
%
0.30
302
3057
35
339
1.03
0.03
2.1
2.3
—
—
—
0
0
345
3472
0.99
0.03
3.4
3.6
1.02
1.02
ratio
0.02
308
3145
52
509
1.02
0.03
1.2
1.2
—
—
—
0
0
78
768
1.02
0.03
1.0
1.1
—
—
—
0
0
70
711
0.98
0.02
1.2
1.3
—
32.46
u/ml
—
0
5
105
1062
0.99
0.02
1.3
1.2
283.60
278.32
u/ml
0.06
62
644
68
670
1.02
0.02
3.3
3.3
10.94
13.18
index
1.17
35
364
23
238
0.97
0.02
1.4
1.3
8.00
11.64
mm/h
1.32
23
238
10
93
1.08
0.02
1.1
1.2
—
—
—
0
0
104
1030
1.01
0.02
1.6
1.4
160.94
154.14
au/ml
0.28
33
290
17
177
0.96
0.01
1.1
1.1
—
4.43
—
0
7
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
19
183
1.04
0.01
1.5
1.2
107.11
104.84
%
0.12
19
170
58
572
1.01
0.01
2.2
2.4
29.74
28.04
iu/ml
—
9
77
86
854
1.01
0.00
1.1
1.1
—
—
—
0
0
14
137
1.02
0.00
1.0
1.2
—
—
—
0
0
48
483
0.99
0.00
1.1
1.0
686.38
717.05
ng/l
0.20
32
325
43
434
0.99
0.00
1.3
1.2
14.41
25.03
u/l
2.20
34
361
45
446
1.01
0.00
1.3
1.2
69.03
91.51
u/l
2.64
36
380
49
494
0.99
0.00
1.4
1.3
—
—
—
0
0
42
415
1.01
0.00
1.6
1.5
—
—
—
0
0
31
312
0.99
0.00
1.2
1.2
0.50
0.56
ratio
0.92
20
188
13
129
1.01
0.00
1.0
1.1
—
16.00
u/ml
—
0
7
18
179
1.01
0.00
1.4
1.3
84.00
87.35
%
—
6
93
39
391
1.00
0.00
1.5
1.6
80.00
82.81
umol/l
0.20
39
391
0
6
0.00
0.00
0.0
1.0
—
16.67
—
0
6
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
5
52
0.96
0.00
1.0
1.1
—
—
—
0
0
0
6
0.00
0.00
0.0
1.2
—
1.00
—
0
6
5
52
0.96
0.00
4.4
5.3
—
—
—
0
0
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
7
78
0.90
-0.00
1.0
1.1
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.6
—
26.93
—
0
7
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
8
79
1.01
-0.00
1.1
1.0
—
—
—
0
0
6
59
1.02
-0.00
1.0
1.1
—
—
—
0
0
6
62
0.97
-0.00
1.2
1.6
1.39
1.37
umol/l
—
6
42
7
75
0.93
-0.00
1.1
1.6
0.37
0.48
e9/l
—
7
75
9
93
0.97
-0.00
1.3
2.0
15.21
18.21
umol/l
—
9
93
6
68
0.88
-0.00
1.3
2.0
—
—
—
0
0
9
92
0.98
-0.00
7.9
11.4
4.33
5.14
mmol/l
—
9
92
8
85
0.94
-0.00
1.1
1.2
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: CD2_BENIGN_SKIN_EYELID – Benign neoplasm: Skin of eyelid, including canthus
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).